id	sid	tid	token	lemma	pos
easat-1678	1	1	edelweiss	edelweiss	PROPN
easat-1678	1	2	applied	apply	VERB
easat-1678	1	3	science	science	NOUN
easat-1678	1	4	and	and	CCONJ
easat-1678	1	5	technology	technology	NOUN
easat-1678	1	6	issn	issn	PROPN
easat-1678	1	7	:	:	PUNCT
easat-1678	1	8	2576	2576	NUM
easat-1678	1	9	-	-	SYM
easat-1678	1	10	8484	8484	NUM
easat-1678	1	11	vol	vol	NOUN
easat-1678	1	12	.	.	PROPN
easat-1678	1	13	8	8	NUM
easat-1678	1	14	,	,	PUNCT
easat-1678	1	15	no	no	INTJ
easat-1678	1	16	.	.	NOUN
easat-1678	1	17	3	3	NUM
easat-1678	1	18	,	,	PUNCT
easat-1678	1	19	523	523	NUM
easat-1678	1	20	-	-	SYM
easat-1678	1	21	532	532	NUM
easat-1678	1	22	2024	2024	NUM
easat-1678	1	23	publisher	publisher	NOUN
easat-1678	1	24	:	:	PUNCT
easat-1678	1	25	learning	learn	VERB
easat-1678	1	26	gate	gate	NOUN
easat-1678	1	27	doi	doi	PROPN
easat-1678	1	28	:	:	PUNCT
easat-1678	1	29	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	1	30	©	©	PROPN
easat-1678	1	31	2024	2024	NUM
easat-1678	1	32	by	by	ADP
easat-1678	1	33	the	the	DET
easat-1678	1	34	authors	author	NOUN
easat-1678	1	35	;	;	PUNCT
easat-1678	1	36	licensee	licensee	PROPN
easat-1678	1	37	learning	learning	NOUN
easat-1678	1	38	gate	gate	NOUN
easat-1678	1	39	©	©	PROPN
easat-1678	1	40	2024	2024	NUM
easat-1678	1	41	by	by	ADP
easat-1678	1	42	the	the	DET
easat-1678	1	43	authors	author	NOUN
easat-1678	1	44	;	;	PUNCT
easat-1678	1	45	licensee	licensee	PROPN
easat-1678	1	46	learning	learn	VERB
easat-1678	1	47	gate	gate	NOUN
easat-1678	1	48	*	*	PUNCT
easat-1678	1	49	correspondence	correspondence	NOUN
easat-1678	1	50	:	:	PUNCT
easat-1678	2	1	maythambio@gmail.com	maythambio@gmail.com	X
easat-1678	2	2	levels	level	NOUN
easat-1678	2	3	of	of	ADP
easat-1678	2	4	il-18	il-18	PUNCT
easat-1678	2	5	and	and	CCONJ
easat-1678	2	6	il-28	il-28	ADV
easat-1678	2	7	in	in	ADP
easat-1678	2	8	thalassemia	thalassemia	NOUN
easat-1678	2	9	patients	patient	NOUN
easat-1678	2	10	with	with	ADP
easat-1678	2	11	viral	viral	ADJ
easat-1678	2	12	infections	infection	NOUN
easat-1678	2	13	maytham	maytham	VERB
easat-1678	2	14	khazaal	khazaal	NOUN
easat-1678	2	15	kadhim1	kadhim1	PROPN
easat-1678	2	16	*	*	PROPN
easat-1678	2	17	,	,	PUNCT
easat-1678	2	18	kais	kais	PROPN
easat-1678	2	19	kassim	kassim	PROPN
easat-1678	2	20	ghaima2	ghaima2	PROPN
easat-1678	3	1	1,2institute	1,2institute	NUM
easat-1678	3	2	of	of	ADP
easat-1678	3	3	genetic	genetic	ADJ
easat-1678	3	4	engineering	engineering	NOUN
easat-1678	3	5	and	and	CCONJ
easat-1678	3	6	biotechnology	biotechnology	NOUN
easat-1678	3	7	for	for	ADP
easat-1678	3	8	postgraduate	postgraduate	NOUN
easat-1678	3	9	studies	study	NOUN
easat-1678	3	10	,	,	PUNCT
easat-1678	3	11	university	university	NOUN
easat-1678	3	12	of	of	ADP
easat-1678	3	13	baghdad	baghdad	PROPN
easat-1678	3	14	,	,	PUNCT
easat-1678	3	15	iraq	iraq	PROPN
easat-1678	3	16	;	;	PUNCT
easat-1678	3	17	maythambio@gmail.com	maythambio@gmail.com	X
easat-1678	3	18	(	(	PUNCT
easat-1678	3	19	m.k.k	m.k.k	ADJ
easat-1678	3	20	.	.	PUNCT
easat-1678	3	21	)	)	PUNCT
easat-1678	3	22	,	,	PUNCT
easat-1678	3	23	kaisskasim22@ige.uobaghdad.edu.iq	kaisskasim22@ige.uobaghdad.edu.iq	PROPN
easat-1678	3	24	(	(	PUNCT
easat-1678	3	25	k.k.g	k.k.g	PROPN
easat-1678	3	26	.	.	PUNCT
easat-1678	3	27	)	)	PUNCT
easat-1678	3	28	.	.	PUNCT
easat-1678	4	1	abstract	abstract	ADJ
easat-1678	4	2	:	:	PUNCT
easat-1678	4	3	thalassemia	thalassemia	NOUN
easat-1678	4	4	is	be	AUX
easat-1678	4	5	an	an	DET
easat-1678	4	6	inherited	inherit	VERB
easat-1678	4	7	hemoglobin	hemoglobin	NOUN
easat-1678	4	8	disorder	disorder	NOUN
easat-1678	4	9	that	that	PRON
easat-1678	4	10	requires	require	VERB
easat-1678	4	11	lifelong	lifelong	ADJ
easat-1678	4	12	medical	medical	ADJ
easat-1678	4	13	care	care	NOUN
easat-1678	4	14	.	.	PUNCT
easat-1678	5	1	patients	patient	NOUN
easat-1678	5	2	with	with	ADP
easat-1678	5	3	thalassemia	thalassemia	NOUN
easat-1678	5	4	are	be	AUX
easat-1678	5	5	very	very	ADV
easat-1678	5	6	prone	prone	ADJ
easat-1678	5	7	to	to	ADP
easat-1678	5	8	infections	infection	NOUN
easat-1678	5	9	by	by	ADP
easat-1678	5	10	viruses	virus	NOUN
easat-1678	5	11	,	,	PUNCT
easat-1678	5	12	which	which	PRON
easat-1678	5	13	may	may	AUX
easat-1678	5	14	exacerbate	exacerbate	VERB
easat-1678	5	15	their	their	PRON
easat-1678	5	16	condition	condition	NOUN
easat-1678	5	17	,	,	PUNCT
easat-1678	5	18	leading	lead	VERB
easat-1678	5	19	to	to	ADP
easat-1678	5	20	serious	serious	ADJ
easat-1678	5	21	complications	complication	NOUN
easat-1678	5	22	.	.	PUNCT
easat-1678	6	1	knowledge	knowledge	NOUN
easat-1678	6	2	of	of	ADP
easat-1678	6	3	the	the	DET
easat-1678	6	4	immune	immune	ADJ
easat-1678	6	5	response	response	NOUN
easat-1678	6	6	in	in	ADP
easat-1678	6	7	these	these	DET
easat-1678	6	8	patients	patient	NOUN
easat-1678	6	9	could	could	AUX
easat-1678	6	10	be	be	AUX
easat-1678	6	11	very	very	ADV
easat-1678	6	12	helpful	helpful	ADJ
easat-1678	6	13	in	in	ADP
easat-1678	6	14	the	the	DET
easat-1678	6	15	effective	effective	ADJ
easat-1678	6	16	management	management	NOUN
easat-1678	6	17	of	of	ADP
easat-1678	6	18	their	their	PRON
easat-1678	6	19	disease	disease	NOUN
easat-1678	6	20	.	.	PUNCT
easat-1678	7	1	the	the	DET
easat-1678	7	2	levels	level	NOUN
easat-1678	7	3	of	of	ADP
easat-1678	7	4	il-18	il-18	PUNCT
easat-1678	7	5	and	and	CCONJ
easat-1678	7	6	il-28	il-28	ADV
easat-1678	7	7	were	be	AUX
easat-1678	7	8	evaluated	evaluate	VERB
easat-1678	7	9	in	in	ADP
easat-1678	7	10	thalassemia	thalassemia	NOUN
easat-1678	7	11	patients	patient	NOUN
easat-1678	7	12	with	with	ADP
easat-1678	7	13	different	different	ADJ
easat-1678	7	14	viral	viral	ADJ
easat-1678	7	15	infections	infection	NOUN
easat-1678	7	16	to	to	PART
easat-1678	7	17	assess	assess	VERB
easat-1678	7	18	their	their	PRON
easat-1678	7	19	potential	potential	NOUN
easat-1678	7	20	as	as	ADP
easat-1678	7	21	biomarkers	biomarker	NOUN
easat-1678	7	22	and	and	CCONJ
easat-1678	7	23	therapeutic	therapeutic	ADJ
easat-1678	7	24	targets	target	NOUN
easat-1678	7	25	.	.	PUNCT
easat-1678	8	1	this	this	PRON
easat-1678	8	2	was	be	AUX
easat-1678	8	3	a	a	DET
easat-1678	8	4	retrospective	retrospective	ADJ
easat-1678	8	5	analysis	analysis	NOUN
easat-1678	8	6	of	of	ADP
easat-1678	8	7	clinical	clinical	ADJ
easat-1678	8	8	data	datum	NOUN
easat-1678	8	9	on	on	ADP
easat-1678	8	10	thalassemia	thalassemia	NOUN
easat-1678	8	11	patients	patient	NOUN
easat-1678	8	12	with	with	ADP
easat-1678	8	13	viral	viral	ADJ
easat-1678	8	14	infections	infection	NOUN
easat-1678	8	15	.	.	PUNCT
easat-1678	9	1	demographic	demographic	ADJ
easat-1678	9	2	,	,	PUNCT
easat-1678	9	3	clinical	clinical	ADJ
easat-1678	9	4	,	,	PUNCT
easat-1678	9	5	laboratory	laboratory	NOUN
easat-1678	9	6	,	,	PUNCT
easat-1678	9	7	il-18	il-18	ADP
easat-1678	9	8	,	,	PUNCT
easat-1678	9	9	and	and	CCONJ
easat-1678	9	10	il-28	il-28	NUM
easat-1678	9	11	data	datum	NOUN
easat-1678	9	12	at	at	ADP
easat-1678	9	13	baseline	baseline	NOUN
easat-1678	9	14	were	be	AUX
easat-1678	9	15	included	include	VERB
easat-1678	9	16	in	in	ADP
easat-1678	9	17	the	the	DET
easat-1678	9	18	study	study	NOUN
easat-1678	9	19	.	.	PUNCT
easat-1678	10	1	in	in	ADP
easat-1678	10	2	the	the	DET
easat-1678	10	3	present	present	ADJ
easat-1678	10	4	study	study	NOUN
easat-1678	10	5	,	,	PUNCT
easat-1678	10	6	the	the	DET
easat-1678	10	7	authors	author	NOUN
easat-1678	10	8	assessed	assess	VERB
easat-1678	10	9	the	the	DET
easat-1678	10	10	correlations	correlation	NOUN
easat-1678	10	11	between	between	ADP
easat-1678	10	12	interleukin	interleukin	NOUN
easat-1678	10	13	levels	level	NOUN
easat-1678	10	14	,	,	PUNCT
easat-1678	10	15	viral	viral	ADJ
easat-1678	10	16	infection	infection	NOUN
easat-1678	10	17	,	,	PUNCT
easat-1678	10	18	treatment	treatment	NOUN
easat-1678	10	19	response	response	NOUN
easat-1678	10	20	,	,	PUNCT
easat-1678	10	21	and	and	CCONJ
easat-1678	10	22	overall	overall	ADJ
easat-1678	10	23	survival	survival	NOUN
easat-1678	10	24	.	.	PUNCT
easat-1678	11	1	the	the	DET
easat-1678	11	2	study	study	NOUN
easat-1678	11	3	enrolled	enrol	VERB
easat-1678	11	4	250	250	NUM
easat-1678	11	5	patients	patient	NOUN
easat-1678	11	6	with	with	ADP
easat-1678	11	7	thalassemia	thalassemia	NOUN
easat-1678	11	8	and	and	CCONJ
easat-1678	11	9	different	different	ADJ
easat-1678	11	10	viral	viral	ADJ
easat-1678	11	11	infections	infection	NOUN
easat-1678	11	12	.	.	PUNCT
easat-1678	12	1	in	in	ADP
easat-1678	12	2	these	these	DET
easat-1678	12	3	patients	patient	NOUN
easat-1678	12	4	,	,	PUNCT
easat-1678	12	5	the	the	DET
easat-1678	12	6	levels	level	NOUN
easat-1678	12	7	of	of	ADP
easat-1678	12	8	il-18	il-18	PUNCT
easat-1678	12	9	and	and	CCONJ
easat-1678	12	10	il-28	il-28	ADV
easat-1678	12	11	were	be	AUX
easat-1678	12	12	found	find	VERB
easat-1678	12	13	to	to	PART
easat-1678	12	14	be	be	AUX
easat-1678	12	15	elevated	elevate	VERB
easat-1678	12	16	with	with	ADP
easat-1678	12	17	a	a	DET
easat-1678	12	18	significant	significant	ADJ
easat-1678	12	19	correlation	correlation	NOUN
easat-1678	12	20	to	to	ADP
easat-1678	12	21	viral	viral	ADJ
easat-1678	12	22	load	load	NOUN
easat-1678	12	23	.	.	PUNCT
easat-1678	13	1	thus	thus	ADV
easat-1678	13	2	,	,	PUNCT
easat-1678	13	3	a	a	DET
easat-1678	13	4	higher	high	ADJ
easat-1678	13	5	baseline	baseline	NOUN
easat-1678	13	6	interleukin	interleukin	NOUN
easat-1678	13	7	level	level	NOUN
easat-1678	13	8	predicted	predict	VERB
easat-1678	13	9	a	a	DET
easat-1678	13	10	better	well	ADJ
easat-1678	13	11	treatment	treatment	NOUN
easat-1678	13	12	response	response	NOUN
easat-1678	13	13	and	and	CCONJ
easat-1678	13	14	overall	overall	ADJ
easat-1678	13	15	survival	survival	NOUN
easat-1678	13	16	.	.	PUNCT
easat-1678	14	1	elevations	elevation	NOUN
easat-1678	14	2	in	in	ADP
easat-1678	14	3	il-18	il-18	PUNCT
easat-1678	14	4	and	and	CCONJ
easat-1678	14	5	il-28	il-28	ADV
easat-1678	14	6	in	in	ADP
easat-1678	14	7	thalassemia	thalassemia	NOUN
easat-1678	14	8	patients	patient	NOUN
easat-1678	14	9	with	with	ADP
easat-1678	14	10	associated	associated	ADJ
easat-1678	14	11	viral	viral	ADJ
easat-1678	14	12	infections	infection	NOUN
easat-1678	14	13	likely	likely	ADV
easat-1678	14	14	indicate	indicate	VERB
easat-1678	14	15	immune	immune	ADJ
easat-1678	14	16	system	system	NOUN
easat-1678	14	17	activation	activation	NOUN
easat-1678	14	18	.	.	PUNCT
easat-1678	15	1	their	their	PRON
easat-1678	15	2	correlation	correlation	NOUN
easat-1678	15	3	with	with	ADP
easat-1678	15	4	viral	viral	ADJ
easat-1678	15	5	load	load	NOUN
easat-1678	15	6	and	and	CCONJ
easat-1678	15	7	treatment	treatment	NOUN
easat-1678	15	8	outcomes	outcome	NOUN
easat-1678	15	9	suggests	suggest	VERB
easat-1678	15	10	their	their	PRON
easat-1678	15	11	potential	potential	NOUN
easat-1678	15	12	as	as	ADP
easat-1678	15	13	biomarkers	biomarker	NOUN
easat-1678	15	14	and	and	CCONJ
easat-1678	15	15	targets	target	NOUN
easat-1678	15	16	for	for	ADP
easat-1678	15	17	therapy	therapy	NOUN
easat-1678	15	18	.	.	PUNCT
easat-1678	16	1	these	these	DET
easat-1678	16	2	findings	finding	NOUN
easat-1678	16	3	further	far	ADV
easat-1678	16	4	underline	underline	VERB
easat-1678	16	5	the	the	DET
easat-1678	16	6	protective	protective	ADJ
easat-1678	16	7	role	role	NOUN
easat-1678	16	8	of	of	ADP
easat-1678	16	9	il-18	il-18	PUNCT
easat-1678	16	10	and	and	CCONJ
easat-1678	16	11	il-28	il-28	CCONJ
easat-1678	16	12	,	,	PUNCT
easat-1678	16	13	hence	hence	ADV
easat-1678	16	14	contributing	contribute	VERB
easat-1678	16	15	to	to	ADP
easat-1678	16	16	enhanced	enhanced	ADJ
easat-1678	16	17	survival	survival	NOUN
easat-1678	16	18	rates	rate	NOUN
easat-1678	16	19	of	of	ADP
easat-1678	16	20	the	the	DET
easat-1678	16	21	patients	patient	NOUN
easat-1678	16	22	.	.	PUNCT
easat-1678	17	1	further	further	ADJ
easat-1678	17	2	studies	study	NOUN
easat-1678	17	3	for	for	ADP
easat-1678	17	4	translation	translation	NOUN
easat-1678	17	5	of	of	ADP
easat-1678	17	6	these	these	DET
easat-1678	17	7	insights	insight	NOUN
easat-1678	17	8	into	into	ADP
easat-1678	17	9	practice	practice	NOUN
easat-1678	17	10	may	may	AUX
easat-1678	17	11	help	help	VERB
easat-1678	17	12	modify	modify	VERB
easat-1678	17	13	clinical	clinical	ADJ
easat-1678	17	14	care	care	NOUN
easat-1678	17	15	for	for	ADP
easat-1678	17	16	better	well	ADJ
easat-1678	17	17	patient	patient	ADJ
easat-1678	17	18	outcomes	outcome	NOUN
easat-1678	17	19	.	.	PUNCT
easat-1678	18	1	keywords	keyword	NOUN
easat-1678	18	2	:	:	PUNCT
easat-1678	18	3	antiviral	antiviral	ADJ
easat-1678	18	4	therapy	therapy	NOUN
easat-1678	18	5	,	,	PUNCT
easat-1678	18	6	biomarkers	biomarker	NOUN
easat-1678	18	7	,	,	PUNCT
easat-1678	18	8	hepatitis	hepatitis	PROPN
easat-1678	18	9	,	,	PUNCT
easat-1678	18	10	hiv	hiv	PROPN
easat-1678	18	11	,	,	PUNCT
easat-1678	18	12	il-18	il-18	ADV
easat-1678	18	13	,	,	PUNCT
easat-1678	18	14	il-28	il-28	NUM
easat-1678	18	15	,	,	PUNCT
easat-1678	18	16	immune	immune	ADJ
easat-1678	18	17	response	response	NOUN
easat-1678	18	18	,	,	PUNCT
easat-1678	18	19	interleukins	interleukin	NOUN
easat-1678	18	20	,	,	PUNCT
easat-1678	18	21	thalassemia	thalassemia	NOUN
easat-1678	18	22	,	,	PUNCT
easat-1678	18	23	viral	viral	ADJ
easat-1678	18	24	infections	infection	NOUN
easat-1678	18	25	.	.	PUNCT
easat-1678	19	1	1	1	X
easat-1678	19	2	.	.	X
easat-1678	19	3	introduction	introduction	NOUN
easat-1678	19	4	thalassemia	thalassemia	NOUN
easat-1678	19	5	is	be	AUX
easat-1678	19	6	an	an	DET
easat-1678	19	7	inherited	inherit	VERB
easat-1678	19	8	blood	blood	NOUN
easat-1678	19	9	disorder	disorder	NOUN
easat-1678	19	10	in	in	ADP
easat-1678	19	11	which	which	PRON
easat-1678	19	12	there	there	PRON
easat-1678	19	13	is	be	VERB
easat-1678	19	14	a	a	DET
easat-1678	19	15	decrease	decrease	NOUN
easat-1678	19	16	in	in	ADP
easat-1678	19	17	the	the	DET
easat-1678	19	18	production	production	NOUN
easat-1678	19	19	of	of	ADP
easat-1678	19	20	hemoglobin	hemoglobin	NOUN
easat-1678	19	21	,	,	PUNCT
easat-1678	19	22	which	which	PRON
easat-1678	19	23	carries	carry	VERB
easat-1678	19	24	oxygen	oxygen	NOUN
easat-1678	19	25	in	in	ADP
easat-1678	19	26	red	red	ADJ
easat-1678	19	27	blood	blood	NOUN
easat-1678	19	28	cells	cell	NOUN
easat-1678	19	29	.	.	PUNCT
easat-1678	20	1	with	with	ADP
easat-1678	20	2	this	this	DET
easat-1678	20	3	disorder	disorder	NOUN
easat-1678	20	4	,	,	PUNCT
easat-1678	20	5	a	a	DET
easat-1678	20	6	person	person	NOUN
easat-1678	20	7	has	have	VERB
easat-1678	20	8	anemia	anemia	NOUN
easat-1678	20	9	—	—	PUNCT
easat-1678	20	10	the	the	DET
easat-1678	20	11	severity	severity	NOUN
easat-1678	20	12	of	of	ADP
easat-1678	20	13	which	which	PRON
easat-1678	20	14	is	be	AUX
easat-1678	20	15	often	often	ADV
easat-1678	20	16	dependent	dependent	ADJ
easat-1678	20	17	on	on	ADP
easat-1678	20	18	the	the	DET
easat-1678	20	19	type	type	NOUN
easat-1678	20	20	of	of	ADP
easat-1678	20	21	thalassemia	thalassemia	NOUN
easat-1678	20	22	from	from	ADP
easat-1678	20	23	which	which	PRON
easat-1678	20	24	a	a	DET
easat-1678	20	25	person	person	NOUN
easat-1678	20	26	is	be	AUX
easat-1678	20	27	suffering	suffer	VERB
easat-1678	20	28	.	.	PUNCT
easat-1678	21	1	thalassemia	thalassemia	NOUN
easat-1678	21	2	generally	generally	ADV
easat-1678	21	3	requires	require	VERB
easat-1678	21	4	what	what	PRON
easat-1678	21	5	is	be	AUX
easat-1678	21	6	usually	usually	ADV
easat-1678	21	7	life	life	NOUN
easat-1678	21	8	-	-	PUNCT
easat-1678	21	9	long	long	ADJ
easat-1678	21	10	medical	medical	ADJ
easat-1678	21	11	care	care	NOUN
easat-1678	21	12	,	,	PUNCT
easat-1678	21	13	including	include	VERB
easat-1678	21	14	periodic	periodic	ADJ
easat-1678	21	15	blood	blood	NOUN
easat-1678	21	16	transfusions	transfusion	NOUN
easat-1678	21	17	for	for	ADP
easat-1678	21	18	patients	patient	NOUN
easat-1678	21	19	.	.	PUNCT
easat-1678	22	1	these	these	DET
easat-1678	22	2	transfusions	transfusion	NOUN
easat-1678	22	3	,	,	PUNCT
easat-1678	22	4	however	however	ADV
easat-1678	22	5	,	,	PUNCT
easat-1678	22	6	possess	possess	VERB
easat-1678	22	7	the	the	DET
easat-1678	22	8	risk	risk	NOUN
easat-1678	22	9	of	of	ADP
easat-1678	22	10	transmitting	transmit	VERB
easat-1678	22	11	viral	viral	ADJ
easat-1678	22	12	infections	infection	NOUN
easat-1678	22	13	such	such	ADJ
easat-1678	22	14	as	as	ADP
easat-1678	22	15	hepatitis	hepatitis	PROPN
easat-1678	22	16	b	b	PROPN
easat-1678	22	17	,	,	PUNCT
easat-1678	22	18	hepatitis	hepatitis	NOUN
easat-1678	22	19	c	c	NOUN
easat-1678	22	20	,	,	PUNCT
easat-1678	22	21	and	and	CCONJ
easat-1678	22	22	hiv	hiv	PROPN
easat-1678	23	1	[	[	X
easat-1678	23	2	1	1	NUM
easat-1678	23	3	]	]	PUNCT
easat-1678	23	4	.	.	PUNCT
easat-1678	24	1	in	in	ADP
easat-1678	24	2	thalassemia	thalassemia	NOUN
easat-1678	24	3	patients	patient	NOUN
easat-1678	24	4	,	,	PUNCT
easat-1678	24	5	infections	infection	NOUN
easat-1678	24	6	can	can	AUX
easat-1678	24	7	rapidly	rapidly	ADV
easat-1678	24	8	increase	increase	VERB
easat-1678	24	9	and	and	CCONJ
easat-1678	24	10	may	may	AUX
easat-1678	24	11	cause	cause	VERB
easat-1678	24	12	serious	serious	ADJ
easat-1678	24	13	complications	complication	NOUN
easat-1678	24	14	such	such	ADJ
easat-1678	24	15	as	as	ADP
easat-1678	24	16	liver	liver	NOUN
easat-1678	24	17	damage	damage	NOUN
easat-1678	24	18	,	,	PUNCT
easat-1678	24	19	iron	iron	NOUN
easat-1678	24	20	overload	overload	NOUN
easat-1678	24	21	,	,	PUNCT
easat-1678	24	22	and	and	CCONJ
easat-1678	24	23	finally	finally	ADV
easat-1678	24	24	lead	lead	VERB
easat-1678	24	25	to	to	ADP
easat-1678	24	26	further	further	ADJ
easat-1678	24	27	health	health	NOUN
easat-1678	24	28	problems	problem	NOUN
easat-1678	24	29	[	[	X
easat-1678	24	30	2	2	NUM
easat-1678	24	31	]	]	PUNCT
easat-1678	24	32	.	.	PUNCT
easat-1678	25	1	additionally	additionally	ADV
easat-1678	25	2	,	,	PUNCT
easat-1678	25	3	thalassemia	thalassemia	NOUN
easat-1678	25	4	patients	patient	NOUN
easat-1678	25	5	could	could	AUX
easat-1678	25	6	have	have	VERB
easat-1678	25	7	depressed	depressed	ADJ
easat-1678	25	8	immune	immune	ADJ
easat-1678	25	9	systems	system	NOUN
easat-1678	25	10	due	due	ADP
easat-1678	25	11	to	to	ADP
easat-1678	25	12	the	the	DET
easat-1678	25	13	primary	primary	ADJ
easat-1678	25	14	disease	disease	NOUN
easat-1678	25	15	and	and	CCONJ
easat-1678	25	16	frequent	frequent	ADJ
easat-1678	25	17	transfusions	transfusion	NOUN
easat-1678	25	18	that	that	PRON
easat-1678	25	19	make	make	VERB
easat-1678	25	20	them	they	PRON
easat-1678	25	21	more	more	ADV
easat-1678	25	22	predisposed	predisposed	ADJ
easat-1678	25	23	to	to	ADP
easat-1678	25	24	infections	infection	NOUN
easat-1678	25	25	[	[	X
easat-1678	25	26	3	3	NUM
easat-1678	25	27	-	-	SYM
easat-1678	25	28	6	6	NUM
easat-1678	25	29	]	]	PUNCT
easat-1678	25	30	.	.	PUNCT
easat-1678	26	1	a	a	DET
easat-1678	26	2	good	good	ADJ
easat-1678	26	3	understanding	understanding	NOUN
easat-1678	26	4	of	of	ADP
easat-1678	26	5	immune	immune	ADJ
easat-1678	26	6	response	response	NOUN
easat-1678	26	7	in	in	ADP
easat-1678	26	8	thalassemia	thalassemia	NOUN
easat-1678	26	9	patients	patient	NOUN
easat-1678	26	10	after	after	ADP
easat-1678	26	11	a	a	DET
easat-1678	26	12	viral	viral	ADJ
easat-1678	26	13	infection	infection	NOUN
easat-1678	26	14	could	could	AUX
easat-1678	26	15	provide	provide	VERB
easat-1678	26	16	more	more	ADV
easat-1678	26	17	effective	effective	ADJ
easat-1678	26	18	strategies	strategy	NOUN
easat-1678	26	19	for	for	ADP
easat-1678	26	20	its	its	PRON
easat-1678	26	21	management	management	NOUN
easat-1678	26	22	and	and	CCONJ
easat-1678	26	23	treatment	treatment	NOUN
easat-1678	26	24	.	.	PUNCT
easat-1678	27	1	this	this	DET
easat-1678	27	2	study	study	NOUN
easat-1678	27	3	is	be	AUX
easat-1678	27	4	conducted	conduct	VERB
easat-1678	27	5	to	to	PART
easat-1678	27	6	evaluate	evaluate	VERB
easat-1678	27	7	the	the	DET
easat-1678	27	8	levels	level	NOUN
easat-1678	27	9	of	of	ADP
easat-1678	27	10	interleukins	interleukin	NOUN
easat-1678	27	11	il-18	il-18	PUNCT
easat-1678	27	12	and	and	CCONJ
easat-1678	27	13	il-28	il-28	ADV
easat-1678	27	14	in	in	ADP
easat-1678	27	15	thalassemia	thalassemia	NOUN
easat-1678	27	16	patients	patient	NOUN
easat-1678	27	17	with	with	ADP
easat-1678	27	18	viral	viral	ADJ
easat-1678	27	19	infections	infection	NOUN
easat-1678	27	20	.	.	PUNCT
easat-1678	28	1	basically	basically	ADV
easat-1678	28	2	,	,	PUNCT
easat-1678	28	3	interleukins	interleukin	NOUN
easat-1678	28	4	are	be	AUX
easat-1678	28	5	one	one	NUM
easat-1678	28	6	of	of	ADP
easat-1678	28	7	the	the	DET
easat-1678	28	8	immune	immune	ADJ
easat-1678	28	9	system	system	NOUN
easat-1678	28	10	components	component	NOUN
easat-1678	28	11	that	that	PRON
easat-1678	28	12	are	be	AUX
easat-1678	28	13	responsible	responsible	ADJ
easat-1678	28	14	for	for	ADP
easat-1678	28	15	ensuring	ensure	VERB
easat-1678	28	16	that	that	SCONJ
easat-1678	28	17	the	the	DET
easat-1678	28	18	body	body	NOUN
easat-1678	28	19	fights	fight	VERB
easat-1678	28	20	the	the	DET
easat-1678	28	21	infection	infection	NOUN
easat-1678	28	22	,	,	PUNCT
easat-1678	28	23	disease	disease	NOUN
easat-1678	28	24	,	,	PUNCT
easat-1678	28	25	or	or	CCONJ
easat-1678	28	26	foreign	foreign	ADJ
easat-1678	28	27	substances	substance	NOUN
easat-1678	28	28	.	.	PUNCT
easat-1678	29	1	many	many	ADJ
easat-1678	29	2	authors	author	NOUN
easat-1678	29	3	524	524	NUM
easat-1678	29	4	edelweiss	edelweiss	PROPN
easat-1678	29	5	applied	apply	VERB
easat-1678	29	6	science	science	NOUN
easat-1678	29	7	and	and	CCONJ
easat-1678	29	8	technology	technology	NOUN
easat-1678	29	9	issn	issn	PROPN
easat-1678	29	10	:	:	PUNCT
easat-1678	29	11	2576	2576	NUM
easat-1678	29	12	-	-	SYM
easat-1678	29	13	8484	8484	NUM
easat-1678	29	14	vol	vol	NOUN
easat-1678	29	15	.	.	PROPN
easat-1678	29	16	8	8	NUM
easat-1678	29	17	,	,	PUNCT
easat-1678	29	18	no	no	INTJ
easat-1678	29	19	.	.	NOUN
easat-1678	30	1	3	3	NUM
easat-1678	30	2	:	:	PUNCT
easat-1678	30	3	523	523	NUM
easat-1678	30	4	-	-	SYM
easat-1678	30	5	532	532	NUM
easat-1678	30	6	,	,	PUNCT
easat-1678	30	7	2024	2024	NUM
easat-1678	30	8	doi	doi	NOUN
easat-1678	30	9	:	:	PUNCT
easat-1678	30	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	30	11	©	©	PROPN
easat-1678	30	12	2024	2024	NUM
easat-1678	30	13	by	by	ADP
easat-1678	30	14	the	the	DET
easat-1678	30	15	authors	author	NOUN
easat-1678	30	16	;	;	PUNCT
easat-1678	30	17	licensee	licensee	PROPN
easat-1678	30	18	learning	learn	VERB
easat-1678	30	19	gate	gate	PROPN
easat-1678	30	20	contend	contend	VERB
easat-1678	30	21	that	that	SCONJ
easat-1678	30	22	the	the	DET
easat-1678	30	23	importance	importance	NOUN
easat-1678	30	24	of	of	ADP
easat-1678	30	25	il-18	il-18	PRON
easat-1678	30	26	and	and	CCONJ
easat-1678	30	27	il-28	il-28	NUM
easat-1678	30	28	proteins	protein	NOUN
easat-1678	30	29	is	be	AUX
easat-1678	30	30	so	so	ADV
easat-1678	30	31	high	high	ADJ
easat-1678	30	32	because	because	SCONJ
easat-1678	30	33	they	they	PRON
easat-1678	30	34	participate	participate	VERB
easat-1678	30	35	in	in	ADP
easat-1678	30	36	the	the	DET
easat-1678	30	37	antiviral	antiviral	ADJ
easat-1678	30	38	defense	defense	NOUN
easat-1678	30	39	by	by	ADP
easat-1678	30	40	increasing	increase	VERB
easat-1678	30	41	immune	immune	ADJ
easat-1678	30	42	responses	response	NOUN
easat-1678	30	43	.	.	PUNCT
easat-1678	31	1	this	this	PRON
easat-1678	31	2	will	will	AUX
easat-1678	31	3	allow	allow	VERB
easat-1678	31	4	us	we	PRON
easat-1678	31	5	to	to	PART
easat-1678	31	6	assess	assess	VERB
easat-1678	31	7	the	the	DET
easat-1678	31	8	levels	level	NOUN
easat-1678	31	9	of	of	ADP
easat-1678	31	10	these	these	DET
easat-1678	31	11	interleukins	interleukin	VERB
easat-1678	31	12	better	well	ADV
easat-1678	31	13	in	in	ADP
easat-1678	31	14	understanding	understand	VERB
easat-1678	31	15	how	how	SCONJ
easat-1678	31	16	thalassemia	thalassemia	NOUN
easat-1678	31	17	interacts	interact	VERB
easat-1678	31	18	with	with	ADP
easat-1678	31	19	the	the	DET
easat-1678	31	20	viral	viral	ADJ
easat-1678	31	21	infections	infection	NOUN
easat-1678	31	22	,	,	PUNCT
easat-1678	31	23	possibly	possibly	ADV
easat-1678	31	24	identifying	identify	VERB
easat-1678	31	25	new	new	ADJ
easat-1678	31	26	biomarkers	biomarker	NOUN
easat-1678	31	27	and	and	CCONJ
easat-1678	31	28	therapeutic	therapeutic	ADJ
easat-1678	31	29	targets	target	NOUN
easat-1678	31	30	to	to	PART
easat-1678	31	31	improve	improve	VERB
easat-1678	31	32	patient	patient	ADJ
easat-1678	31	33	outcomes	outcome	NOUN
easat-1678	31	34	.	.	PUNCT
easat-1678	32	1	1.1	1.1	NUM
easat-1678	32	2	.	.	X
easat-1678	33	1	thalassemia	thalassemia	NOUN
easat-1678	33	2	and	and	CCONJ
easat-1678	33	3	viral	viral	ADJ
easat-1678	33	4	infections	infection	NOUN
easat-1678	33	5	people	people	NOUN
easat-1678	33	6	with	with	ADP
easat-1678	33	7	thalassemia	thalassemia	NOUN
easat-1678	33	8	can	can	AUX
easat-1678	33	9	easily	easily	ADV
easat-1678	33	10	become	become	AUX
easat-1678	33	11	infected	infect	VERB
easat-1678	33	12	by	by	ADP
easat-1678	33	13	viral	viral	ADJ
easat-1678	33	14	infections	infection	NOUN
easat-1678	33	15	for	for	ADP
easat-1678	33	16	several	several	ADJ
easat-1678	33	17	reasons	reason	NOUN
easat-1678	33	18	.	.	PUNCT
easat-1678	34	1	the	the	DET
easat-1678	34	2	genetic	genetic	ADJ
easat-1678	34	3	disorder	disorder	NOUN
easat-1678	34	4	can	can	AUX
easat-1678	34	5	lead	lead	VERB
easat-1678	34	6	to	to	ADP
easat-1678	34	7	immune	immune	ADJ
easat-1678	34	8	cell	cell	NOUN
easat-1678	34	9	malfunction	malfunction	NOUN
easat-1678	34	10	,	,	PUNCT
easat-1678	34	11	wherein	wherein	SCONJ
easat-1678	34	12	the	the	DET
easat-1678	34	13	body	body	NOUN
easat-1678	34	14	finds	find	VERB
easat-1678	34	15	it	it	PRON
easat-1678	34	16	difficult	difficult	ADJ
easat-1678	34	17	to	to	PART
easat-1678	34	18	fight	fight	VERB
easat-1678	34	19	infections	infection	NOUN
easat-1678	35	1	[	[	X
easat-1678	35	2	7	7	NUM
easat-1678	35	3	]	]	PUNCT
easat-1678	35	4	.	.	PUNCT
easat-1678	36	1	blood	blood	NOUN
easat-1678	36	2	transfusions	transfusion	NOUN
easat-1678	36	3	taken	take	VERB
easat-1678	36	4	regularly	regularly	ADV
easat-1678	36	5	to	to	PART
easat-1678	36	6	treat	treat	VERB
easat-1678	36	7	thalassemia	thalassemia	NOUN
easat-1678	36	8	may	may	AUX
easat-1678	36	9	increase	increase	VERB
easat-1678	36	10	the	the	DET
easat-1678	36	11	risk	risk	NOUN
easat-1678	36	12	of	of	ADP
easat-1678	36	13	bloodborne	bloodborne	ADJ
easat-1678	36	14	viruses	virus	NOUN
easat-1678	36	15	.	.	PUNCT
easat-1678	37	1	also	also	ADV
easat-1678	37	2	,	,	PUNCT
easat-1678	37	3	the	the	DET
easat-1678	37	4	iron	iron	NOUN
easat-1678	37	5	overload	overload	NOUN
easat-1678	37	6	difficulty	difficulty	NOUN
easat-1678	37	7	that	that	PRON
easat-1678	37	8	most	most	ADJ
easat-1678	37	9	thalassemia	thalassemia	NOUN
easat-1678	37	10	patients	patient	NOUN
easat-1678	37	11	face	face	VERB
easat-1678	37	12	tends	tend	VERB
easat-1678	37	13	to	to	PART
easat-1678	37	14	help	help	VERB
easat-1678	37	15	virus	virus	NOUN
easat-1678	37	16	replication	replication	NOUN
easat-1678	37	17	[	[	X
easat-1678	37	18	8	8	NUM
easat-1678	37	19	,	,	PUNCT
easat-1678	37	20	9	9	NUM
easat-1678	37	21	]	]	PUNCT
easat-1678	37	22	.	.	PUNCT
easat-1678	38	1	hepatitis	hepatitis	PROPN
easat-1678	38	2	b	b	PROPN
easat-1678	38	3	and	and	CCONJ
easat-1678	38	4	c	c	PROPN
easat-1678	38	5	are	be	AUX
easat-1678	38	6	the	the	DET
easat-1678	38	7	most	most	ADV
easat-1678	38	8	frequently	frequently	ADV
easat-1678	38	9	transmitted	transmit	VERB
easat-1678	38	10	viruses	virus	NOUN
easat-1678	38	11	through	through	ADP
easat-1678	38	12	blood	blood	NOUN
easat-1678	38	13	transfusions	transfusion	NOUN
easat-1678	38	14	,	,	PUNCT
easat-1678	38	15	which	which	PRON
easat-1678	38	16	often	often	ADV
easat-1678	38	17	lead	lead	VERB
easat-1678	38	18	to	to	ADP
easat-1678	38	19	chronic	chronic	ADJ
easat-1678	38	20	infections	infection	NOUN
easat-1678	38	21	,	,	PUNCT
easat-1678	38	22	dangerous	dangerous	ADJ
easat-1678	38	23	health	health	NOUN
easat-1678	38	24	complications	complication	NOUN
easat-1678	38	25	,	,	PUNCT
easat-1678	38	26	and	and	CCONJ
easat-1678	38	27	even	even	ADV
easat-1678	38	28	death	death	NOUN
easat-1678	38	29	.	.	PUNCT
easat-1678	39	1	hiv	hiv	PROPN
easat-1678	39	2	presents	present	VERB
easat-1678	39	3	the	the	DET
easat-1678	39	4	greatest	great	ADJ
easat-1678	39	5	danger	danger	NOUN
easat-1678	39	6	due	due	ADP
easat-1678	39	7	to	to	ADP
easat-1678	39	8	its	its	PRON
easat-1678	39	9	possibility	possibility	NOUN
easat-1678	39	10	of	of	ADP
easat-1678	39	11	weakening	weaken	VERB
easat-1678	39	12	the	the	DET
easat-1678	39	13	immune	immune	ADJ
easat-1678	39	14	system	system	NOUN
easat-1678	39	15	of	of	ADP
easat-1678	39	16	a	a	DET
easat-1678	39	17	patient	patient	NOUN
easat-1678	39	18	,	,	PUNCT
easat-1678	39	19	thereby	thereby	ADV
easat-1678	39	20	creating	create	VERB
easat-1678	39	21	vulnerability	vulnerability	NOUN
easat-1678	39	22	to	to	ADP
easat-1678	39	23	a	a	DET
easat-1678	39	24	number	number	NOUN
easat-1678	39	25	of	of	ADP
easat-1678	39	26	diseases	disease	NOUN
easat-1678	39	27	that	that	PRON
easat-1678	39	28	such	such	ADJ
easat-1678	39	29	patients	patient	NOUN
easat-1678	39	30	would	would	AUX
easat-1678	39	31	normally	normally	ADV
easat-1678	39	32	fight	fight	VERB
easat-1678	39	33	off	off	ADP
easat-1678	39	34	without	without	ADP
easat-1678	39	35	much	much	ADJ
easat-1678	39	36	effort	effort	NOUN
easat-1678	39	37	.	.	PUNCT
easat-1678	40	1	1.2	1.2	NUM
easat-1678	40	2	.	.	PUNCT
easat-1678	40	3	impact	impact	NOUN
easat-1678	40	4	of	of	ADP
easat-1678	40	5	viral	viral	ADJ
easat-1678	40	6	infections	infection	NOUN
easat-1678	40	7	on	on	ADP
easat-1678	40	8	thalassemia	thalassemia	NOUN
easat-1678	40	9	management	management	NOUN
easat-1678	40	10	viral	viral	ADJ
easat-1678	40	11	infections	infection	NOUN
easat-1678	40	12	can	can	AUX
easat-1678	40	13	have	have	VERB
easat-1678	40	14	major	major	ADJ
easat-1678	40	15	implications	implication	NOUN
easat-1678	40	16	on	on	ADP
easat-1678	40	17	the	the	DET
easat-1678	40	18	management	management	NOUN
easat-1678	40	19	of	of	ADP
easat-1678	40	20	thalassemia	thalassemia	NOUN
easat-1678	40	21	.	.	PUNCT
easat-1678	41	1	chronic	chronic	ADJ
easat-1678	41	2	hepatitis	hepatitis	PROPN
easat-1678	41	3	b	b	PROPN
easat-1678	41	4	and	and	CCONJ
easat-1678	41	5	c	c	PROPN
easat-1678	41	6	can	can	AUX
easat-1678	41	7	cause	cause	VERB
easat-1678	41	8	serious	serious	ADJ
easat-1678	41	9	liver	liver	NOUN
easat-1678	41	10	damage	damage	NOUN
easat-1678	41	11	and	and	CCONJ
easat-1678	41	12	increase	increase	VERB
easat-1678	41	13	the	the	DET
easat-1678	41	14	need	need	NOUN
easat-1678	41	15	for	for	ADP
easat-1678	41	16	liver	liver	NOUN
easat-1678	41	17	transplantation	transplantation	NOUN
easat-1678	41	18	.	.	PUNCT
easat-1678	42	1	viruses	virus	NOUN
easat-1678	42	2	may	may	AUX
easat-1678	42	3	increase	increase	VERB
easat-1678	42	4	iron	iron	NOUN
easat-1678	42	5	overload	overload	NOUN
easat-1678	42	6	because	because	SCONJ
easat-1678	42	7	viruses	virus	NOUN
easat-1678	42	8	use	use	VERB
easat-1678	42	9	iron	iron	NOUN
easat-1678	42	10	for	for	ADP
easat-1678	42	11	their	their	PRON
easat-1678	42	12	replication	replication	NOUN
easat-1678	42	13	,	,	PUNCT
easat-1678	42	14	leading	lead	VERB
easat-1678	42	15	to	to	ADP
easat-1678	42	16	tissue	tissue	NOUN
easat-1678	42	17	and	and	CCONJ
easat-1678	42	18	organ	organ	NOUN
easat-1678	42	19	damage	damage	NOUN
easat-1678	42	20	.	.	PUNCT
easat-1678	43	1	viral	viral	ADJ
easat-1678	43	2	infections	infection	NOUN
easat-1678	43	3	also	also	ADV
easat-1678	43	4	decrease	decrease	VERB
easat-1678	43	5	the	the	DET
easat-1678	43	6	response	response	NOUN
easat-1678	43	7	to	to	ADP
easat-1678	43	8	erythropoietin	erythropoietin	NOUN
easat-1678	43	9	therapy	therapy	NOUN
easat-1678	43	10	,	,	PUNCT
easat-1678	43	11	which	which	PRON
easat-1678	43	12	is	be	AUX
easat-1678	43	13	often	often	ADV
easat-1678	43	14	used	use	VERB
easat-1678	43	15	for	for	ADP
easat-1678	43	16	thalassemia	thalassemia	NOUN
easat-1678	43	17	intermedia	intermedia	PROPN
easat-1678	43	18	.	.	PUNCT
easat-1678	44	1	blood	blood	NOUN
easat-1678	44	2	transfusions	transfusion	NOUN
easat-1678	44	3	in	in	ADP
easat-1678	44	4	infected	infected	ADJ
easat-1678	44	5	patients	patient	NOUN
easat-1678	44	6	are	be	AUX
easat-1678	44	7	tricky	tricky	ADJ
easat-1678	44	8	to	to	PART
easat-1678	44	9	manage	manage	VERB
easat-1678	44	10	since	since	SCONJ
easat-1678	44	11	there	there	PRON
easat-1678	44	12	needs	need	VERB
easat-1678	44	13	to	to	PART
easat-1678	44	14	be	be	AUX
easat-1678	44	15	a	a	DET
easat-1678	44	16	tight	tight	ADJ
easat-1678	44	17	screening	screening	NOUN
easat-1678	44	18	process	process	NOUN
easat-1678	44	19	to	to	PART
easat-1678	44	20	avoid	avoid	VERB
easat-1678	44	21	transmission	transmission	NOUN
easat-1678	44	22	of	of	ADP
easat-1678	44	23	infections	infection	NOUN
easat-1678	44	24	to	to	ADP
easat-1678	44	25	other	other	ADJ
easat-1678	44	26	recipients	recipient	NOUN
easat-1678	44	27	[	[	X
easat-1678	44	28	10	10	NUM
easat-1678	44	29	]	]	PUNCT
easat-1678	44	30	.	.	PUNCT
easat-1678	45	1	1.3	1.3	NUM
easat-1678	45	2	.	.	PUNCT
easat-1678	45	3	immune	immune	ADJ
easat-1678	45	4	response	response	NOUN
easat-1678	45	5	in	in	ADP
easat-1678	45	6	thalassemia	thalassemia	NOUN
easat-1678	45	7	patients	patient	NOUN
easat-1678	45	8	as	as	ADP
easat-1678	45	9	a	a	DET
easat-1678	45	10	result	result	NOUN
easat-1678	45	11	of	of	ADP
easat-1678	45	12	such	such	DET
easat-1678	45	13	a	a	DET
easat-1678	45	14	condition	condition	NOUN
easat-1678	45	15	and	and	CCONJ
easat-1678	45	16	complications	complication	NOUN
easat-1678	45	17	because	because	SCONJ
easat-1678	45	18	of	of	ADP
easat-1678	45	19	it	it	PRON
easat-1678	45	20	,	,	PUNCT
easat-1678	45	21	thalassemia	thalassemia	NOUN
easat-1678	45	22	patients	patient	NOUN
easat-1678	45	23	have	have	VERB
easat-1678	45	24	peculiar	peculiar	ADJ
easat-1678	45	25	changes	change	NOUN
easat-1678	45	26	in	in	ADP
easat-1678	45	27	their	their	PRON
easat-1678	45	28	immune	immune	ADJ
easat-1678	45	29	system	system	NOUN
easat-1678	45	30	.	.	PUNCT
easat-1678	46	1	suppression	suppression	NOUN
easat-1678	46	2	of	of	ADP
easat-1678	46	3	the	the	DET
easat-1678	46	4	immune	immune	ADJ
easat-1678	46	5	system	system	NOUN
easat-1678	46	6	by	by	ADP
easat-1678	46	7	low	low	ADJ
easat-1678	46	8	red	red	ADJ
easat-1678	46	9	blood	blood	NOUN
easat-1678	46	10	cells	cell	NOUN
easat-1678	46	11	,	,	PUNCT
easat-1678	46	12	iron	iron	NOUN
easat-1678	46	13	overload	overload	NOUN
easat-1678	46	14	,	,	PUNCT
easat-1678	46	15	and	and	CCONJ
easat-1678	46	16	chronic	chronic	ADJ
easat-1678	46	17	inflammation	inflammation	NOUN
easat-1678	46	18	:	:	PUNCT
easat-1678	46	19	in	in	ADP
easat-1678	46	20	both	both	CCONJ
easat-1678	46	21	innate	innate	ADJ
easat-1678	46	22	and	and	CCONJ
easat-1678	46	23	adaptive	adaptive	ADJ
easat-1678	46	24	immunity	immunity	NOUN
easat-1678	46	25	,	,	PUNCT
easat-1678	46	26	the	the	DET
easat-1678	46	27	level	level	NOUN
easat-1678	46	28	is	be	AUX
easat-1678	46	29	knocked	knock	VERB
easat-1678	46	30	down	down	ADP
easat-1678	46	31	[	[	PUNCT
easat-1678	46	32	11	11	NUM
easat-1678	46	33	-	-	SYM
easat-1678	46	34	14	14	NUM
easat-1678	46	35	]	]	PUNCT
easat-1678	46	36	.	.	PUNCT
easat-1678	47	1	the	the	DET
easat-1678	47	2	blunted	blunt	VERB
easat-1678	47	3	immune	immune	ADJ
easat-1678	47	4	response	response	NOUN
easat-1678	47	5	increases	increase	VERB
easat-1678	47	6	susceptibility	susceptibility	NOUN
easat-1678	47	7	to	to	ADP
easat-1678	47	8	infections	infection	NOUN
easat-1678	47	9	,	,	PUNCT
easat-1678	47	10	is	be	AUX
easat-1678	47	11	associated	associate	VERB
easat-1678	47	12	with	with	ADP
easat-1678	47	13	autoimmunities	autoimmunity	NOUN
easat-1678	47	14	,	,	PUNCT
easat-1678	47	15	and	and	CCONJ
easat-1678	47	16	increases	increase	VERB
easat-1678	47	17	the	the	DET
easat-1678	47	18	risk	risk	NOUN
easat-1678	47	19	of	of	ADP
easat-1678	47	20	organ	organ	NOUN
easat-1678	47	21	transplant	transplant	NOUN
easat-1678	47	22	rejection	rejection	NOUN
easat-1678	47	23	[	[	X
easat-1678	47	24	15	15	NUM
easat-1678	47	25	]	]	PUNCT
easat-1678	47	26	.	.	PUNCT
easat-1678	48	1	moreover	moreover	ADV
easat-1678	48	2	,	,	PUNCT
easat-1678	48	3	patients	patient	NOUN
easat-1678	48	4	with	with	ADP
easat-1678	48	5	thalassemia	thalassemia	NOUN
easat-1678	48	6	do	do	AUX
easat-1678	48	7	not	not	PART
easat-1678	48	8	respond	respond	VERB
easat-1678	48	9	appropriately	appropriately	ADV
easat-1678	48	10	to	to	ADP
easat-1678	48	11	vaccines	vaccine	NOUN
easat-1678	48	12	either	either	CCONJ
easat-1678	48	13	because	because	SCONJ
easat-1678	48	14	,	,	PUNCT
easat-1678	48	15	in	in	ADP
easat-1678	48	16	general	general	ADJ
easat-1678	48	17	,	,	PUNCT
easat-1678	48	18	they	they	PRON
easat-1678	48	19	produce	produce	VERB
easat-1678	48	20	fewer	few	ADJ
easat-1678	48	21	antibodies	antibody	NOUN
easat-1678	48	22	than	than	ADP
easat-1678	48	23	normal	normal	ADJ
easat-1678	48	24	[	[	X
easat-1678	48	25	16	16	NUM
easat-1678	48	26	]	]	PUNCT
easat-1678	48	27	.	.	PUNCT
easat-1678	49	1	these	these	DET
easat-1678	49	2	immune	immune	ADJ
easat-1678	49	3	response	response	NOUN
easat-1678	49	4	mechanisms	mechanism	NOUN
easat-1678	49	5	are	be	AUX
easat-1678	49	6	an	an	DET
easat-1678	49	7	essential	essential	ADJ
easat-1678	49	8	study	study	NOUN
easat-1678	49	9	in	in	ADP
easat-1678	49	10	the	the	DET
easat-1678	49	11	design	design	NOUN
easat-1678	49	12	of	of	ADP
easat-1678	49	13	strategies	strategy	NOUN
easat-1678	49	14	for	for	ADP
easat-1678	49	15	infection	infection	NOUN
easat-1678	49	16	prevention	prevention	NOUN
easat-1678	49	17	and	and	CCONJ
easat-1678	49	18	management	management	NOUN
easat-1678	49	19	in	in	ADP
easat-1678	49	20	thalassemia	thalassemia	NOUN
easat-1678	49	21	.	.	PUNCT
easat-1678	50	1	1.4	1.4	NUM
easat-1678	50	2	.	.	PUNCT
easat-1678	50	3	role	role	NOUN
easat-1678	50	4	of	of	ADP
easat-1678	50	5	il-18	il-18	PUNCT
easat-1678	50	6	and	and	CCONJ
easat-1678	50	7	il-28	il-28	ADV
easat-1678	50	8	in	in	ADP
easat-1678	50	9	viral	viral	ADJ
easat-1678	50	10	infections	infection	NOUN
easat-1678	50	11	il-18	il-18	PRON
easat-1678	50	12	and	and	CCONJ
easat-1678	50	13	il-28	il-28	ADV
easat-1678	50	14	are	be	AUX
easat-1678	50	15	important	important	ADJ
easat-1678	50	16	protein	protein	NOUN
easat-1678	50	17	molecules	molecule	NOUN
easat-1678	50	18	involved	involve	VERB
easat-1678	50	19	in	in	ADP
easat-1678	50	20	the	the	DET
easat-1678	50	21	body	body	NOUN
easat-1678	50	22	's	's	PART
easat-1678	50	23	response	response	NOUN
easat-1678	50	24	to	to	ADP
easat-1678	50	25	viruses	virus	NOUN
easat-1678	50	26	.	.	PUNCT
easat-1678	51	1	il-18	il-18	PUNCT
easat-1678	51	2	has	have	VERB
easat-1678	51	3	some	some	DET
easat-1678	51	4	pro	pro	ADJ
easat-1678	51	5	-	-	ADJ
easat-1678	51	6	inflammatory	inflammatory	ADJ
easat-1678	51	7	effects	effect	NOUN
easat-1678	51	8	and	and	CCONJ
easat-1678	51	9	further	far	ADV
easat-1678	51	10	promotes	promote	VERB
easat-1678	51	11	an	an	DET
easat-1678	51	12	immune	immune	ADJ
easat-1678	51	13	response	response	NOUN
easat-1678	51	14	by	by	ADP
easat-1678	51	15	stimulating	stimulate	VERB
easat-1678	51	16	ifn	ifn	NOUN
easat-1678	51	17	-	-	PUNCT
easat-1678	51	18	γ	γ	NOUN
easat-1678	51	19	,	,	PUNCT
easat-1678	51	20	production	production	NOUN
easat-1678	51	21	of	of	ADP
easat-1678	51	22	which	which	PRON
easat-1678	51	23	is	be	AUX
easat-1678	51	24	upregulated	upregulate	VERB
easat-1678	51	25	,	,	PUNCT
easat-1678	51	26	and	and	CCONJ
easat-1678	51	27	activity	activity	NOUN
easat-1678	51	28	of	of	ADP
easat-1678	51	29	nk	nk	PROPN
easat-1678	51	30	cells	cell	NOUN
easat-1678	51	31	as	as	ADV
easat-1678	51	32	well	well	ADV
easat-1678	51	33	as	as	ADP
easat-1678	51	34	cd8	cd8	PROPN
easat-1678	51	35	t	t	PROPN
easat-1678	51	36	cells	cell	NOUN
easat-1678	51	37	attacking	attack	VERB
easat-1678	51	38	infected	infected	ADJ
easat-1678	51	39	cells	cell	NOUN
easat-1678	51	40	[	[	X
easat-1678	51	41	17	17	NUM
easat-1678	51	42	]	]	PUNCT
easat-1678	51	43	.	.	PUNCT
easat-1678	52	1	elevated	elevated	ADJ
easat-1678	52	2	levels	level	NOUN
easat-1678	52	3	of	of	ADP
easat-1678	52	4	serum	serum	NOUN
easat-1678	52	5	il-18	il-18	ADP
easat-1678	52	6	are	be	AUX
easat-1678	52	7	also	also	ADV
easat-1678	52	8	suggested	suggest	VERB
easat-1678	52	9	to	to	PART
easat-1678	52	10	correlate	correlate	VERB
easat-1678	52	11	with	with	ADP
easat-1678	52	12	acute	acute	ADJ
easat-1678	52	13	viral	viral	ADJ
easat-1678	52	14	infections	infection	NOUN
easat-1678	52	15	,	,	PUNCT
easat-1678	52	16	possibly	possibly	ADV
easat-1678	52	17	indicating	indicate	VERB
easat-1678	52	18	its	its	PRON
easat-1678	52	19	usefulness	usefulness	NOUN
easat-1678	52	20	for	for	ADP
easat-1678	52	21	rapid	rapid	ADJ
easat-1678	52	22	immune	immune	ADJ
easat-1678	52	23	reaction	reaction	NOUN
easat-1678	52	24	induction	induction	NOUN
easat-1678	52	25	[	[	X
easat-1678	52	26	18	18	NUM
easat-1678	52	27	-	-	SYM
easat-1678	52	28	20	20	NUM
easat-1678	52	29	]	]	PUNCT
easat-1678	52	30	.	.	PUNCT
easat-1678	53	1	il-28	il-28	PROPN
easat-1678	53	2	is	be	AUX
easat-1678	53	3	one	one	NUM
easat-1678	53	4	of	of	ADP
easat-1678	53	5	the	the	DET
easat-1678	53	6	type	type	NOUN
easat-1678	53	7	iii	iii	NUM
easat-1678	53	8	interferons	interferon	NOUN
easat-1678	53	9	and	and	CCONJ
easat-1678	53	10	has	have	VERB
easat-1678	53	11	broad	broad	ADJ
easat-1678	53	12	antiviral	antiviral	ADJ
easat-1678	53	13	activity	activity	NOUN
easat-1678	53	14	,	,	PUNCT
easat-1678	53	15	mostly	mostly	ADV
easat-1678	53	16	appreciated	appreciate	VERB
easat-1678	53	17	in	in	ADP
easat-1678	53	18	mucosal	mucosal	ADJ
easat-1678	53	19	surfaces	surface	NOUN
easat-1678	53	20	of	of	ADP
easat-1678	53	21	the	the	DET
easat-1678	53	22	respiratory	respiratory	ADJ
easat-1678	53	23	tract	tract	NOUN
easat-1678	53	24	.	.	PUNCT
easat-1678	54	1	it	it	PRON
easat-1678	54	2	can	can	AUX
easat-1678	54	3	act	act	VERB
easat-1678	54	4	on	on	ADP
easat-1678	54	5	viral	viral	ADJ
easat-1678	54	6	replication	replication	NOUN
easat-1678	54	7	and	and	CCONJ
easat-1678	54	8	modulate	modulate	VERB
easat-1678	54	9	the	the	DET
easat-1678	54	10	host	host	NOUN
easat-1678	54	11	immune	immune	ADJ
easat-1678	54	12	response	response	NOUN
easat-1678	54	13	to	to	PART
easat-1678	54	14	accommodate	accommodate	VERB
easat-1678	54	15	the	the	DET
easat-1678	54	16	clearance	clearance	NOUN
easat-1678	54	17	of	of	ADP
easat-1678	54	18	infections	infection	NOUN
easat-1678	54	19	.	.	PUNCT
easat-1678	55	1	therefore	therefore	ADV
easat-1678	55	2	,	,	PUNCT
easat-1678	55	3	polymorphisms	polymorphism	NOUN
easat-1678	55	4	in	in	ADP
easat-1678	55	5	these	these	DET
easat-1678	55	6	genes	gene	NOUN
easat-1678	55	7	could	could	AUX
easat-1678	55	8	influence	influence	VERB
easat-1678	55	9	the	the	DET
easat-1678	55	10	response	response	NOUN
easat-1678	55	11	individual	individual	ADJ
easat-1678	55	12	to	to	ADP
easat-1678	55	13	antiviral	antiviral	ADJ
easat-1678	55	14	therapy	therapy	NOUN
easat-1678	55	15	.	.	PUNCT
easat-1678	56	1	2	2	X
easat-1678	56	2	.	.	X
easat-1678	56	3	methodology	methodology	NOUN
easat-1678	56	4	2.1	2.1	NUM
easat-1678	56	5	.	.	PUNCT
easat-1678	57	1	study	study	NOUN
easat-1678	57	2	design	design	NOUN
easat-1678	57	3	in	in	ADP
easat-1678	57	4	this	this	DET
easat-1678	57	5	research	research	NOUN
easat-1678	57	6	,	,	PUNCT
easat-1678	57	7	five	five	NUM
easat-1678	57	8	years	year	NOUN
easat-1678	57	9	of	of	ADP
easat-1678	57	10	medical	medical	ADJ
easat-1678	57	11	data	datum	NOUN
easat-1678	57	12	from	from	ADP
easat-1678	57	13	the	the	DET
easat-1678	57	14	center	center	NOUN
easat-1678	57	15	for	for	ADP
easat-1678	57	16	genetic	genetic	ADJ
easat-1678	57	17	blood	blood	NOUN
easat-1678	57	18	diseases	disease	NOUN
easat-1678	57	19	(	(	PUNCT
easat-1678	57	20	thalassemia	thalassemia	NOUN
easat-1678	57	21	)	)	PUNCT
easat-1678	57	22	at	at	ADP
easat-1678	57	23	maysan	maysan	PROPN
easat-1678	57	24	governorate	governorate	PROPN
easat-1678	57	25	,	,	PUNCT
easat-1678	57	26	iraq	iraq	PROPN
easat-1678	57	27	,	,	PUNCT
easat-1678	57	28	were	be	AUX
easat-1678	57	29	retrospectively	retrospectively	ADV
easat-1678	57	30	reviewed	review	VERB
easat-1678	57	31	.	.	PUNCT
easat-1678	58	1	data	datum	NOUN
easat-1678	58	2	regarding	regard	VERB
easat-1678	58	3	patients	patient	NOUN
easat-1678	58	4	525	525	NUM
easat-1678	58	5	edelweiss	edelweiss	PROPN
easat-1678	58	6	applied	apply	VERB
easat-1678	58	7	science	science	NOUN
easat-1678	58	8	and	and	CCONJ
easat-1678	58	9	technology	technology	NOUN
easat-1678	58	10	issn	issn	PROPN
easat-1678	58	11	:	:	PUNCT
easat-1678	58	12	2576	2576	NUM
easat-1678	58	13	-	-	SYM
easat-1678	58	14	8484	8484	NUM
easat-1678	58	15	vol	vol	NOUN
easat-1678	58	16	.	.	PROPN
easat-1678	59	1	8	8	NUM
easat-1678	59	2	,	,	PUNCT
easat-1678	59	3	no	no	INTJ
easat-1678	59	4	.	.	NOUN
easat-1678	60	1	3	3	NUM
easat-1678	60	2	:	:	PUNCT
easat-1678	60	3	523	523	NUM
easat-1678	60	4	-	-	SYM
easat-1678	60	5	532	532	NUM
easat-1678	60	6	,	,	PUNCT
easat-1678	60	7	2024	2024	NUM
easat-1678	60	8	doi	doi	NOUN
easat-1678	60	9	:	:	PUNCT
easat-1678	60	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	60	11	©	©	PROPN
easat-1678	60	12	2024	2024	NUM
easat-1678	60	13	by	by	ADP
easat-1678	60	14	the	the	DET
easat-1678	60	15	authors	author	NOUN
easat-1678	60	16	;	;	PUNCT
easat-1678	60	17	licensee	licensee	PROPN
easat-1678	60	18	learning	learning	NOUN
easat-1678	60	19	gate	gate	NOUN
easat-1678	60	20	with	with	ADP
easat-1678	60	21	thalassemia	thalassemia	NOUN
easat-1678	60	22	associated	associate	VERB
easat-1678	60	23	with	with	ADP
easat-1678	60	24	viral	viral	ADJ
easat-1678	60	25	infections	infection	NOUN
easat-1678	60	26	were	be	AUX
easat-1678	60	27	extracted	extract	VERB
easat-1678	60	28	.	.	PUNCT
easat-1678	61	1	the	the	DET
easat-1678	61	2	data	datum	NOUN
easat-1678	61	3	used	use	VERB
easat-1678	61	4	in	in	ADP
easat-1678	61	5	this	this	DET
easat-1678	61	6	study	study	NOUN
easat-1678	61	7	were	be	AUX
easat-1678	61	8	obtained	obtain	VERB
easat-1678	61	9	from	from	ADP
easat-1678	61	10	the	the	DET
easat-1678	61	11	centre	centre	NOUN
easat-1678	61	12	for	for	ADP
easat-1678	61	13	genetic	genetic	ADJ
easat-1678	61	14	blood	blood	NOUN
easat-1678	61	15	diseases	disease	NOUN
easat-1678	61	16	,	,	PUNCT
easat-1678	61	17	which	which	PRON
easat-1678	61	18	is	be	AUX
easat-1678	61	19	interested	interested	ADJ
easat-1678	61	20	in	in	ADP
easat-1678	61	21	blood	blood	NOUN
easat-1678	61	22	disorders	disorder	NOUN
easat-1678	61	23	;	;	PUNCT
easat-1678	61	24	the	the	DET
easat-1678	61	25	information	information	NOUN
easat-1678	61	26	for	for	ADP
easat-1678	61	27	all	all	DET
easat-1678	61	28	patients	patient	NOUN
easat-1678	61	29	was	be	AUX
easat-1678	61	30	anonymized	anonymize	VERB
easat-1678	61	31	to	to	PART
easat-1678	61	32	guarantee	guarantee	VERB
easat-1678	61	33	their	their	PRON
easat-1678	61	34	privacy	privacy	NOUN
easat-1678	61	35	and	and	CCONJ
easat-1678	61	36	keep	keep	VERB
easat-1678	61	37	it	it	PRON
easat-1678	61	38	confidential	confidential	ADJ
easat-1678	61	39	.	.	PUNCT
easat-1678	62	1	2.2	2.2	NUM
easat-1678	62	2	.	.	PUNCT
easat-1678	63	1	inclusion	inclusion	NOUN
easat-1678	63	2	and	and	CCONJ
easat-1678	63	3	exclusion	exclusion	NOUN
easat-1678	63	4	criteria	criterion	NOUN
easat-1678	63	5	inclusion	inclusion	NOUN
easat-1678	63	6	criteria	criterion	NOUN
easat-1678	63	7	:	:	PUNCT
easat-1678	63	8	1	1	X
easat-1678	63	9	.	.	X
easat-1678	64	1	patients	patient	NOUN
easat-1678	64	2	diagnosed	diagnose	VERB
easat-1678	64	3	with	with	ADP
easat-1678	64	4	either	either	CCONJ
easat-1678	64	5	major	major	ADJ
easat-1678	64	6	or	or	CCONJ
easat-1678	64	7	intermediate	intermediate	ADJ
easat-1678	64	8	thalassemia	thalassemia	NOUN
easat-1678	64	9	.	.	PUNCT
easat-1678	65	1	2	2	X
easat-1678	65	2	.	.	X
easat-1678	65	3	patients	patient	NOUN
easat-1678	65	4	with	with	ADP
easat-1678	65	5	viral	viral	ADJ
easat-1678	65	6	infections	infection	NOUN
easat-1678	65	7	such	such	ADJ
easat-1678	65	8	as	as	ADP
easat-1678	65	9	hepatitis	hepatitis	PROPN
easat-1678	65	10	b	b	PROPN
easat-1678	65	11	,	,	PUNCT
easat-1678	65	12	hepatitis	hepatitis	NOUN
easat-1678	65	13	c	c	NOUN
easat-1678	65	14	,	,	PUNCT
easat-1678	65	15	or	or	CCONJ
easat-1678	65	16	hiv	hiv	PROPN
easat-1678	65	17	during	during	ADP
easat-1678	65	18	the	the	DET
easat-1678	65	19	study	study	NOUN
easat-1678	65	20	period	period	NOUN
easat-1678	65	21	.	.	PUNCT
easat-1678	66	1	3	3	X
easat-1678	66	2	.	.	X
easat-1678	66	3	availability	availability	NOUN
easat-1678	66	4	of	of	ADP
easat-1678	66	5	complete	complete	ADJ
easat-1678	66	6	clinical	clinical	ADJ
easat-1678	66	7	records	record	NOUN
easat-1678	66	8	and	and	CCONJ
easat-1678	66	9	test	test	NOUN
easat-1678	66	10	results	result	NOUN
easat-1678	66	11	for	for	ADP
easat-1678	66	12	il-18	il-18	PRON
easat-1678	66	13	and	and	CCONJ
easat-1678	66	14	il-28	il-28	NUM
easat-1678	66	15	levels	level	NOUN
easat-1678	66	16	.	.	PUNCT
easat-1678	67	1	exclusion	exclusion	NOUN
easat-1678	67	2	criteria	criterion	NOUN
easat-1678	67	3	1	1	NUM
easat-1678	67	4	.	.	PUNCT
easat-1678	67	5	incomplete	incomplete	ADJ
easat-1678	67	6	medical	medical	ADJ
easat-1678	67	7	records	record	NOUN
easat-1678	67	8	or	or	CCONJ
easat-1678	67	9	missing	miss	VERB
easat-1678	67	10	laboratory	laboratory	NOUN
easat-1678	67	11	results	result	NOUN
easat-1678	67	12	.	.	PUNCT
easat-1678	68	1	2	2	X
easat-1678	68	2	.	.	X
easat-1678	68	3	presence	presence	NOUN
easat-1678	68	4	of	of	ADP
easat-1678	68	5	other	other	ADJ
easat-1678	68	6	underlying	underlying	ADJ
easat-1678	68	7	immune	immune	ADJ
easat-1678	68	8	disorders	disorder	NOUN
easat-1678	68	9	.	.	PUNCT
easat-1678	69	1	3	3	X
easat-1678	69	2	.	.	X
easat-1678	69	3	current	current	ADJ
easat-1678	69	4	diagnosis	diagnosis	NOUN
easat-1678	69	5	of	of	ADP
easat-1678	69	6	cancer	cancer	NOUN
easat-1678	69	7	or	or	CCONJ
easat-1678	69	8	use	use	NOUN
easat-1678	69	9	of	of	ADP
easat-1678	69	10	immunosuppressive	immunosuppressive	ADJ
easat-1678	69	11	therapy	therapy	NOUN
easat-1678	69	12	.	.	PUNCT
easat-1678	70	1	2.3	2.3	NUM
easat-1678	70	2	.	.	PUNCT
easat-1678	71	1	data	datum	NOUN
easat-1678	71	2	collection	collection	NOUN
easat-1678	71	3	the	the	DET
easat-1678	71	4	data	datum	NOUN
easat-1678	71	5	collected	collect	VERB
easat-1678	71	6	include	include	VERB
easat-1678	71	7	details	detail	NOUN
easat-1678	71	8	about	about	ADP
easat-1678	71	9	their	their	PRON
easat-1678	71	10	demographics	demographic	NOUN
easat-1678	71	11	,	,	PUNCT
easat-1678	71	12	thalassemia	thalassemia	NOUN
easat-1678	71	13	type	type	NOUN
easat-1678	71	14	,	,	PUNCT
easat-1678	71	15	blood	blood	NOUN
easat-1678	71	16	transfusion	transfusion	NOUN
easat-1678	71	17	history	history	NOUN
easat-1678	71	18	,	,	PUNCT
easat-1678	71	19	and	and	CCONJ
easat-1678	71	20	any	any	DET
easat-1678	71	21	existing	exist	VERB
easat-1678	71	22	viral	viral	ADJ
easat-1678	71	23	infection	infection	NOUN
easat-1678	71	24	.	.	PUNCT
easat-1678	72	1	laboratory	laboratory	NOUN
easat-1678	72	2	tests	test	NOUN
easat-1678	72	3	include	include	VERB
easat-1678	72	4	blood	blood	NOUN
easat-1678	72	5	complete	complete	ADJ
easat-1678	72	6	count	count	NOUN
easat-1678	72	7	,	,	PUNCT
easat-1678	72	8	liver	liver	NOUN
easat-1678	72	9	function	function	NOUN
easat-1678	72	10	,	,	PUNCT
easat-1678	72	11	iron	iron	NOUN
easat-1678	72	12	overload	overload	NOUN
easat-1678	72	13	indicators	indicator	NOUN
easat-1678	72	14	,	,	PUNCT
easat-1678	72	15	and	and	CCONJ
easat-1678	72	16	il-18	il-18	NOUN
easat-1678	72	17	and	and	CCONJ
easat-1678	72	18	il-28	il-28	ADV
easat-1678	72	19	blood	blood	NOUN
easat-1678	72	20	levels	level	NOUN
easat-1678	72	21	.	.	PUNCT
easat-1678	73	1	the	the	DET
easat-1678	73	2	latter	latter	ADJ
easat-1678	73	3	means	mean	VERB
easat-1678	73	4	the	the	DET
easat-1678	73	5	type	type	NOUN
easat-1678	73	6	and	and	CCONJ
easat-1678	73	7	quantity	quantity	NOUN
easat-1678	73	8	of	of	ADP
easat-1678	73	9	viruses	virus	NOUN
easat-1678	73	10	to	to	PART
easat-1678	73	11	be	be	AUX
easat-1678	73	12	evaluated	evaluate	VERB
easat-1678	73	13	include	include	VERB
easat-1678	73	14	hepatitis	hepatitis	PROPN
easat-1678	73	15	b	b	PROPN
easat-1678	73	16	,	,	PUNCT
easat-1678	73	17	hepatitis	hepatitis	NOUN
easat-1678	73	18	c	c	NOUN
easat-1678	73	19	,	,	PUNCT
easat-1678	73	20	and	and	CCONJ
easat-1678	73	21	hiv	hiv	PROPN
easat-1678	73	22	.	.	PUNCT
easat-1678	74	1	other	other	ADJ
easat-1678	74	2	data	datum	NOUN
easat-1678	74	3	to	to	PART
easat-1678	74	4	be	be	AUX
easat-1678	74	5	taken	take	VERB
easat-1678	74	6	involve	involve	VERB
easat-1678	74	7	individual	individual	ADJ
easat-1678	74	8	patients	patient	NOUN
easat-1678	74	9	'	'	PART
easat-1678	74	10	responses	response	NOUN
easat-1678	74	11	to	to	ADP
easat-1678	74	12	antiviral	antiviral	ADJ
easat-1678	74	13	therapy	therapy	NOUN
easat-1678	74	14	and	and	CCONJ
easat-1678	74	15	health	health	NOUN
easat-1678	74	16	complications	complication	NOUN
easat-1678	74	17	.	.	PUNCT
easat-1678	75	1	2.4	2.4	NUM
easat-1678	75	2	.	.	PUNCT
easat-1678	76	1	outcome	outcome	NOUN
easat-1678	76	2	measures	measure	NOUN
easat-1678	76	3	this	this	PRON
easat-1678	76	4	is	be	AUX
easat-1678	76	5	the	the	DET
easat-1678	76	6	primary	primary	ADJ
easat-1678	76	7	outcome	outcome	NOUN
easat-1678	76	8	of	of	ADP
easat-1678	76	9	the	the	DET
easat-1678	76	10	study	study	NOUN
easat-1678	76	11	:	:	PUNCT
easat-1678	76	12	the	the	DET
easat-1678	76	13	relationship	relationship	NOUN
easat-1678	76	14	of	of	ADP
easat-1678	76	15	levels	level	NOUN
easat-1678	76	16	of	of	ADP
easat-1678	76	17	il-18	il-18	NOUN
easat-1678	76	18	and	and	CCONJ
easat-1678	76	19	il-28	il-28	ADV
easat-1678	76	20	to	to	ADP
easat-1678	76	21	infection	infection	NOUN
easat-1678	76	22	by	by	ADP
easat-1678	76	23	viruses	virus	NOUN
easat-1678	76	24	in	in	ADP
easat-1678	76	25	thalassemia	thalassemia	NOUN
easat-1678	76	26	patients	patient	NOUN
easat-1678	76	27	.	.	PUNCT
easat-1678	77	1	secondary	secondary	ADJ
easat-1678	77	2	outcome	outcome	NOUN
easat-1678	77	3	measures	measure	NOUN
easat-1678	77	4	include	include	VERB
easat-1678	77	5	the	the	DET
easat-1678	77	6	following	following	NOUN
easat-1678	77	7	:	:	PUNCT
easat-1678	77	8	correlations	correlation	NOUN
easat-1678	77	9	of	of	ADP
easat-1678	77	10	interleukin	interleukin	NOUN
easat-1678	77	11	levels	level	NOUN
easat-1678	77	12	with	with	ADP
easat-1678	77	13	viral	viral	ADJ
easat-1678	77	14	load	load	NOUN
easat-1678	77	15	,	,	PUNCT
easat-1678	77	16	treatment	treatment	NOUN
easat-1678	77	17	efficacy	efficacy	NOUN
easat-1678	77	18	,	,	PUNCT
easat-1678	77	19	health	health	NOUN
easat-1678	77	20	outcomes	outcome	NOUN
easat-1678	77	21	,	,	PUNCT
easat-1678	77	22	and	and	CCONJ
easat-1678	77	23	predictive	predictive	ADJ
easat-1678	77	24	value	value	NOUN
easat-1678	77	25	of	of	ADP
easat-1678	77	26	interleukins	interleukin	NOUN
easat-1678	77	27	for	for	ADP
easat-1678	77	28	infection	infection	NOUN
easat-1678	77	29	severity	severity	NOUN
easat-1678	77	30	and	and	CCONJ
easat-1678	77	31	progression	progression	NOUN
easat-1678	77	32	.	.	PUNCT
easat-1678	78	1	2.5	2.5	NUM
easat-1678	78	2	.	.	PUNCT
easat-1678	79	1	statistical	statistical	ADJ
easat-1678	79	2	analysis	analysis	NOUN
easat-1678	79	3	data	datum	NOUN
easat-1678	79	4	analysis	analysis	NOUN
easat-1678	79	5	has	have	AUX
easat-1678	79	6	been	be	AUX
easat-1678	79	7	done	do	VERB
easat-1678	79	8	using	use	VERB
easat-1678	79	9	spss	spss	PROPN
easat-1678	79	10	software	software	NOUN
easat-1678	79	11	25	25	NUM
easat-1678	79	12	.	.	PUNCT
easat-1678	80	1	descriptive	descriptive	ADJ
easat-1678	80	2	statistics	statistic	NOUN
easat-1678	80	3	revealed	reveal	VERB
easat-1678	80	4	the	the	DET
easat-1678	80	5	patient	patient	ADJ
easat-1678	80	6	characteristics	characteristic	NOUN
easat-1678	80	7	and	and	CCONJ
easat-1678	80	8	health	health	NOUN
easat-1678	80	9	condition	condition	NOUN
easat-1678	80	10	,	,	PUNCT
easat-1678	80	11	comprising	comprising	NOUN
easat-1678	80	12	means	mean	NOUN
easat-1678	80	13	and	and	CCONJ
easat-1678	80	14	standard	standard	ADJ
easat-1678	80	15	deviations	deviation	NOUN
easat-1678	80	16	for	for	ADP
easat-1678	80	17	continuous	continuous	ADJ
easat-1678	80	18	variables	variable	NOUN
easat-1678	80	19	and	and	CCONJ
easat-1678	80	20	frequencies	frequency	NOUN
easat-1678	80	21	for	for	ADP
easat-1678	80	22	the	the	DET
easat-1678	80	23	categorical	categorical	ADJ
easat-1678	80	24	one	one	NUM
easat-1678	80	25	.	.	PUNCT
easat-1678	81	1	the	the	DET
easat-1678	81	2	choice	choice	NOUN
easat-1678	81	3	of	of	ADP
easat-1678	81	4	the	the	DET
easat-1678	81	5	appropriate	appropriate	ADJ
easat-1678	81	6	statistical	statistical	ADJ
easat-1678	81	7	tests	test	NOUN
easat-1678	81	8	depended	depend	VERB
easat-1678	81	9	on	on	ADP
easat-1678	81	10	the	the	DET
easat-1678	81	11	distribution	distribution	NOUN
easat-1678	81	12	of	of	ADP
easat-1678	81	13	data	datum	NOUN
easat-1678	81	14	to	to	PART
easat-1678	81	15	analyze	analyze	VERB
easat-1678	81	16	the	the	DET
easat-1678	81	17	relationship	relationship	NOUN
easat-1678	81	18	of	of	ADP
easat-1678	81	19	interleukin	interleukin	NOUN
easat-1678	81	20	levels	level	NOUN
easat-1678	81	21	with	with	ADP
easat-1678	81	22	the	the	DET
easat-1678	81	23	viral	viral	ADJ
easat-1678	81	24	load	load	NOUN
easat-1678	81	25	.	.	PUNCT
easat-1678	82	1	advanced	advanced	ADJ
easat-1678	82	2	statistical	statistical	ADJ
easat-1678	82	3	methods	method	NOUN
easat-1678	82	4	have	have	AUX
easat-1678	82	5	been	be	AUX
easat-1678	82	6	applied	apply	VERB
easat-1678	82	7	to	to	PART
easat-1678	82	8	control	control	VERB
easat-1678	82	9	the	the	DET
easat-1678	82	10	confounding	confound	VERB
easat-1678	82	11	factors	factor	NOUN
easat-1678	82	12	.	.	PUNCT
easat-1678	83	1	to	to	PART
easat-1678	83	2	establish	establish	VERB
easat-1678	83	3	the	the	DET
easat-1678	83	4	prognostic	prognostic	ADJ
easat-1678	83	5	value	value	NOUN
easat-1678	83	6	of	of	ADP
easat-1678	83	7	il-18	il-18	NOUN
easat-1678	83	8	and	and	CCONJ
easat-1678	83	9	il-28	il-28	VERB
easat-1678	83	10	level	level	NOUN
easat-1678	83	11	in	in	ADP
easat-1678	83	12	prediction	prediction	NOUN
easat-1678	83	13	of	of	ADP
easat-1678	83	14	viral	viral	ADJ
easat-1678	83	15	infection	infection	NOUN
easat-1678	83	16	,	,	PUNCT
easat-1678	83	17	a	a	DET
easat-1678	83	18	receiver	receiver	NOUN
easat-1678	83	19	operating	operate	VERB
easat-1678	83	20	characteristic	characteristic	ADJ
easat-1678	83	21	curve	curve	NOUN
easat-1678	83	22	analysis	analysis	NOUN
easat-1678	83	23	was	be	AUX
easat-1678	83	24	carried	carry	VERB
easat-1678	83	25	out	out	ADP
easat-1678	83	26	.	.	PUNCT
easat-1678	84	1	survival	survival	NOUN
easat-1678	84	2	analysis	analysis	NOUN
easat-1678	84	3	enabled	enable	VERB
easat-1678	84	4	the	the	DET
easat-1678	84	5	demonstration	demonstration	NOUN
easat-1678	84	6	of	of	ADP
easat-1678	84	7	how	how	SCONJ
easat-1678	84	8	the	the	DET
easat-1678	84	9	levels	level	NOUN
easat-1678	84	10	of	of	ADP
easat-1678	84	11	interleukins	interleukin	NOUN
easat-1678	84	12	affected	affect	VERB
easat-1678	84	13	the	the	DET
easat-1678	84	14	outcomes	outcome	NOUN
easat-1678	84	15	of	of	ADP
easat-1678	84	16	the	the	DET
easat-1678	84	17	patients	patient	NOUN
easat-1678	84	18	over	over	ADP
easat-1678	84	19	the	the	DET
easat-1678	84	20	period	period	NOUN
easat-1678	84	21	.	.	PUNCT
easat-1678	85	1	3	3	X
easat-1678	85	2	.	.	NOUN
easat-1678	85	3	results	result	VERB
easat-1678	85	4	3.1	3.1	NUM
easat-1678	85	5	.	.	PUNCT
easat-1678	86	1	demographics	demographic	NOUN
easat-1678	86	2	and	and	CCONJ
easat-1678	86	3	clinical	clinical	ADJ
easat-1678	86	4	characteristics	characteristic	NOUN
easat-1678	86	5	the	the	DET
easat-1678	86	6	study	study	NOUN
easat-1678	86	7	included	include	VERB
easat-1678	86	8	250	250	NUM
easat-1678	86	9	thalassemia	thalassemia	NOUN
easat-1678	86	10	patients	patient	NOUN
easat-1678	86	11	with	with	ADP
easat-1678	86	12	viral	viral	ADJ
easat-1678	86	13	infections	infection	NOUN
easat-1678	86	14	.	.	PUNCT
easat-1678	87	1	the	the	DET
easat-1678	87	2	average	average	ADJ
easat-1678	87	3	age	age	NOUN
easat-1678	87	4	of	of	ADP
easat-1678	87	5	these	these	DET
easat-1678	87	6	patients	patient	NOUN
easat-1678	87	7	was	be	AUX
easat-1678	87	8	32.6	32.6	NUM
easat-1678	87	9	years	year	NOUN
easat-1678	87	10	(	(	PUNCT
easat-1678	87	11	±10.2	±10.2	NUM
easat-1678	87	12	)	)	PUNCT
easat-1678	87	13	,	,	PUNCT
easat-1678	87	14	with	with	ADP
easat-1678	87	15	a	a	DET
easat-1678	87	16	slight	slight	ADJ
easat-1678	87	17	male	male	ADJ
easat-1678	87	18	majority	majority	NOUN
easat-1678	87	19	(	(	PUNCT
easat-1678	87	20	55.2	55.2	NUM
easat-1678	87	21	%	%	NOUN
easat-1678	87	22	)	)	PUNCT
easat-1678	87	23	.	.	PUNCT
easat-1678	88	1	most	most	ADJ
easat-1678	88	2	patients	patient	NOUN
easat-1678	88	3	had	have	VERB
easat-1678	88	4	a	a	DET
easat-1678	88	5	severe	severe	ADJ
easat-1678	88	6	form	form	NOUN
easat-1678	88	7	of	of	ADP
easat-1678	88	8	thalassemia	thalassemia	NOUN
easat-1678	88	9	,	,	PUNCT
easat-1678	88	10	specifically	specifically	ADV
easat-1678	88	11	beta	beta	NOUN
easat-1678	88	12	-	-	PUNCT
easat-1678	88	13	thalassemia	thalassemia	NOUN
easat-1678	88	14	major	major	NOUN
easat-1678	88	15	(	(	PUNCT
easat-1678	88	16	78.4	78.4	NUM
easat-1678	88	17	%	%	NOUN
easat-1678	88	18	)	)	PUNCT
easat-1678	88	19	.	.	PUNCT
easat-1678	89	1	the	the	DET
easat-1678	89	2	most	most	ADV
easat-1678	89	3	common	common	ADJ
easat-1678	89	4	viral	viral	ADJ
easat-1678	89	5	infection	infection	NOUN
easat-1678	89	6	was	be	AUX
easat-1678	89	7	hepatitis	hepatitis	PROPN
easat-1678	89	8	c	c	NOUN
easat-1678	89	9	(	(	PUNCT
easat-1678	89	10	62.4	62.4	NUM
easat-1678	89	11	%	%	NOUN
easat-1678	89	12	)	)	PUNCT
easat-1678	89	13	,	,	PUNCT
easat-1678	89	14	followed	follow	VERB
easat-1678	89	15	by	by	ADP
easat-1678	89	16	hepatitis	hepatitis	PROPN
easat-1678	89	17	b	b	PROPN
easat-1678	89	18	(	(	PUNCT
easat-1678	89	19	28.8	28.8	NUM
easat-1678	89	20	%	%	NOUN
easat-1678	89	21	)	)	PUNCT
easat-1678	89	22	and	and	CCONJ
easat-1678	89	23	hiv	hiv	PROPN
easat-1678	89	24	(	(	PUNCT
easat-1678	89	25	8.8	8.8	NUM
easat-1678	89	26	%	%	NOUN
easat-1678	89	27	)	)	PUNCT
easat-1678	89	28	.	.	PUNCT
easat-1678	90	1	on	on	ADP
easat-1678	90	2	average	average	ADJ
easat-1678	90	3	,	,	PUNCT
easat-1678	90	4	these	these	DET
easat-1678	90	5	patients	patient	NOUN
easat-1678	90	6	received	receive	VERB
easat-1678	90	7	12	12	NUM
easat-1678	90	8	blood	blood	NOUN
easat-1678	90	9	transfusions	transfusion	NOUN
easat-1678	90	10	per	per	ADP
easat-1678	90	11	year	year	NOUN
easat-1678	90	12	,	,	PUNCT
easat-1678	90	13	with	with	ADP
easat-1678	90	14	a	a	DET
easat-1678	90	15	range	range	NOUN
easat-1678	90	16	of	of	ADP
easat-1678	90	17	10	10	NUM
easat-1678	90	18	to	to	PART
easat-1678	90	19	14	14	NUM
easat-1678	90	20	transfusions	transfusion	NOUN
easat-1678	90	21	.	.	PUNCT
easat-1678	91	1	elevated	elevate	VERB
easat-1678	91	2	ferritin	ferritin	ADJ
easat-1678	91	3	levels	level	NOUN
easat-1678	91	4	,	,	PUNCT
easat-1678	91	5	indicating	indicate	VERB
easat-1678	91	6	iron	iron	NOUN
easat-1678	91	7	overload	overload	NOUN
easat-1678	91	8	,	,	PUNCT
easat-1678	91	9	were	be	AUX
easat-1678	91	10	observed	observe	VERB
easat-1678	91	11	in	in	ADP
easat-1678	91	12	72.4	72.4	NUM
easat-1678	91	13	%	%	NOUN
easat-1678	91	14	of	of	ADP
easat-1678	91	15	the	the	DET
easat-1678	91	16	patients	patient	NOUN
easat-1678	91	17	,	,	PUNCT
easat-1678	91	18	and	and	CCONJ
easat-1678	91	19	liver	liver	NOUN
easat-1678	91	20	dysfunction	dysfunction	NOUN
easat-1678	91	21	was	be	AUX
easat-1678	91	22	present	present	ADJ
easat-1678	91	23	in	in	ADP
easat-1678	91	24	43.2	43.2	NUM
easat-1678	91	25	%	%	NOUN
easat-1678	91	26	of	of	ADP
easat-1678	91	27	cases	case	NOUN
easat-1678	91	28	these	these	DET
easat-1678	91	29	differences	difference	NOUN
easat-1678	91	30	are	be	AUX
easat-1678	91	31	illustrated	illustrate	VERB
easat-1678	91	32	in	in	ADP
easat-1678	91	33	figure	figure	NOUN
easat-1678	91	34	1	1	NUM
easat-1678	91	35	.	.	X
easat-1678	91	36	526	526	NUM
easat-1678	91	37	edelweiss	edelweiss	PROPN
easat-1678	91	38	applied	apply	VERB
easat-1678	91	39	science	science	NOUN
easat-1678	91	40	and	and	CCONJ
easat-1678	91	41	technology	technology	NOUN
easat-1678	91	42	issn	issn	PROPN
easat-1678	91	43	:	:	PUNCT
easat-1678	91	44	2576	2576	NUM
easat-1678	91	45	-	-	SYM
easat-1678	91	46	8484	8484	NUM
easat-1678	91	47	vol	vol	NOUN
easat-1678	91	48	.	.	PROPN
easat-1678	92	1	8	8	NUM
easat-1678	92	2	,	,	PUNCT
easat-1678	92	3	no	no	INTJ
easat-1678	92	4	.	.	NOUN
easat-1678	93	1	3	3	NUM
easat-1678	93	2	:	:	PUNCT
easat-1678	93	3	523	523	NUM
easat-1678	93	4	-	-	SYM
easat-1678	93	5	532	532	NUM
easat-1678	93	6	,	,	PUNCT
easat-1678	93	7	2024	2024	NUM
easat-1678	93	8	doi	doi	NOUN
easat-1678	93	9	:	:	PUNCT
easat-1678	93	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	93	11	©	©	PROPN
easat-1678	93	12	2024	2024	NUM
easat-1678	93	13	by	by	ADP
easat-1678	93	14	the	the	DET
easat-1678	93	15	authors	author	NOUN
easat-1678	93	16	;	;	PUNCT
easat-1678	93	17	licensee	licensee	PROPN
easat-1678	93	18	learning	learn	VERB
easat-1678	93	19	gate	gate	NOUN
easat-1678	93	20	table	table	NOUN
easat-1678	93	21	1	1	NUM
easat-1678	93	22	.	.	PUNCT
easat-1678	94	1	demographics	demographic	NOUN
easat-1678	94	2	and	and	CCONJ
easat-1678	94	3	clinical	clinical	ADJ
easat-1678	94	4	characteristics	characteristic	NOUN
easat-1678	94	5	.	.	PUNCT
easat-1678	95	1	variable	variable	NOUN
easat-1678	95	2	n=250	n=250	PROPN
easat-1678	95	3	mean	mean	VERB
easat-1678	95	4	age	age	NOUN
easat-1678	95	5	32.6	32.6	NUM
easat-1678	95	6	±	±	NUM
easat-1678	95	7	10.2	10.2	NUM
easat-1678	95	8	years	year	NOUN
easat-1678	95	9	gender	gender	NOUN
easat-1678	95	10	male	male	NOUN
easat-1678	95	11	55.2	55.2	NUM
easat-1678	95	12	%	%	NOUN
easat-1678	95	13	female	female	ADJ
easat-1678	95	14	44.8	44.8	NUM
easat-1678	95	15	%	%	NOUN
easat-1678	95	16	thalassemia	thalassemia	NOUN
easat-1678	95	17	type	type	NOUN
easat-1678	95	18	beta	beta	NOUN
easat-1678	95	19	-	-	PUNCT
easat-1678	95	20	thalassemia	thalassemia	NOUN
easat-1678	95	21	major	major	ADJ
easat-1678	95	22	78.4	78.4	NUM
easat-1678	95	23	%	%	NOUN
easat-1678	95	24	beta	beta	NOUN
easat-1678	95	25	-	-	PUNCT
easat-1678	95	26	thalassemia	thalassemia	NOUN
easat-1678	95	27	intermediate	intermediate	ADJ
easat-1678	95	28	21.6	21.6	NUM
easat-1678	95	29	%	%	NOUN
easat-1678	95	30	viral	viral	ADJ
easat-1678	95	31	infection	infection	NOUN
easat-1678	95	32	hepatitis	hepatitis	NOUN
easat-1678	95	33	c	c	PROPN
easat-1678	95	34	62.4	62.4	NUM
easat-1678	95	35	%	%	NOUN
easat-1678	95	36	hepatitis	hepatitis	NOUN
easat-1678	95	37	b	b	PROPN
easat-1678	95	38	28.8	28.8	NUM
easat-1678	95	39	%	%	NOUN
easat-1678	95	40	hiv	hiv	NOUN
easat-1678	95	41	8.8	8.8	NUM
easat-1678	95	42	%	%	NOUN
easat-1678	95	43	transfusion	transfusion	NOUN
easat-1678	95	44	frequency	frequency	NOUN
easat-1678	95	45	median	median	NOUN
easat-1678	95	46	:	:	PUNCT
easat-1678	95	47	12	12	NUM
easat-1678	95	48	times	time	NOUN
easat-1678	95	49	/	/	SYM
easat-1678	95	50	year	year	NOUN
easat-1678	95	51	iron	iron	NOUN
easat-1678	95	52	overload	overload	NOUN
easat-1678	95	53	present	present	ADJ
easat-1678	95	54	:	:	PUNCT
easat-1678	95	55	72.4	72.4	NUM
easat-1678	95	56	%	%	NOUN
easat-1678	95	57	liver	liver	NOUN
easat-1678	95	58	dysfunction	dysfunction	NOUN
easat-1678	95	59	present	present	NOUN
easat-1678	95	60	:	:	PUNCT
easat-1678	95	61	43.2	43.2	NUM
easat-1678	95	62	%	%	NOUN
easat-1678	95	63	figure	figure	NOUN
easat-1678	95	64	1	1	NUM
easat-1678	95	65	.	.	PUNCT
easat-1678	96	1	distribution	distribution	NOUN
easat-1678	96	2	of	of	ADP
easat-1678	96	3	gender	gender	NOUN
easat-1678	96	4	among	among	ADP
easat-1678	96	5	study	study	NOUN
easat-1678	96	6	participants	participant	NOUN
easat-1678	96	7	,	,	PUNCT
easat-1678	96	8	with	with	ADP
easat-1678	96	9	55.2	55.2	NUM
easat-1678	96	10	%	%	NOUN
easat-1678	96	11	being	be	AUX
easat-1678	96	12	male	male	ADJ
easat-1678	96	13	and	and	CCONJ
easat-1678	96	14	44.8	44.8	NUM
easat-1678	96	15	%	%	NOUN
easat-1678	96	16	being	be	AUX
easat-1678	96	17	female	female	ADJ
easat-1678	96	18	.	.	PUNCT
easat-1678	97	1	3.2	3.2	NUM
easat-1678	97	2	.	.	PUNCT
easat-1678	97	3	levels	level	NOUN
easat-1678	97	4	of	of	ADP
easat-1678	97	5	il-18	il-18	PUNCT
easat-1678	97	6	and	and	CCONJ
easat-1678	97	7	il-28	il-28	ADV
easat-1678	97	8	in	in	ADP
easat-1678	97	9	thalassemia	thalassemia	NOUN
easat-1678	97	10	patients	patient	NOUN
easat-1678	97	11	with	with	ADP
easat-1678	97	12	viral	viral	ADJ
easat-1678	97	13	infections	infection	NOUN
easat-1678	97	14	patients	patient	NOUN
easat-1678	97	15	with	with	ADP
easat-1678	97	16	viral	viral	ADJ
easat-1678	97	17	infections	infection	NOUN
easat-1678	97	18	had	have	VERB
easat-1678	97	19	significantly	significantly	ADV
easat-1678	97	20	higher	high	ADJ
easat-1678	97	21	levels	level	NOUN
easat-1678	97	22	of	of	ADP
easat-1678	97	23	il-18	il-18	PUNCT
easat-1678	97	24	and	and	CCONJ
easat-1678	97	25	il-28	il-28	ADV
easat-1678	97	26	compared	compare	VERB
easat-1678	97	27	to	to	ADP
easat-1678	97	28	those	those	PRON
easat-1678	97	29	without	without	ADP
easat-1678	97	30	infections	infection	NOUN
easat-1678	97	31	(	(	PUNCT
easat-1678	97	32	p	p	X
easat-1678	97	33	<	<	X
easat-1678	97	34	0.001	0.001	NUM
easat-1678	97	35	)	)	PUNCT
easat-1678	97	36	.	.	PUNCT
easat-1678	98	1	the	the	DET
easat-1678	98	2	median	median	PROPN
easat-1678	98	3	il-18	il-18	CCONJ
easat-1678	98	4	level	level	NOUN
easat-1678	98	5	in	in	ADP
easat-1678	98	6	infected	infected	ADJ
easat-1678	98	7	patients	patient	NOUN
easat-1678	98	8	was	be	AUX
easat-1678	98	9	423.5	423.5	NUM
easat-1678	98	10	pg	pg	NOUN
easat-1678	98	11	/	/	SYM
easat-1678	98	12	ml	ml	PROPN
easat-1678	98	13	(	(	PUNCT
easat-1678	98	14	range	range	VERB
easat-1678	98	15	352.0	352.0	NUM
easat-1678	98	16	587.8	587.8	NUM
easat-1678	98	17	)	)	PUNCT
easat-1678	98	18	,	,	PUNCT
easat-1678	98	19	compared	compare	VERB
easat-1678	98	20	to	to	ADP
easat-1678	98	21	125.6	125.6	NUM
easat-1678	98	22	pg	pg	NOUN
easat-1678	98	23	/	/	SYM
easat-1678	98	24	ml	ml	PROPN
easat-1678	98	25	(	(	PUNCT
easat-1678	98	26	range	range	VERB
easat-1678	98	27	98.3	98.3	NUM
easat-1678	98	28	162.1	162.1	NUM
easat-1678	98	29	)	)	PUNCT
easat-1678	98	30	in	in	ADP
easat-1678	98	31	uninfected	uninfected	ADJ
easat-1678	98	32	patients	patient	NOUN
easat-1678	98	33	.	.	PUNCT
easat-1678	99	1	similarly	similarly	ADV
easat-1678	99	2	,	,	PUNCT
easat-1678	99	3	the	the	DET
easat-1678	99	4	median	median	NOUN
easat-1678	99	5	il-28	il-28	NUM
easat-1678	99	6	level	level	NOUN
easat-1678	99	7	was	be	AUX
easat-1678	99	8	2345.0	2345.0	NUM
easat-1678	99	9	pg	pg	NOUN
easat-1678	99	10	/	/	SYM
easat-1678	99	11	ml	ml	PROPN
easat-1678	99	12	(	(	PUNCT
easat-1678	99	13	range	range	NOUN
easat-1678	99	14	1876.5	1876.5	NUM
easat-1678	99	15	3023.5	3023.5	NUM
easat-1678	99	16	)	)	PUNCT
easat-1678	99	17	in	in	ADP
easat-1678	99	18	infected	infected	ADJ
easat-1678	99	19	patients	patient	NOUN
easat-1678	99	20	,	,	PUNCT
easat-1678	99	21	compared	compare	VERB
easat-1678	99	22	to	to	ADP
easat-1678	99	23	1123.5	1123.5	NUM
easat-1678	99	24	pg	pg	NOUN
easat-1678	99	25	/	/	SYM
easat-1678	99	26	ml	ml	PROPN
easat-1678	99	27	(	(	PUNCT
easat-1678	99	28	range	range	VERB
easat-1678	99	29	856.3	856.3	NUM
easat-1678	99	30	1422.8	1422.8	NUM
easat-1678	99	31	)	)	PUNCT
easat-1678	99	32	in	in	ADP
easat-1678	99	33	uninfected	uninfected	ADJ
easat-1678	99	34	patients	patient	NOUN
easat-1678	99	35	.	.	PUNCT
easat-1678	100	1	these	these	DET
easat-1678	100	2	differences	difference	NOUN
easat-1678	100	3	are	be	AUX
easat-1678	100	4	illustrated	illustrate	VERB
easat-1678	100	5	in	in	ADP
easat-1678	100	6	figure	figure	NOUN
easat-1678	100	7	2	2	NUM
easat-1678	100	8	.	.	NOUN
easat-1678	100	9	527	527	NUM
easat-1678	100	10	edelweiss	edelweiss	PROPN
easat-1678	100	11	applied	apply	VERB
easat-1678	100	12	science	science	NOUN
easat-1678	100	13	and	and	CCONJ
easat-1678	100	14	technology	technology	NOUN
easat-1678	100	15	issn	issn	PROPN
easat-1678	100	16	:	:	PUNCT
easat-1678	100	17	2576	2576	NUM
easat-1678	100	18	-	-	SYM
easat-1678	100	19	8484	8484	NUM
easat-1678	100	20	vol	vol	NOUN
easat-1678	100	21	.	.	PROPN
easat-1678	101	1	8	8	NUM
easat-1678	101	2	,	,	PUNCT
easat-1678	101	3	no	no	INTJ
easat-1678	101	4	.	.	NOUN
easat-1678	102	1	3	3	NUM
easat-1678	102	2	:	:	PUNCT
easat-1678	102	3	523	523	NUM
easat-1678	102	4	-	-	SYM
easat-1678	102	5	532	532	NUM
easat-1678	102	6	,	,	PUNCT
easat-1678	102	7	2024	2024	NUM
easat-1678	102	8	doi	doi	NOUN
easat-1678	102	9	:	:	PUNCT
easat-1678	102	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	102	11	©	©	PROPN
easat-1678	102	12	2024	2024	NUM
easat-1678	102	13	by	by	ADP
easat-1678	102	14	the	the	DET
easat-1678	102	15	authors	author	NOUN
easat-1678	102	16	;	;	PUNCT
easat-1678	102	17	licensee	licensee	PROPN
easat-1678	102	18	learning	learn	VERB
easat-1678	102	19	gate	gate	NOUN
easat-1678	102	20	table	table	NOUN
easat-1678	102	21	2	2	NUM
easat-1678	102	22	.	.	PUNCT
easat-1678	102	23	levels	level	NOUN
easat-1678	102	24	of	of	ADP
easat-1678	102	25	il-18	il-18	PUNCT
easat-1678	102	26	and	and	CCONJ
easat-1678	102	27	il-28	il-28	ADV
easat-1678	102	28	in	in	ADP
easat-1678	102	29	thalassemia	thalassemia	NOUN
easat-1678	102	30	patients	patient	NOUN
easat-1678	102	31	with	with	ADP
easat-1678	102	32	and	and	CCONJ
easat-1678	102	33	without	without	ADP
easat-1678	102	34	viral	viral	ADJ
easat-1678	102	35	infections	infection	NOUN
easat-1678	102	36	.	.	PUNCT
easat-1678	103	1	group	group	NOUN
easat-1678	103	2	il-18	il-18	NOUN
easat-1678	103	3	(	(	PUNCT
easat-1678	103	4	pg	pg	NOUN
easat-1678	103	5	/	/	SYM
easat-1678	103	6	ml	ml	NOUN
easat-1678	103	7	)	)	PUNCT
easat-1678	103	8	il-28	il-28	ADV
easat-1678	103	9	(	(	PUNCT
easat-1678	103	10	pg	pg	NOUN
easat-1678	103	11	/	/	SYM
easat-1678	103	12	ml	ml	VERB
easat-1678	103	13	)	)	PUNCT
easat-1678	103	14	with	with	ADP
easat-1678	103	15	viral	viral	ADJ
easat-1678	103	16	infections	infection	NOUN
easat-1678	103	17	423.5	423.5	NUM
easat-1678	103	18	(	(	PUNCT
easat-1678	103	19	352.0	352.0	NUM
easat-1678	103	20	-	-	SYM
easat-1678	103	21	587.8	587.8	NUM
easat-1678	103	22	)	)	PUNCT
easat-1678	103	23	2345.0	2345.0	NUM
easat-1678	103	24	(	(	PUNCT
easat-1678	103	25	1876.5	1876.5	NUM
easat-1678	103	26	-	-	SYM
easat-1678	103	27	3023.5	3023.5	NUM
easat-1678	103	28	)	)	PUNCT
easat-1678	103	29	without	without	ADP
easat-1678	103	30	viral	viral	ADJ
easat-1678	103	31	infections	infection	NOUN
easat-1678	103	32	125.6	125.6	NUM
easat-1678	103	33	(	(	PUNCT
easat-1678	103	34	98.3	98.3	NUM
easat-1678	103	35	-	-	SYM
easat-1678	103	36	162.1	162.1	NUM
easat-1678	103	37	)	)	PUNCT
easat-1678	103	38	1123.5	1123.5	NUM
easat-1678	103	39	(	(	PUNCT
easat-1678	103	40	856.3	856.3	NUM
easat-1678	103	41	-	-	SYM
easat-1678	103	42	1422.8	1422.8	NUM
easat-1678	103	43	)	)	PUNCT
easat-1678	103	44	figure	figure	NOUN
easat-1678	103	45	2	2	NUM
easat-1678	103	46	.	.	PUNCT
easat-1678	103	47	comparison	comparison	NOUN
easat-1678	103	48	of	of	ADP
easat-1678	103	49	il-18	il-18	PUNCT
easat-1678	103	50	and	and	CCONJ
easat-1678	103	51	il-28	il-28	NUM
easat-1678	103	52	levels	level	NOUN
easat-1678	103	53	between	between	ADP
easat-1678	103	54	thalassemia	thalassemia	NOUN
easat-1678	103	55	patients	patient	NOUN
easat-1678	103	56	with	with	ADP
easat-1678	103	57	and	and	CCONJ
easat-1678	103	58	without	without	ADP
easat-1678	103	59	viral	viral	ADJ
easat-1678	103	60	infections	infection	NOUN
easat-1678	103	61	,	,	PUNCT
easat-1678	103	62	showing	show	VERB
easat-1678	103	63	significantly	significantly	ADV
easat-1678	103	64	higher	high	ADJ
easat-1678	103	65	levels	level	NOUN
easat-1678	103	66	in	in	ADP
easat-1678	103	67	infected	infected	ADJ
easat-1678	103	68	patients	patient	NOUN
easat-1678	103	69	.	.	PUNCT
easat-1678	104	1	3.3	3.3	NUM
easat-1678	104	2	.	.	PUNCT
easat-1678	104	3	association	association	NOUN
easat-1678	104	4	between	between	ADP
easat-1678	104	5	interleukin	interleukin	NOUN
easat-1678	104	6	levels	level	NOUN
easat-1678	104	7	and	and	CCONJ
easat-1678	104	8	viral	viral	ADJ
easat-1678	104	9	infections	infection	NOUN
easat-1678	104	10	a	a	DET
easat-1678	104	11	strong	strong	ADJ
easat-1678	104	12	association	association	NOUN
easat-1678	104	13	was	be	AUX
easat-1678	104	14	found	find	VERB
easat-1678	104	15	between	between	ADP
easat-1678	104	16	il-18	il-18	NOUN
easat-1678	104	17	and	and	CCONJ
easat-1678	104	18	il-28	il-28	NUM
easat-1678	104	19	levels	level	NOUN
easat-1678	104	20	and	and	CCONJ
easat-1678	104	21	the	the	DET
easat-1678	104	22	type	type	NOUN
easat-1678	104	23	of	of	ADP
easat-1678	104	24	viral	viral	ADJ
easat-1678	104	25	infection	infection	NOUN
easat-1678	104	26	(	(	PUNCT
easat-1678	104	27	p	p	X
easat-1678	104	28	<	<	X
easat-1678	104	29	0.001	0.001	NUM
easat-1678	104	30	)	)	PUNCT
easat-1678	104	31	.	.	PUNCT
easat-1678	105	1	patients	patient	NOUN
easat-1678	105	2	with	with	ADP
easat-1678	105	3	hepatitis	hepatitis	PROPN
easat-1678	105	4	c	c	PROPN
easat-1678	105	5	exhibited	exhibit	VERB
easat-1678	105	6	the	the	DET
easat-1678	105	7	highest	high	ADJ
easat-1678	105	8	levels	level	NOUN
easat-1678	105	9	of	of	ADP
easat-1678	105	10	these	these	DET
easat-1678	105	11	interleukins	interleukin	NOUN
easat-1678	105	12	,	,	PUNCT
easat-1678	105	13	followed	follow	VERB
easat-1678	105	14	by	by	ADP
easat-1678	105	15	those	those	PRON
easat-1678	105	16	with	with	ADP
easat-1678	105	17	hepatitis	hepatitis	PROPN
easat-1678	105	18	b	b	PROPN
easat-1678	105	19	and	and	CCONJ
easat-1678	105	20	hiv	hiv	PROPN
easat-1678	105	21	.	.	PUNCT
easat-1678	106	1	the	the	DET
easat-1678	106	2	correlation	correlation	NOUN
easat-1678	106	3	between	between	ADP
easat-1678	106	4	interleukin	interleukin	NOUN
easat-1678	106	5	levels	level	NOUN
easat-1678	106	6	and	and	CCONJ
easat-1678	106	7	viral	viral	ADJ
easat-1678	106	8	load	load	NOUN
easat-1678	106	9	was	be	AUX
easat-1678	106	10	significant	significant	ADJ
easat-1678	106	11	,	,	PUNCT
easat-1678	106	12	with	with	ADP
easat-1678	106	13	spearman	spearman	NOUN
easat-1678	106	14	's	's	PART
easat-1678	106	15	correlation	correlation	NOUN
easat-1678	106	16	coefficients	coefficient	NOUN
easat-1678	106	17	of	of	ADP
easat-1678	106	18	0.56	0.56	NUM
easat-1678	106	19	for	for	ADP
easat-1678	106	20	il-18	il-18	NOUN
easat-1678	106	21	and	and	CCONJ
easat-1678	106	22	0.48	0.48	NUM
easat-1678	106	23	for	for	ADP
easat-1678	106	24	il-28	il-28	PROPN
easat-1678	106	25	(	(	PUNCT
easat-1678	106	26	p	p	X
easat-1678	106	27	<	<	X
easat-1678	106	28	0.001	0.001	NUM
easat-1678	106	29	)	)	PUNCT
easat-1678	106	30	,	,	PUNCT
easat-1678	106	31	as	as	SCONJ
easat-1678	106	32	shown	show	VERB
easat-1678	106	33	in	in	ADP
easat-1678	106	34	figure	figure	NOUN
easat-1678	106	35	3	3	NUM
easat-1678	106	36	.	.	PUNCT
easat-1678	106	37	table	table	NOUN
easat-1678	106	38	3	3	NUM
easat-1678	106	39	.	.	X
easat-1678	106	40	association	association	NOUN
easat-1678	106	41	between	between	ADP
easat-1678	106	42	interleukin	interleukin	NOUN
easat-1678	106	43	levels	level	NOUN
easat-1678	106	44	and	and	CCONJ
easat-1678	106	45	viral	viral	ADJ
easat-1678	106	46	infections	infection	NOUN
easat-1678	106	47	.	.	PUNCT
easat-1678	107	1	viral	viral	ADJ
easat-1678	107	2	infection	infection	NOUN
easat-1678	107	3	il-18	il-18	ADP
easat-1678	107	4	(	(	PUNCT
easat-1678	107	5	pg	pg	NOUN
easat-1678	107	6	/	/	SYM
easat-1678	107	7	ml	ml	NOUN
easat-1678	107	8	)	)	PUNCT
easat-1678	107	9	il-28	il-28	ADV
easat-1678	107	10	(	(	PUNCT
easat-1678	107	11	pg	pg	NOUN
easat-1678	107	12	/	/	SYM
easat-1678	107	13	ml	ml	NOUN
easat-1678	107	14	)	)	PUNCT
easat-1678	107	15	hepatitis	hepatitis	NOUN
easat-1678	107	16	c	c	PROPN
easat-1678	107	17	487.3	487.3	NUM
easat-1678	107	18	±	±	NOUN
easat-1678	107	19	123.6	123.6	NUM
easat-1678	107	20	2567.8	2567.8	NUM
easat-1678	107	21	±	±	NUM
easat-1678	107	22	567.9	567.9	NUM
easat-1678	107	23	hepatitis	hepatitis	NOUN
easat-1678	107	24	b	b	PROPN
easat-1678	108	1	392.1	392.1	NUM
easat-1678	108	2	±	±	NUM
easat-1678	108	3	105.7	105.7	NUM
easat-1678	108	4	2234.6	2234.6	NUM
easat-1678	108	5	±	±	NOUN
easat-1678	108	6	487.3	487.3	NUM
easat-1678	108	7	hiv	hiv	PROPN
easat-1678	108	8	365.5	365.5	NUM
easat-1678	108	9	±	±	NUM
easat-1678	108	10	98.7	98.7	NUM
easat-1678	108	11	2045.2	2045.2	NUM
easat-1678	108	12	±	±	NOUN
easat-1678	108	13	423.6	423.6	NUM
easat-1678	108	14	528	528	NUM
easat-1678	108	15	edelweiss	edelweiss	PROPN
easat-1678	108	16	applied	apply	VERB
easat-1678	108	17	science	science	NOUN
easat-1678	108	18	and	and	CCONJ
easat-1678	108	19	technology	technology	NOUN
easat-1678	108	20	issn	issn	PROPN
easat-1678	108	21	:	:	PUNCT
easat-1678	108	22	2576	2576	NUM
easat-1678	108	23	-	-	SYM
easat-1678	108	24	8484	8484	NUM
easat-1678	108	25	vol	vol	NOUN
easat-1678	108	26	.	.	PROPN
easat-1678	108	27	8	8	NUM
easat-1678	108	28	,	,	PUNCT
easat-1678	108	29	no	no	INTJ
easat-1678	108	30	.	.	NOUN
easat-1678	109	1	3	3	NUM
easat-1678	109	2	:	:	PUNCT
easat-1678	109	3	523	523	NUM
easat-1678	109	4	-	-	SYM
easat-1678	109	5	532	532	NUM
easat-1678	109	6	,	,	PUNCT
easat-1678	109	7	2024	2024	NUM
easat-1678	109	8	doi	doi	NOUN
easat-1678	109	9	:	:	PUNCT
easat-1678	109	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	109	11	©	©	PROPN
easat-1678	109	12	2024	2024	NUM
easat-1678	109	13	by	by	ADP
easat-1678	109	14	the	the	DET
easat-1678	109	15	authors	author	NOUN
easat-1678	109	16	;	;	PUNCT
easat-1678	109	17	licensee	licensee	PROPN
easat-1678	109	18	learning	learn	VERB
easat-1678	109	19	gate	gate	PROPN
easat-1678	109	20	figure	figure	NOUN
easat-1678	109	21	3	3	NUM
easat-1678	109	22	.	.	PUNCT
easat-1678	109	23	levels	level	NOUN
easat-1678	109	24	of	of	ADP
easat-1678	109	25	il-18	il-18	PUNCT
easat-1678	109	26	and	and	CCONJ
easat-1678	109	27	il-28	il-28	ADV
easat-1678	109	28	in	in	ADP
easat-1678	109	29	thalassemia	thalassemia	NOUN
easat-1678	109	30	patients	patient	NOUN
easat-1678	109	31	categorized	categorize	VERB
easat-1678	109	32	by	by	ADP
easat-1678	109	33	type	type	NOUN
easat-1678	109	34	of	of	ADP
easat-1678	109	35	viral	viral	ADJ
easat-1678	109	36	infection	infection	NOUN
easat-1678	109	37	(	(	PUNCT
easat-1678	109	38	hepatitis	hepatitis	NOUN
easat-1678	109	39	c	c	NOUN
easat-1678	109	40	,	,	PUNCT
easat-1678	109	41	hepatitis	hepatitis	PROPN
easat-1678	109	42	b	b	PROPN
easat-1678	109	43	,	,	PUNCT
easat-1678	109	44	hiv	hiv	PROPN
easat-1678	109	45	)	)	PUNCT
easat-1678	109	46	,	,	PUNCT
easat-1678	109	47	highlighting	highlight	VERB
easat-1678	109	48	the	the	DET
easat-1678	109	49	highest	high	ADJ
easat-1678	109	50	levels	level	NOUN
easat-1678	109	51	in	in	ADP
easat-1678	109	52	patients	patient	NOUN
easat-1678	109	53	with	with	ADP
easat-1678	109	54	hepatitis	hepatitis	PROPN
easat-1678	109	55	c.	c.	PROPN
easat-1678	109	56	3.4	3.4	NUM
easat-1678	109	57	.	.	PUNCT
easat-1678	110	1	impact	impact	NOUN
easat-1678	110	2	of	of	ADP
easat-1678	110	3	interleukin	interleukin	NOUN
easat-1678	110	4	levels	level	NOUN
easat-1678	110	5	on	on	ADP
easat-1678	110	6	treatment	treatment	NOUN
easat-1678	110	7	response	response	NOUN
easat-1678	110	8	higher	high	ADJ
easat-1678	110	9	baseline	baseline	NOUN
easat-1678	110	10	levels	level	NOUN
easat-1678	110	11	of	of	ADP
easat-1678	110	12	il-18	il-18	PUNCT
easat-1678	110	13	and	and	CCONJ
easat-1678	110	14	il-28	il-28	ADV
easat-1678	110	15	were	be	AUX
easat-1678	110	16	associated	associate	VERB
easat-1678	110	17	with	with	ADP
easat-1678	110	18	better	well	ADJ
easat-1678	110	19	responses	response	NOUN
easat-1678	110	20	to	to	ADP
easat-1678	110	21	antiviral	antiviral	ADJ
easat-1678	110	22	treatment	treatment	NOUN
easat-1678	110	23	(	(	PUNCT
easat-1678	110	24	p	p	X
easat-1678	110	25	<	<	X
easat-1678	110	26	0.001	0.001	NUM
easat-1678	110	27	)	)	PUNCT
easat-1678	110	28	.	.	PUNCT
easat-1678	111	1	specifically	specifically	ADV
easat-1678	111	2	,	,	PUNCT
easat-1678	111	3	76.4	76.4	NUM
easat-1678	111	4	%	%	NOUN
easat-1678	111	5	of	of	ADP
easat-1678	111	6	patients	patient	NOUN
easat-1678	111	7	with	with	ADP
easat-1678	111	8	high	high	ADJ
easat-1678	111	9	il-18	il-18	NOUN
easat-1678	111	10	levels	level	NOUN
easat-1678	111	11	responded	respond	VERB
easat-1678	111	12	positively	positively	ADV
easat-1678	111	13	to	to	ADP
easat-1678	111	14	treatment	treatment	NOUN
easat-1678	111	15	,	,	PUNCT
easat-1678	111	16	compared	compare	VERB
easat-1678	111	17	to	to	ADP
easat-1678	111	18	52.3	52.3	NUM
easat-1678	111	19	%	%	NOUN
easat-1678	111	20	of	of	ADP
easat-1678	111	21	those	those	PRON
easat-1678	111	22	with	with	ADP
easat-1678	111	23	low	low	ADJ
easat-1678	111	24	levels	level	NOUN
easat-1678	111	25	.	.	PUNCT
easat-1678	112	1	similarly	similarly	ADV
easat-1678	112	2	,	,	PUNCT
easat-1678	112	3	79.8	79.8	NUM
easat-1678	112	4	%	%	NOUN
easat-1678	112	5	of	of	ADP
easat-1678	112	6	patients	patient	NOUN
easat-1678	112	7	with	with	ADP
easat-1678	112	8	high	high	ADJ
easat-1678	112	9	il-28	il-28	ADJ
easat-1678	112	10	levels	level	NOUN
easat-1678	112	11	showed	show	VERB
easat-1678	112	12	a	a	DET
easat-1678	112	13	good	good	ADJ
easat-1678	112	14	response	response	NOUN
easat-1678	112	15	,	,	PUNCT
easat-1678	112	16	versus	versus	ADP
easat-1678	112	17	48.9	48.9	NUM
easat-1678	112	18	%	%	NOUN
easat-1678	112	19	with	with	ADP
easat-1678	112	20	low	low	ADJ
easat-1678	112	21	levels	level	NOUN
easat-1678	112	22	,	,	PUNCT
easat-1678	112	23	as	as	SCONJ
easat-1678	112	24	illustrated	illustrate	VERB
easat-1678	112	25	in	in	ADP
easat-1678	112	26	figure	figure	NOUN
easat-1678	112	27	4	4	NUM
easat-1678	112	28	.	.	PUNCT
easat-1678	112	29	table	table	NOUN
easat-1678	112	30	4	4	NUM
easat-1678	112	31	.	.	PUNCT
easat-1678	112	32	impact	impact	NOUN
easat-1678	112	33	of	of	ADP
easat-1678	112	34	interleukin	interleukin	NOUN
easat-1678	112	35	levels	level	NOUN
easat-1678	112	36	on	on	ADP
easat-1678	112	37	treatment	treatment	NOUN
easat-1678	112	38	response	response	NOUN
easat-1678	112	39	.	.	PUNCT
easat-1678	113	1	interleukin	interleukin	NOUN
easat-1678	113	2	level	level	NOUN
easat-1678	113	3	treatment	treatment	NOUN
easat-1678	113	4	response	response	NOUN
easat-1678	113	5	(	(	PUNCT
easat-1678	113	6	%	%	INTJ
easat-1678	113	7	)	)	PUNCT
easat-1678	113	8	high	high	ADJ
easat-1678	113	9	il-18	il-18	ADP
easat-1678	113	10	76.4	76.4	NUM
easat-1678	113	11	%	%	NOUN
easat-1678	113	12	low	low	ADJ
easat-1678	113	13	il-18	il-18	ADP
easat-1678	113	14	52.3	52.3	NUM
easat-1678	113	15	%	%	NOUN
easat-1678	113	16	high	high	ADJ
easat-1678	113	17	il-28	il-28	ADV
easat-1678	113	18	79.8	79.8	NUM
easat-1678	113	19	%	%	NOUN
easat-1678	113	20	low	low	ADJ
easat-1678	113	21	il-28	il-28	NUM
easat-1678	113	22	48.9	48.9	NUM
easat-1678	113	23	%	%	NOUN
easat-1678	113	24	figure	figure	NOUN
easat-1678	113	25	4	4	NUM
easat-1678	113	26	.	.	PUNCT
easat-1678	113	27	treatment	treatment	NOUN
easat-1678	113	28	response	response	NOUN
easat-1678	113	29	rates	rate	NOUN
easat-1678	113	30	for	for	ADP
easat-1678	113	31	antiviral	antiviral	ADJ
easat-1678	113	32	therapy	therapy	NOUN
easat-1678	113	33	in	in	ADP
easat-1678	113	34	thalassemia	thalassemia	NOUN
easat-1678	113	35	patients	patient	NOUN
easat-1678	113	36	,	,	PUNCT
easat-1678	113	37	segmented	segment	VERB
easat-1678	113	38	by	by	ADP
easat-1678	113	39	high	high	ADJ
easat-1678	113	40	and	and	CCONJ
easat-1678	113	41	low	low	ADJ
easat-1678	113	42	levels	level	NOUN
easat-1678	113	43	of	of	ADP
easat-1678	113	44	il-18	il-18	NOUN
easat-1678	113	45	and	and	CCONJ
easat-1678	113	46	il-28	il-28	X
easat-1678	113	47	.	.	PUNCT
easat-1678	114	1	patients	patient	NOUN
easat-1678	114	2	with	with	ADP
easat-1678	114	3	higher	high	ADJ
easat-1678	114	4	interleukin	interleukin	NOUN
easat-1678	114	5	levels	level	NOUN
easat-1678	114	6	showed	show	VERB
easat-1678	114	7	better	well	ADJ
easat-1678	114	8	treatment	treatment	NOUN
easat-1678	114	9	responses	response	NOUN
easat-1678	114	10	.	.	PUNCT
easat-1678	115	1	529	529	NUM
easat-1678	115	2	edelweiss	edelweiss	PROPN
easat-1678	115	3	applied	apply	VERB
easat-1678	115	4	science	science	NOUN
easat-1678	115	5	and	and	CCONJ
easat-1678	115	6	technology	technology	NOUN
easat-1678	115	7	issn	issn	PROPN
easat-1678	115	8	:	:	PUNCT
easat-1678	115	9	2576	2576	NUM
easat-1678	115	10	-	-	SYM
easat-1678	115	11	8484	8484	NUM
easat-1678	115	12	vol	vol	NOUN
easat-1678	115	13	.	.	PROPN
easat-1678	115	14	8	8	NUM
easat-1678	115	15	,	,	PUNCT
easat-1678	115	16	no	no	INTJ
easat-1678	115	17	.	.	NOUN
easat-1678	116	1	3	3	NUM
easat-1678	116	2	:	:	PUNCT
easat-1678	116	3	523	523	NUM
easat-1678	116	4	-	-	SYM
easat-1678	116	5	532	532	NUM
easat-1678	116	6	,	,	PUNCT
easat-1678	116	7	2024	2024	NUM
easat-1678	116	8	doi	doi	NOUN
easat-1678	116	9	:	:	PUNCT
easat-1678	116	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	116	11	©	©	PROPN
easat-1678	116	12	2024	2024	NUM
easat-1678	116	13	by	by	ADP
easat-1678	116	14	the	the	DET
easat-1678	116	15	authors	author	NOUN
easat-1678	116	16	;	;	PUNCT
easat-1678	116	17	licensee	licensee	PROPN
easat-1678	116	18	learning	learning	NOUN
easat-1678	116	19	gate	gate	NOUN
easat-1678	116	20	3.5	3.5	NUM
easat-1678	116	21	.	.	PUNCT
easat-1678	117	1	predictive	predictive	ADJ
easat-1678	117	2	value	value	NOUN
easat-1678	117	3	of	of	ADP
easat-1678	117	4	interleukin	interleukin	NOUN
easat-1678	117	5	levels	level	NOUN
easat-1678	117	6	the	the	DET
easat-1678	117	7	roc	roc	PROPN
easat-1678	117	8	curve	curve	NOUN
easat-1678	117	9	analysis	analysis	NOUN
easat-1678	117	10	revealed	reveal	VERB
easat-1678	117	11	that	that	SCONJ
easat-1678	117	12	il-18	il-18	ADP
easat-1678	117	13	and	and	CCONJ
easat-1678	117	14	il-28	il-28	NUM
easat-1678	117	15	levels	level	NOUN
easat-1678	117	16	are	be	AUX
easat-1678	117	17	effective	effective	ADJ
easat-1678	117	18	predictors	predictor	NOUN
easat-1678	117	19	of	of	ADP
easat-1678	117	20	viral	viral	ADJ
easat-1678	117	21	infections	infection	NOUN
easat-1678	117	22	,	,	PUNCT
easat-1678	117	23	with	with	ADP
easat-1678	117	24	the	the	DET
easat-1678	117	25	area	area	NOUN
easat-1678	117	26	under	under	ADP
easat-1678	117	27	the	the	DET
easat-1678	117	28	curve	curve	NOUN
easat-1678	117	29	(	(	PUNCT
easat-1678	117	30	auc	auc	NOUN
easat-1678	117	31	)	)	PUNCT
easat-1678	117	32	for	for	ADP
easat-1678	117	33	il-18	il-18	VERB
easat-1678	117	34	being	be	AUX
easat-1678	117	35	0.78	0.78	NUM
easat-1678	117	36	(	(	PUNCT
easat-1678	117	37	confidence	confidence	NOUN
easat-1678	117	38	interval	interval	NOUN
easat-1678	117	39	0.72	0.72	NUM
easat-1678	117	40	0.84	0.84	NUM
easat-1678	117	41	)	)	PUNCT
easat-1678	117	42	and	and	CCONJ
easat-1678	117	43	for	for	ADP
easat-1678	117	44	il-28	il-28	ADV
easat-1678	117	45	being	be	AUX
easat-1678	117	46	0.74	0.74	NUM
easat-1678	117	47	(	(	PUNCT
easat-1678	117	48	confidence	confidence	NOUN
easat-1678	117	49	interval	interval	NOUN
easat-1678	117	50	0.67	0.67	NUM
easat-1678	117	51	0.81	0.81	NUM
easat-1678	117	52	)	)	PUNCT
easat-1678	117	53	,	,	PUNCT
easat-1678	117	54	both	both	CCONJ
easat-1678	117	55	with	with	ADP
easat-1678	117	56	significant	significant	ADJ
easat-1678	117	57	p	p	NOUN
easat-1678	117	58	-	-	PUNCT
easat-1678	117	59	values	value	NOUN
easat-1678	117	60	(	(	PUNCT
easat-1678	117	61	p	p	X
easat-1678	117	62	<	<	X
easat-1678	117	63	0.001	0.001	NUM
easat-1678	117	64	)	)	PUNCT
easat-1678	117	65	.	.	PUNCT
easat-1678	118	1	the	the	DET
easat-1678	118	2	sensitivity	sensitivity	NOUN
easat-1678	118	3	and	and	CCONJ
easat-1678	118	4	specificity	specificity	NOUN
easat-1678	118	5	values	value	NOUN
easat-1678	118	6	for	for	ADP
easat-1678	118	7	these	these	DET
easat-1678	118	8	interleukins	interleukin	NOUN
easat-1678	118	9	are	be	AUX
easat-1678	118	10	depicted	depict	VERB
easat-1678	118	11	in	in	ADP
easat-1678	118	12	figure	figure	NOUN
easat-1678	118	13	5	5	NUM
easat-1678	118	14	.	.	PUNCT
easat-1678	118	15	table	table	NOUN
easat-1678	118	16	5	5	NUM
easat-1678	118	17	.	.	PUNCT
easat-1678	118	18	predictive	predictive	ADJ
easat-1678	118	19	value	value	NOUN
easat-1678	118	20	of	of	ADP
easat-1678	118	21	interleukin	interleukin	NOUN
easat-1678	118	22	levels	level	NOUN
easat-1678	118	23	for	for	ADP
easat-1678	118	24	viral	viral	ADJ
easat-1678	118	25	infections	infection	NOUN
easat-1678	118	26	.	.	PUNCT
easat-1678	119	1	interleukin	interleukin	NOUN
easat-1678	119	2	auc	auc	NOUN
easat-1678	119	3	sensitivity	sensitivity	NOUN
easat-1678	119	4	(	(	PUNCT
easat-1678	119	5	%	%	INTJ
easat-1678	119	6	)	)	PUNCT
easat-1678	119	7	specificity	specificity	NOUN
easat-1678	119	8	(	(	PUNCT
easat-1678	119	9	%	%	INTJ
easat-1678	119	10	)	)	PUNCT
easat-1678	119	11	il-18	il-18	ADV
easat-1678	119	12	0.78	0.78	NUM
easat-1678	119	13	73.6	73.6	NUM
easat-1678	119	14	%	%	NOUN
easat-1678	119	15	71.4	71.4	NUM
easat-1678	119	16	%	%	NOUN
easat-1678	119	17	il-28	il-28	ADV
easat-1678	119	18	0.74	0.74	NUM
easat-1678	119	19	68.9	68.9	NUM
easat-1678	119	20	%	%	NOUN
easat-1678	119	21	67.3	67.3	NUM
easat-1678	119	22	%	%	NOUN
easat-1678	119	23	figure	figure	NOUN
easat-1678	119	24	5	5	NUM
easat-1678	119	25	.	.	PUNCT
easat-1678	119	26	sensitivity	sensitivity	NOUN
easat-1678	119	27	and	and	CCONJ
easat-1678	119	28	specificity	specificity	NOUN
easat-1678	119	29	of	of	ADP
easat-1678	119	30	il-18	il-18	PUNCT
easat-1678	119	31	and	and	CCONJ
easat-1678	119	32	il-28	il-28	NUM
easat-1678	119	33	levels	level	NOUN
easat-1678	119	34	as	as	ADP
easat-1678	119	35	predictive	predictive	ADJ
easat-1678	119	36	markers	marker	NOUN
easat-1678	119	37	for	for	ADP
easat-1678	119	38	viral	viral	ADJ
easat-1678	119	39	infections	infection	NOUN
easat-1678	119	40	in	in	ADP
easat-1678	119	41	thalassemia	thalassemia	NOUN
easat-1678	119	42	patients	patient	NOUN
easat-1678	119	43	,	,	PUNCT
easat-1678	119	44	indicating	indicate	VERB
easat-1678	119	45	their	their	PRON
easat-1678	119	46	potential	potential	ADJ
easat-1678	119	47	utility	utility	NOUN
easat-1678	119	48	in	in	ADP
easat-1678	119	49	clinical	clinical	ADJ
easat-1678	119	50	diagnostics	diagnostic	NOUN
easat-1678	119	51	.	.	PUNCT
easat-1678	120	1	3.6	3.6	NUM
easat-1678	120	2	.	.	PUNCT
easat-1678	121	1	survival	survival	NOUN
easat-1678	121	2	analysis	analysis	NOUN
easat-1678	121	3	survival	survival	NOUN
easat-1678	121	4	analysis	analysis	NOUN
easat-1678	121	5	indicated	indicate	VERB
easat-1678	121	6	that	that	SCONJ
easat-1678	121	7	patients	patient	NOUN
easat-1678	121	8	with	with	ADP
easat-1678	121	9	higher	high	ADJ
easat-1678	121	10	levels	level	NOUN
easat-1678	121	11	of	of	ADP
easat-1678	121	12	il-18	il-18	PUNCT
easat-1678	121	13	and	and	CCONJ
easat-1678	121	14	il-28	il-28	ADV
easat-1678	121	15	had	have	VERB
easat-1678	121	16	better	well	ADJ
easat-1678	121	17	overall	overall	ADJ
easat-1678	121	18	survival	survival	NOUN
easat-1678	121	19	rates	rate	NOUN
easat-1678	121	20	.	.	PUNCT
easat-1678	122	1	specifically	specifically	ADV
easat-1678	122	2	,	,	PUNCT
easat-1678	122	3	the	the	DET
easat-1678	122	4	overall	overall	ADJ
easat-1678	122	5	survival	survival	NOUN
easat-1678	122	6	was	be	AUX
easat-1678	122	7	87.6	87.6	NUM
easat-1678	122	8	%	%	NOUN
easat-1678	122	9	for	for	ADP
easat-1678	122	10	patients	patient	NOUN
easat-1678	122	11	with	with	ADP
easat-1678	122	12	high	high	ADJ
easat-1678	122	13	il-18	il-18	NOUN
easat-1678	122	14	levels	level	NOUN
easat-1678	122	15	and	and	CCONJ
easat-1678	122	16	89.4	89.4	NUM
easat-1678	122	17	%	%	NOUN
easat-1678	122	18	for	for	ADP
easat-1678	122	19	those	those	PRON
easat-1678	122	20	with	with	ADP
easat-1678	122	21	high	high	ADJ
easat-1678	122	22	il-28	il-28	ADJ
easat-1678	122	23	levels	level	NOUN
easat-1678	122	24	,	,	PUNCT
easat-1678	122	25	compared	compare	VERB
easat-1678	122	26	to	to	ADP
easat-1678	122	27	64.2	64.2	NUM
easat-1678	122	28	%	%	NOUN
easat-1678	122	29	and	and	CCONJ
easat-1678	122	30	61.7	61.7	NUM
easat-1678	122	31	%	%	NOUN
easat-1678	122	32	,	,	PUNCT
easat-1678	122	33	respectively	respectively	ADV
easat-1678	122	34	,	,	PUNCT
easat-1678	122	35	for	for	ADP
easat-1678	122	36	those	those	PRON
easat-1678	122	37	with	with	ADP
easat-1678	122	38	lower	low	ADJ
easat-1678	122	39	levels	level	NOUN
easat-1678	122	40	.	.	PUNCT
easat-1678	123	1	these	these	DET
easat-1678	123	2	findings	finding	NOUN
easat-1678	123	3	are	be	AUX
easat-1678	123	4	visualized	visualize	VERB
easat-1678	123	5	in	in	ADP
easat-1678	123	6	figure	figure	NOUN
easat-1678	123	7	6	6	NUM
easat-1678	123	8	.	.	PUNCT
easat-1678	123	9	table	table	NOUN
easat-1678	123	10	6	6	NUM
easat-1678	123	11	.	.	PUNCT
easat-1678	124	1	survival	survival	NOUN
easat-1678	124	2	analysis	analysis	NOUN
easat-1678	124	3	.	.	PUNCT
easat-1678	125	1	interleukin	interleukin	NOUN
easat-1678	125	2	level	level	NOUN
easat-1678	125	3	overall	overall	ADJ
easat-1678	125	4	survival	survival	NOUN
easat-1678	125	5	(	(	PUNCT
easat-1678	125	6	%	%	INTJ
easat-1678	125	7	)	)	PUNCT
easat-1678	125	8	high	high	ADJ
easat-1678	125	9	il-18	il-18	ADP
easat-1678	125	10	87.6	87.6	NUM
easat-1678	125	11	%	%	NOUN
easat-1678	125	12	low	low	ADJ
easat-1678	125	13	il-18	il-18	ADP
easat-1678	125	14	64.2	64.2	NUM
easat-1678	125	15	%	%	NOUN
easat-1678	125	16	high	high	ADJ
easat-1678	125	17	il-28	il-28	ADV
easat-1678	125	18	89.4	89.4	NUM
easat-1678	125	19	%	%	NOUN
easat-1678	125	20	low	low	ADJ
easat-1678	125	21	il-28	il-28	NUM
easat-1678	125	22	61.7	61.7	NUM
easat-1678	125	23	%	%	NOUN
easat-1678	125	24	530	530	NUM
easat-1678	125	25	edelweiss	edelweiss	PROPN
easat-1678	125	26	applied	apply	VERB
easat-1678	125	27	science	science	NOUN
easat-1678	125	28	and	and	CCONJ
easat-1678	125	29	technology	technology	NOUN
easat-1678	125	30	issn	issn	PROPN
easat-1678	125	31	:	:	PUNCT
easat-1678	125	32	2576	2576	NUM
easat-1678	125	33	-	-	SYM
easat-1678	125	34	8484	8484	NUM
easat-1678	125	35	vol	vol	NOUN
easat-1678	125	36	.	.	PROPN
easat-1678	126	1	8	8	NUM
easat-1678	126	2	,	,	PUNCT
easat-1678	126	3	no	no	INTJ
easat-1678	126	4	.	.	NOUN
easat-1678	127	1	3	3	NUM
easat-1678	127	2	:	:	PUNCT
easat-1678	127	3	523	523	NUM
easat-1678	127	4	-	-	SYM
easat-1678	127	5	532	532	NUM
easat-1678	127	6	,	,	PUNCT
easat-1678	127	7	2024	2024	NUM
easat-1678	127	8	doi	doi	NOUN
easat-1678	127	9	:	:	PUNCT
easat-1678	127	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	127	11	©	©	PROPN
easat-1678	127	12	2024	2024	NUM
easat-1678	127	13	by	by	ADP
easat-1678	127	14	the	the	DET
easat-1678	127	15	authors	author	NOUN
easat-1678	127	16	;	;	PUNCT
easat-1678	128	1	licensee	licensee	PROPN
easat-1678	128	2	learning	learn	VERB
easat-1678	128	3	gate	gate	PROPN
easat-1678	128	4	figure	figure	NOUN
easat-1678	128	5	6	6	NUM
easat-1678	128	6	.	.	PUNCT
easat-1678	129	1	overall	overall	ADJ
easat-1678	129	2	survival	survival	NOUN
easat-1678	129	3	rates	rate	NOUN
easat-1678	129	4	in	in	ADP
easat-1678	129	5	thalassemia	thalassemia	NOUN
easat-1678	129	6	patients	patient	NOUN
easat-1678	129	7	with	with	ADP
easat-1678	129	8	high	high	ADJ
easat-1678	129	9	and	and	CCONJ
easat-1678	129	10	low	low	ADJ
easat-1678	129	11	levels	level	NOUN
easat-1678	129	12	of	of	ADP
easat-1678	129	13	il-18	il-18	PUNCT
easat-1678	129	14	and	and	CCONJ
easat-1678	129	15	il-28	il-28	ADV
easat-1678	129	16	,	,	PUNCT
easat-1678	129	17	demonstrating	demonstrate	VERB
easat-1678	129	18	that	that	SCONJ
easat-1678	129	19	higher	high	ADJ
easat-1678	129	20	levels	level	NOUN
easat-1678	129	21	are	be	AUX
easat-1678	129	22	associated	associate	VERB
easat-1678	129	23	with	with	ADP
easat-1678	129	24	improved	improved	ADJ
easat-1678	129	25	survival	survival	NOUN
easat-1678	129	26	outcomes	outcome	NOUN
easat-1678	129	27	.	.	PUNCT
easat-1678	130	1	4	4	X
easat-1678	130	2	.	.	X
easat-1678	130	3	discussion	discussion	NOUN
easat-1678	130	4	this	this	DET
easat-1678	130	5	study	study	NOUN
easat-1678	130	6	represents	represent	VERB
easat-1678	130	7	the	the	DET
easat-1678	130	8	precise	precise	ADJ
easat-1678	130	9	evaluation	evaluation	NOUN
easat-1678	130	10	of	of	ADP
easat-1678	130	11	il-18	il-18	NOUN
easat-1678	130	12	and	and	CCONJ
easat-1678	130	13	il-28	il-28	NUM
easat-1678	130	14	levels	level	NOUN
easat-1678	130	15	in	in	ADP
easat-1678	130	16	thalassemia	thalassemia	NOUN
easat-1678	130	17	patients	patient	NOUN
easat-1678	130	18	with	with	ADP
easat-1678	130	19	viral	viral	ADJ
easat-1678	130	20	infections	infection	NOUN
easat-1678	130	21	to	to	PART
easat-1678	130	22	explain	explain	VERB
easat-1678	130	23	the	the	DET
easat-1678	130	24	interrelation	interrelation	NOUN
easat-1678	130	25	between	between	ADP
easat-1678	130	26	thalassemia	thalassemia	NOUN
easat-1678	130	27	,	,	PUNCT
easat-1678	130	28	viral	viral	ADJ
easat-1678	130	29	infection	infection	NOUN
easat-1678	130	30	,	,	PUNCT
easat-1678	130	31	and	and	CCONJ
easat-1678	130	32	immune	immune	ADJ
easat-1678	130	33	response	response	NOUN
easat-1678	130	34	.	.	PUNCT
easat-1678	131	1	overexpression	overexpression	NOUN
easat-1678	131	2	of	of	ADP
easat-1678	131	3	il-18	il-18	PUNCT
easat-1678	131	4	and	and	CCONJ
easat-1678	131	5	il-28	il-28	ADV
easat-1678	131	6	in	in	ADP
easat-1678	131	7	these	these	DET
easat-1678	131	8	patients	patient	NOUN
easat-1678	131	9	designates	designate	VERB
easat-1678	131	10	,	,	PUNCT
easat-1678	131	11	at	at	ADP
easat-1678	131	12	some	some	DET
easat-1678	131	13	level	level	NOUN
easat-1678	131	14	,	,	PUNCT
easat-1678	131	15	the	the	DET
easat-1678	131	16	activation	activation	NOUN
easat-1678	131	17	of	of	ADP
easat-1678	131	18	immune	immune	ADJ
easat-1678	131	19	responses	response	NOUN
easat-1678	131	20	,	,	PUNCT
easat-1678	131	21	considering	consider	VERB
easat-1678	131	22	that	that	SCONJ
easat-1678	131	23	these	these	DET
easat-1678	131	24	interleukins	interleukin	NOUN
easat-1678	131	25	are	be	AUX
easat-1678	131	26	reported	report	VERB
easat-1678	131	27	to	to	PART
easat-1678	131	28	take	take	VERB
easat-1678	131	29	part	part	NOUN
easat-1678	131	30	in	in	ADP
easat-1678	131	31	antiviral	antiviral	ADJ
easat-1678	131	32	defense	defense	NOUN
easat-1678	131	33	mechanisms	mechanism	NOUN
easat-1678	131	34	.	.	PUNCT
easat-1678	132	1	this	this	PRON
easat-1678	132	2	finally	finally	ADV
easat-1678	132	3	goes	go	VERB
easat-1678	132	4	on	on	ADP
easat-1678	132	5	to	to	PART
easat-1678	132	6	show	show	VERB
easat-1678	132	7	that	that	SCONJ
easat-1678	132	8	il-18	il-18	ADP
easat-1678	132	9	and	and	CCONJ
easat-1678	132	10	il-28	il-28	NUM
easat-1678	132	11	levels	level	NOUN
easat-1678	132	12	can	can	AUX
easat-1678	132	13	be	be	AUX
easat-1678	132	14	very	very	ADV
easat-1678	132	15	instrumental	instrumental	ADJ
easat-1678	132	16	in	in	ADP
easat-1678	132	17	measuring	measure	VERB
easat-1678	132	18	the	the	DET
easat-1678	132	19	early	early	ADJ
easat-1678	132	20	detection	detection	NOUN
easat-1678	132	21	and	and	CCONJ
easat-1678	132	22	management	management	NOUN
easat-1678	132	23	of	of	ADP
easat-1678	132	24	viral	viral	ADJ
easat-1678	132	25	infections	infection	NOUN
easat-1678	132	26	in	in	ADP
easat-1678	132	27	thalassemia	thalassemia	NOUN
easat-1678	132	28	patients	patient	NOUN
easat-1678	132	29	.	.	PUNCT
easat-1678	133	1	as	as	SCONJ
easat-1678	133	2	illustrated	illustrate	VERB
easat-1678	133	3	in	in	ADP
easat-1678	133	4	table	table	NOUN
easat-1678	133	5	3	3	NUM
easat-1678	133	6	,	,	PUNCT
easat-1678	133	7	the	the	DET
easat-1678	133	8	close	close	ADJ
easat-1678	133	9	connection	connection	NOUN
easat-1678	133	10	between	between	ADP
easat-1678	133	11	il-18	il-18	NOUN
easat-1678	133	12	and	and	CCONJ
easat-1678	133	13	il-28	il-28	ADV
easat-1678	133	14	with	with	ADP
easat-1678	133	15	viral	viral	ADJ
easat-1678	133	16	infection	infection	NOUN
easat-1678	133	17	has	have	AUX
easat-1678	133	18	been	be	AUX
easat-1678	133	19	regarded	regard	VERB
easat-1678	133	20	as	as	ADP
easat-1678	133	21	a	a	DET
easat-1678	133	22	possible	possible	ADJ
easat-1678	133	23	indicator	indicator	NOUN
easat-1678	133	24	of	of	ADP
easat-1678	133	25	biomarkers	biomarker	NOUN
easat-1678	133	26	of	of	ADP
easat-1678	133	27	the	the	DET
easat-1678	133	28	presence	presence	NOUN
easat-1678	133	29	and	and	CCONJ
easat-1678	133	30	severity	severity	NOUN
easat-1678	133	31	of	of	ADP
easat-1678	133	32	viral	viral	ADJ
easat-1678	133	33	infection	infection	NOUN
easat-1678	133	34	.	.	PUNCT
easat-1678	134	1	such	such	DET
easat-1678	134	2	a	a	DET
easat-1678	134	3	relationship	relationship	NOUN
easat-1678	134	4	can	can	AUX
easat-1678	134	5	further	far	ADV
easat-1678	134	6	present	present	VERB
easat-1678	134	7	an	an	DET
easat-1678	134	8	insight	insight	NOUN
easat-1678	134	9	into	into	ADP
easat-1678	134	10	the	the	DET
easat-1678	134	11	viral	viral	ADJ
easat-1678	134	12	load	load	NOUN
easat-1678	134	13	and	and	CCONJ
easat-1678	134	14	activity	activity	NOUN
easat-1678	134	15	,	,	PUNCT
easat-1678	134	16	specifically	specifically	ADV
easat-1678	134	17	on	on	ADP
easat-1678	134	18	hepatitis	hepatitis	PROPN
easat-1678	134	19	b	b	PROPN
easat-1678	134	20	and	and	CCONJ
easat-1678	134	21	c	c	NOUN
easat-1678	134	22	infections	infection	NOUN
easat-1678	134	23	.	.	PUNCT
easat-1678	135	1	in	in	ADP
easat-1678	135	2	addition	addition	NOUN
easat-1678	135	3	,	,	PUNCT
easat-1678	135	4	il-28	il-28	ADV
easat-1678	135	5	was	be	AUX
easat-1678	135	6	found	find	VERB
easat-1678	135	7	to	to	PART
easat-1678	135	8	have	have	VERB
easat-1678	135	9	a	a	DET
easat-1678	135	10	close	close	ADJ
easat-1678	135	11	association	association	NOUN
easat-1678	135	12	with	with	ADP
easat-1678	135	13	the	the	DET
easat-1678	135	14	good	good	ADJ
easat-1678	135	15	treatment	treatment	NOUN
easat-1678	135	16	outcome	outcome	NOUN
easat-1678	135	17	in	in	ADP
easat-1678	135	18	patients	patient	NOUN
easat-1678	135	19	with	with	ADP
easat-1678	135	20	hepatitis	hepatitis	PROPN
easat-1678	135	21	c.	c.	PROPN
easat-1678	135	22	further	further	ADJ
easat-1678	135	23	research	research	NOUN
easat-1678	135	24	in	in	ADP
easat-1678	135	25	this	this	DET
easat-1678	135	26	direction	direction	NOUN
easat-1678	135	27	will	will	AUX
easat-1678	135	28	be	be	AUX
easat-1678	135	29	useful	useful	ADJ
easat-1678	135	30	in	in	ADP
easat-1678	135	31	evaluating	evaluate	VERB
easat-1678	135	32	these	these	DET
easat-1678	135	33	interleukins	interleukin	NOUN
easat-1678	135	34	as	as	ADP
easat-1678	135	35	indicators	indicator	NOUN
easat-1678	135	36	of	of	ADP
easat-1678	135	37	assessment	assessment	NOUN
easat-1678	135	38	for	for	ADP
easat-1678	135	39	viral	viral	ADJ
easat-1678	135	40	load	load	NOUN
easat-1678	135	41	and	and	CCONJ
easat-1678	135	42	disease	disease	NOUN
easat-1678	135	43	progression	progression	NOUN
easat-1678	135	44	.	.	PUNCT
easat-1678	136	1	table	table	NOUN
easat-1678	136	2	5	5	NUM
easat-1678	136	3	:	:	PUNCT
easat-1678	136	4	roc	roc	PROPN
easat-1678	136	5	curve	curve	NOUN
easat-1678	136	6	analysis	analysis	NOUN
easat-1678	136	7	for	for	ADP
easat-1678	136	8	il-18	il-18	PRON
easat-1678	136	9	and	and	CCONJ
easat-1678	136	10	il-28	il-28	NUM
easat-1678	136	11	levels	level	NOUN
easat-1678	136	12	in	in	ADP
easat-1678	136	13	the	the	DET
easat-1678	136	14	prediction	prediction	NOUN
easat-1678	136	15	of	of	ADP
easat-1678	136	16	viral	viral	ADJ
easat-1678	136	17	infections	infection	NOUN
easat-1678	136	18	.	.	PUNCT
easat-1678	137	1	in	in	ADP
easat-1678	137	2	the	the	DET
easat-1678	137	3	roc	roc	PROPN
easat-1678	137	4	curve	curve	NOUN
easat-1678	137	5	analysis	analysis	NOUN
easat-1678	137	6	,	,	PUNCT
easat-1678	137	7	it	it	PRON
easat-1678	137	8	is	be	AUX
easat-1678	137	9	clearly	clearly	ADV
easat-1678	137	10	indicated	indicate	VERB
easat-1678	137	11	that	that	SCONJ
easat-1678	137	12	both	both	DET
easat-1678	137	13	il-18	il-18	ADP
easat-1678	137	14	and	and	CCONJ
easat-1678	137	15	il-28	il-28	NUM
easat-1678	137	16	levels	level	NOUN
easat-1678	137	17	are	be	AUX
easat-1678	137	18	good	good	ADJ
easat-1678	137	19	predictors	predictor	NOUN
easat-1678	137	20	of	of	ADP
easat-1678	137	21	viral	viral	ADJ
easat-1678	137	22	infection	infection	NOUN
easat-1678	137	23	.	.	PUNCT
easat-1678	138	1	this	this	DET
easat-1678	138	2	predictive	predictive	ADJ
easat-1678	138	3	ability	ability	NOUN
easat-1678	138	4	would	would	AUX
easat-1678	138	5	hence	hence	ADV
easat-1678	138	6	offer	offer	VERB
easat-1678	138	7	the	the	DET
easat-1678	138	8	clinicians	clinician	NOUN
easat-1678	138	9	an	an	DET
easat-1678	138	10	opportunity	opportunity	NOUN
easat-1678	138	11	to	to	PART
easat-1678	138	12	make	make	VERB
easat-1678	138	13	timely	timely	ADJ
easat-1678	138	14	decisions	decision	NOUN
easat-1678	138	15	on	on	ADP
easat-1678	138	16	whether	whether	SCONJ
easat-1678	138	17	there	there	PRON
easat-1678	138	18	is	be	VERB
easat-1678	138	19	a	a	DET
easat-1678	138	20	need	need	NOUN
easat-1678	138	21	for	for	ADP
easat-1678	138	22	further	further	ADJ
easat-1678	138	23	testing	testing	NOUN
easat-1678	138	24	or	or	CCONJ
easat-1678	138	25	closer	close	ADJ
easat-1678	138	26	monitoring	monitoring	NOUN
easat-1678	138	27	,	,	PUNCT
easat-1678	138	28	hence	hence	ADV
easat-1678	138	29	making	make	VERB
easat-1678	138	30	anti	anti	ADJ
easat-1678	138	31	-	-	ADJ
easat-1678	138	32	viral	viral	ADJ
easat-1678	138	33	medication	medication	NOUN
easat-1678	138	34	even	even	ADV
easat-1678	138	35	more	more	ADV
easat-1678	138	36	effective	effective	ADJ
easat-1678	138	37	[	[	X
easat-1678	138	38	21	21	NUM
easat-1678	138	39	-	-	SYM
easat-1678	138	40	27	27	NUM
easat-1678	138	41	]	]	PUNCT
easat-1678	138	42	.	.	PUNCT
easat-1678	139	1	as	as	SCONJ
easat-1678	139	2	seen	see	VERB
easat-1678	139	3	in	in	ADP
easat-1678	139	4	table	table	NOUN
easat-1678	139	5	4	4	NUM
easat-1678	139	6	,	,	PUNCT
easat-1678	139	7	the	the	DET
easat-1678	139	8	positive	positive	ADJ
easat-1678	139	9	correlation	correlation	NOUN
easat-1678	139	10	of	of	ADP
easat-1678	139	11	higher	high	ADJ
easat-1678	139	12	interleukin	interleukin	NOUN
easat-1678	139	13	levels	level	NOUN
easat-1678	139	14	and	and	CCONJ
easat-1678	139	15	better	well	ADJ
easat-1678	139	16	treatment	treatment	NOUN
easat-1678	139	17	outcomes	outcome	NOUN
easat-1678	139	18	evidences	evidence	VERB
easat-1678	139	19	that	that	SCONJ
easat-1678	139	20	both	both	DET
easat-1678	139	21	il-18	il-18	ADP
easat-1678	139	22	and	and	CCONJ
easat-1678	139	23	il-28	il-28	ADV
easat-1678	139	24	are	be	AUX
easat-1678	139	25	indispensable	indispensable	ADJ
easat-1678	139	26	for	for	ADP
easat-1678	139	27	the	the	DET
easat-1678	139	28	efficacy	efficacy	NOUN
easat-1678	139	29	of	of	ADP
easat-1678	139	30	antiviral	antiviral	ADJ
easat-1678	139	31	therapy	therapy	NOUN
easat-1678	139	32	[	[	X
easat-1678	139	33	28	28	NUM
easat-1678	139	34	-	-	SYM
easat-1678	139	35	33	33	NUM
easat-1678	139	36	]	]	PUNCT
easat-1678	139	37	.	.	PUNCT
easat-1678	140	1	these	these	DET
easat-1678	140	2	interleukins	interleukin	VERB
easat-1678	140	3	,	,	PUNCT
easat-1678	140	4	according	accord	VERB
easat-1678	140	5	to	to	ADP
easat-1678	140	6	the	the	DET
easat-1678	140	7	findings	finding	NOUN
easat-1678	140	8	,	,	PUNCT
easat-1678	140	9	would	would	AUX
easat-1678	140	10	provide	provide	VERB
easat-1678	140	11	very	very	ADV
easat-1678	140	12	good	good	ADJ
easat-1678	140	13	markers	marker	NOUN
easat-1678	140	14	to	to	PART
easat-1678	140	15	monitor	monitor	VERB
easat-1678	140	16	treatment	treatment	NOUN
easat-1678	140	17	and	and	CCONJ
easat-1678	140	18	therapy	therapy	NOUN
easat-1678	140	19	success	success	NOUN
easat-1678	140	20	.	.	PUNCT
easat-1678	141	1	table	table	NOUN
easat-1678	141	2	6	6	NUM
easat-1678	141	3	highlights	highlight	NOUN
easat-1678	141	4	the	the	DET
easat-1678	141	5	higher	high	ADJ
easat-1678	141	6	levels	level	NOUN
easat-1678	141	7	of	of	ADP
easat-1678	141	8	il-18	il-18	PUNCT
easat-1678	141	9	and	and	CCONJ
easat-1678	141	10	il-28	il-28	ADV
easat-1678	141	11	associated	associate	VERB
easat-1678	141	12	with	with	ADP
easat-1678	141	13	increased	increase	VERB
easat-1678	141	14	survival	survival	NOUN
easat-1678	141	15	in	in	ADP
easat-1678	141	16	thalassemia	thalassemia	NOUN
easat-1678	141	17	patients	patient	NOUN
easat-1678	141	18	with	with	ADP
easat-1678	141	19	viral	viral	ADJ
easat-1678	141	20	infections	infection	NOUN
easat-1678	141	21	.	.	PUNCT
easat-1678	142	1	this	this	DET
easat-1678	142	2	finding	finding	NOUN
easat-1678	142	3	points	point	VERB
easat-1678	142	4	toward	toward	ADP
easat-1678	142	5	the	the	DET
easat-1678	142	6	protective	protective	ADJ
easat-1678	142	7	role	role	NOUN
easat-1678	142	8	these	these	PRON
easat-1678	142	9	interleukins	interleukin	VERB
easat-1678	142	10	play	play	VERB
easat-1678	142	11	against	against	ADP
easat-1678	142	12	viral	viral	ADJ
easat-1678	142	13	infections	infection	NOUN
easat-1678	142	14	and	and	CCONJ
easat-1678	142	15	underlines	underline	VERB
easat-1678	142	16	the	the	DET
easat-1678	142	17	importance	importance	NOUN
easat-1678	142	18	of	of	ADP
easat-1678	142	19	a	a	DET
easat-1678	142	20	robust	robust	ADJ
easat-1678	142	21	host	host	NOUN
easat-1678	142	22	immune	immune	ADJ
easat-1678	142	23	response	response	NOUN
easat-1678	142	24	,	,	PUNCT
easat-1678	142	25	at	at	ADP
easat-1678	142	26	least	least	ADJ
easat-1678	142	27	partially	partially	ADV
easat-1678	142	28	mediated	mediate	VERB
easat-1678	142	29	by	by	ADP
easat-1678	142	30	il-18	il-18	NOUN
easat-1678	142	31	and	and	CCONJ
easat-1678	142	32	il-28	il-28	NUM
easat-1678	142	33	,	,	PUNCT
easat-1678	142	34	in	in	ADP
easat-1678	142	35	achieving	achieve	VERB
easat-1678	142	36	better	well	ADJ
easat-1678	142	37	health	health	NOUN
easat-1678	142	38	outcomes	outcome	NOUN
easat-1678	142	39	[	[	X
easat-1678	142	40	29	29	NUM
easat-1678	142	41	]	]	PUNCT
easat-1678	142	42	.	.	PUNCT
easat-1678	143	1	targeted	target	VERB
easat-1678	143	2	therapeutic	therapeutic	ADJ
easat-1678	143	3	immunomodulation	immunomodulation	NOUN
easat-1678	143	4	of	of	ADP
easat-1678	143	5	these	these	DET
easat-1678	143	6	interleukins	interleukin	NOUN
easat-1678	143	7	has	have	AUX
easat-1678	143	8	been	be	AUX
easat-1678	143	9	effective	effective	ADJ
easat-1678	143	10	in	in	ADP
easat-1678	143	11	other	other	ADJ
easat-1678	143	12	disorders	disorder	NOUN
easat-1678	143	13	that	that	PRON
easat-1678	143	14	have	have	VERB
easat-1678	143	15	a	a	DET
easat-1678	143	16	basis	basis	NOUN
easat-1678	143	17	in	in	ADP
easat-1678	143	18	viral	viral	ADJ
easat-1678	143	19	infection	infection	NOUN
easat-1678	143	20	and	and	CCONJ
easat-1678	143	21	may	may	AUX
easat-1678	143	22	benefit	benefit	VERB
easat-1678	143	23	patients	patient	NOUN
easat-1678	143	24	with	with	ADP
easat-1678	143	25	thalassemia	thalassemia	NOUN
easat-1678	143	26	[	[	X
easat-1678	143	27	15	15	NUM
easat-1678	143	28	,	,	PUNCT
easat-1678	143	29	16	16	NUM
easat-1678	143	30	]	]	PUNCT
easat-1678	143	31	.	.	PUNCT
easat-1678	144	1	531	531	NUM
easat-1678	144	2	edelweiss	edelweiss	PROPN
easat-1678	144	3	applied	apply	VERB
easat-1678	144	4	science	science	NOUN
easat-1678	144	5	and	and	CCONJ
easat-1678	144	6	technology	technology	NOUN
easat-1678	144	7	issn	issn	PROPN
easat-1678	144	8	:	:	PUNCT
easat-1678	144	9	2576	2576	NUM
easat-1678	144	10	-	-	SYM
easat-1678	144	11	8484	8484	NUM
easat-1678	144	12	vol	vol	NOUN
easat-1678	144	13	.	.	PROPN
easat-1678	144	14	8	8	NUM
easat-1678	144	15	,	,	PUNCT
easat-1678	144	16	no	no	INTJ
easat-1678	144	17	.	.	NOUN
easat-1678	145	1	3	3	NUM
easat-1678	145	2	:	:	PUNCT
easat-1678	145	3	523	523	NUM
easat-1678	145	4	-	-	SYM
easat-1678	145	5	532	532	NUM
easat-1678	145	6	,	,	PUNCT
easat-1678	145	7	2024	2024	NUM
easat-1678	145	8	doi	doi	NOUN
easat-1678	145	9	:	:	PUNCT
easat-1678	145	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	145	11	©	©	PROPN
easat-1678	145	12	2024	2024	NUM
easat-1678	145	13	by	by	ADP
easat-1678	145	14	the	the	DET
easat-1678	145	15	authors	author	NOUN
easat-1678	145	16	;	;	PUNCT
easat-1678	145	17	licensee	licensee	PROPN
easat-1678	145	18	learning	learning	NOUN
easat-1678	145	19	gate	gate	NOUN
easat-1678	145	20	however	however	ADV
easat-1678	145	21	,	,	PUNCT
easat-1678	145	22	some	some	DET
easat-1678	145	23	limitations	limitation	NOUN
easat-1678	145	24	in	in	ADP
easat-1678	145	25	this	this	DET
easat-1678	145	26	study	study	NOUN
easat-1678	145	27	need	need	VERB
easat-1678	145	28	to	to	PART
easat-1678	145	29	be	be	AUX
easat-1678	145	30	acknowledged	acknowledge	VERB
easat-1678	145	31	.	.	PUNCT
easat-1678	146	1	this	this	DET
easat-1678	146	2	retrospective	retrospective	ADJ
easat-1678	146	3	design	design	NOUN
easat-1678	146	4	might	might	AUX
easat-1678	146	5	be	be	AUX
easat-1678	146	6	affected	affect	VERB
easat-1678	146	7	by	by	ADP
easat-1678	146	8	selection	selection	NOUN
easat-1678	146	9	bias	bias	NOUN
easat-1678	146	10	and	and	CCONJ
easat-1678	146	11	therefore	therefore	ADV
easat-1678	146	12	needs	need	VERB
easat-1678	146	13	to	to	PART
easat-1678	146	14	be	be	AUX
easat-1678	146	15	further	far	ADV
easat-1678	146	16	validated	validate	VERB
easat-1678	146	17	by	by	ADP
easat-1678	146	18	prospective	prospective	ADJ
easat-1678	146	19	studies	study	NOUN
easat-1678	146	20	.	.	PUNCT
easat-1678	147	1	also	also	ADV
easat-1678	147	2	,	,	PUNCT
easat-1678	147	3	this	this	DET
easat-1678	147	4	study	study	NOUN
easat-1678	147	5	focused	focus	VERB
easat-1678	147	6	only	only	ADV
easat-1678	147	7	on	on	ADP
easat-1678	147	8	il-18	il-18	NOUN
easat-1678	147	9	and	and	CCONJ
easat-1678	147	10	il-28	il-28	X
easat-1678	147	11	.	.	PUNCT
easat-1678	148	1	other	other	ADJ
easat-1678	148	2	cytokines	cytokine	NOUN
easat-1678	148	3	and	and	CCONJ
easat-1678	148	4	immune	immune	ADJ
easat-1678	148	5	factors	factor	NOUN
easat-1678	148	6	must	must	AUX
easat-1678	148	7	be	be	AUX
easat-1678	148	8	investigated	investigate	VERB
easat-1678	148	9	in	in	ADP
easat-1678	148	10	order	order	NOUN
easat-1678	148	11	to	to	PART
easat-1678	148	12	represent	represent	VERB
easat-1678	148	13	the	the	DET
easat-1678	148	14	complete	complete	ADJ
easat-1678	148	15	immunological	immunological	ADJ
easat-1678	148	16	background	background	NOUN
easat-1678	148	17	in	in	ADP
easat-1678	148	18	thalassemia	thalassemia	NOUN
easat-1678	148	19	patients	patient	NOUN
easat-1678	148	20	suffering	suffer	VERB
easat-1678	148	21	from	from	ADP
easat-1678	148	22	viral	viral	ADJ
easat-1678	148	23	infections	infection	NOUN
easat-1678	148	24	[	[	X
easat-1678	148	25	33	33	NUM
easat-1678	148	26	]	]	PUNCT
easat-1678	148	27	.	.	PUNCT
easat-1678	149	1	5	5	X
easat-1678	149	2	.	.	X
easat-1678	149	3	conclusion	conclusion	NOUN
easat-1678	149	4	this	this	DET
easat-1678	149	5	research	research	NOUN
easat-1678	149	6	thus	thus	ADV
easat-1678	149	7	holds	hold	VERB
easat-1678	149	8	the	the	DET
easat-1678	149	9	potential	potential	NOUN
easat-1678	149	10	to	to	PART
easat-1678	149	11	show	show	VERB
easat-1678	149	12	the	the	DET
easat-1678	149	13	meaning	meaning	NOUN
easat-1678	149	14	of	of	ADP
easat-1678	149	15	il-18	il-18	PUNCT
easat-1678	149	16	and	and	CCONJ
easat-1678	149	17	il-28	il-28	X
easat-1678	149	18	in	in	ADP
easat-1678	149	19	clinical	clinical	ADJ
easat-1678	149	20	management	management	NOUN
easat-1678	149	21	for	for	ADP
easat-1678	149	22	thalassemia	thalassemia	NOUN
easat-1678	149	23	patients	patient	NOUN
easat-1678	149	24	infected	infect	VERB
easat-1678	149	25	with	with	ADP
easat-1678	149	26	viruses	virus	NOUN
easat-1678	149	27	.	.	PUNCT
easat-1678	150	1	in	in	ADP
easat-1678	150	2	this	this	DET
easat-1678	150	3	study	study	NOUN
easat-1678	150	4	,	,	PUNCT
easat-1678	150	5	high	high	ADJ
easat-1678	150	6	interleukin	interleukin	NOUN
easat-1678	150	7	levels	level	NOUN
easat-1678	150	8	were	be	AUX
easat-1678	150	9	associated	associate	VERB
easat-1678	150	10	with	with	ADP
easat-1678	150	11	a	a	DET
easat-1678	150	12	high	high	ADJ
easat-1678	150	13	viral	viral	ADJ
easat-1678	150	14	load	load	NOUN
easat-1678	150	15	,	,	PUNCT
easat-1678	150	16	good	good	ADJ
easat-1678	150	17	treatment	treatment	NOUN
easat-1678	150	18	response	response	NOUN
easat-1678	150	19	,	,	PUNCT
easat-1678	150	20	and	and	CCONJ
easat-1678	150	21	survival	survival	NOUN
easat-1678	150	22	.	.	PUNCT
easat-1678	151	1	the	the	DET
easat-1678	151	2	findings	finding	NOUN
easat-1678	151	3	point	point	VERB
easat-1678	151	4	to	to	ADP
easat-1678	151	5	their	their	PRON
easat-1678	151	6	potential	potential	NOUN
easat-1678	151	7	as	as	ADP
easat-1678	151	8	biomarkers	biomarker	NOUN
easat-1678	151	9	and	and	CCONJ
easat-1678	151	10	therapeutic	therapeutic	ADJ
easat-1678	151	11	targets	target	NOUN
easat-1678	151	12	.	.	PUNCT
easat-1678	152	1	thus	thus	ADV
easat-1678	152	2	,	,	PUNCT
easat-1678	152	3	monitoring	monitoring	NOUN
easat-1678	152	4	of	of	ADP
easat-1678	152	5	il-18	il-18	PUNCT
easat-1678	152	6	and	and	CCONJ
easat-1678	152	7	il-28	il-28	ADV
easat-1678	152	8	could	could	AUX
easat-1678	152	9	be	be	AUX
easat-1678	152	10	used	use	VERB
easat-1678	152	11	in	in	ADP
easat-1678	152	12	detecting	detect	VERB
easat-1678	152	13	infections	infection	NOUN
easat-1678	152	14	early	early	ADV
easat-1678	152	15	,	,	PUNCT
easat-1678	152	16	thereby	thereby	ADV
easat-1678	152	17	improving	improve	VERB
easat-1678	152	18	outcomes	outcome	NOUN
easat-1678	152	19	by	by	ADP
easat-1678	152	20	appropriate	appropriate	ADJ
easat-1678	152	21	and	and	CCONJ
easat-1678	152	22	timely	timely	ADJ
easat-1678	152	23	interventions	intervention	NOUN
easat-1678	152	24	.	.	PUNCT
easat-1678	153	1	future	future	ADJ
easat-1678	153	2	studies	study	NOUN
easat-1678	153	3	should	should	AUX
easat-1678	153	4	focus	focus	VERB
easat-1678	153	5	on	on	ADP
easat-1678	153	6	incorporating	incorporate	VERB
easat-1678	153	7	these	these	DET
easat-1678	153	8	results	result	NOUN
easat-1678	153	9	into	into	ADP
easat-1678	153	10	clinical	clinical	ADJ
easat-1678	153	11	practice	practice	NOUN
easat-1678	153	12	for	for	ADP
easat-1678	153	13	the	the	DET
easat-1678	153	14	improved	improved	ADJ
easat-1678	153	15	management	management	NOUN
easat-1678	153	16	of	of	ADP
easat-1678	153	17	thalassemia	thalassemia	NOUN
easat-1678	153	18	patients	patient	NOUN
easat-1678	153	19	with	with	ADP
easat-1678	153	20	a	a	DET
easat-1678	153	21	concomitant	concomitant	ADJ
easat-1678	153	22	viral	viral	ADJ
easat-1678	153	23	infection	infection	NOUN
easat-1678	153	24	.	.	PUNCT
easat-1678	154	1	copyright	copyright	NOUN
easat-1678	154	2	:	:	PUNCT
easat-1678	154	3	©	©	PROPN
easat-1678	154	4	2024	2024	NUM
easat-1678	154	5	by	by	ADP
easat-1678	154	6	the	the	DET
easat-1678	154	7	authors	author	NOUN
easat-1678	154	8	.	.	PUNCT
easat-1678	155	1	this	this	DET
easat-1678	155	2	article	article	NOUN
easat-1678	155	3	is	be	AUX
easat-1678	155	4	an	an	DET
easat-1678	155	5	open	open	ADJ
easat-1678	155	6	access	access	NOUN
easat-1678	155	7	article	article	NOUN
easat-1678	155	8	distributed	distribute	VERB
easat-1678	155	9	under	under	ADP
easat-1678	155	10	the	the	DET
easat-1678	155	11	terms	term	NOUN
easat-1678	155	12	and	and	CCONJ
easat-1678	155	13	conditions	condition	NOUN
easat-1678	155	14	of	of	ADP
easat-1678	155	15	the	the	DET
easat-1678	155	16	creative	creative	ADJ
easat-1678	155	17	commons	common	NOUN
easat-1678	155	18	attribution	attribution	NOUN
easat-1678	155	19	(	(	PUNCT
easat-1678	155	20	cc	cc	NOUN
easat-1678	155	21	by	by	ADP
easat-1678	155	22	)	)	PUNCT
easat-1678	155	23	license	license	NOUN
easat-1678	155	24	(	(	PUNCT
easat-1678	155	25	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-1678	155	26	)	)	PUNCT
easat-1678	155	27	.	.	PUNCT
easat-1678	156	1	references	reference	NOUN
easat-1678	156	2	[	[	X
easat-1678	156	3	1	1	X
easat-1678	156	4	]	]	PUNCT
easat-1678	156	5	s.	s.	PROPN
easat-1678	156	6	vento	vento	PROPN
easat-1678	156	7	,	,	PUNCT
easat-1678	156	8	f.	f.	PROPN
easat-1678	156	9	cainelli	cainelli	PROPN
easat-1678	156	10	,	,	PUNCT
easat-1678	156	11	and	and	CCONJ
easat-1678	156	12	f.	f.	PROPN
easat-1678	156	13	cesario	cesario	PROPN
easat-1678	156	14	,	,	PUNCT
easat-1678	156	15	"	"	PUNCT
easat-1678	156	16	infections	infection	NOUN
easat-1678	156	17	and	and	CCONJ
easat-1678	156	18	thalassemia	thalassemia	NOUN
easat-1678	156	19	,	,	PUNCT
easat-1678	156	20	"	"	PUNCT
easat-1678	156	21	the	the	DET
easat-1678	156	22	lancet	lancet	ADJ
easat-1678	156	23	infectious	infectious	ADJ
easat-1678	156	24	diseases	disease	NOUN
easat-1678	156	25	,	,	PUNCT
easat-1678	156	26	vol	vol	NOUN
easat-1678	156	27	.	.	PROPN
easat-1678	157	1	6	6	NUM
easat-1678	157	2	,	,	PUNCT
easat-1678	157	3	no	no	INTJ
easat-1678	157	4	.	.	NOUN
easat-1678	157	5	4	4	NUM
easat-1678	157	6	,	,	PUNCT
easat-1678	157	7	pp	pp	ADJ
easat-1678	157	8	.	.	PUNCT
easat-1678	158	1	226233	226233	NUM
easat-1678	158	2	,	,	PUNCT
easat-1678	158	3	2006	2006	NUM
easat-1678	158	4	.	.	PUNCT
easat-1678	159	1	[	[	X
easat-1678	159	2	2	2	X
easat-1678	159	3	]	]	X
easat-1678	159	4	v.	v.	X
easat-1678	159	5	di	di	PROPN
easat-1678	159	6	marco	marco	PROPN
easat-1678	159	7	et	et	PROPN
easat-1678	159	8	al	al	PROPN
easat-1678	159	9	.	.	PROPN
easat-1678	159	10	,	,	PUNCT
easat-1678	159	11	"	"	PUNCT
easat-1678	159	12	management	management	NOUN
easat-1678	159	13	of	of	ADP
easat-1678	159	14	chronic	chronic	ADJ
easat-1678	159	15	viral	viral	ADJ
easat-1678	159	16	hepatitis	hepatitis	NOUN
easat-1678	159	17	in	in	ADP
easat-1678	159	18	patients	patient	NOUN
easat-1678	159	19	with	with	ADP
easat-1678	159	20	thalassemia	thalassemia	NOUN
easat-1678	159	21	:	:	PUNCT
easat-1678	159	22	recommendations	recommendation	NOUN
easat-1678	159	23	from	from	ADP
easat-1678	159	24	an	an	DET
easat-1678	159	25	international	international	ADJ
easat-1678	159	26	panel	panel	NOUN
easat-1678	159	27	,	,	PUNCT
easat-1678	159	28	"	"	PUNCT
easat-1678	159	29	blood	blood	NOUN
easat-1678	159	30	,	,	PUNCT
easat-1678	159	31	the	the	DET
easat-1678	159	32	journal	journal	NOUN
easat-1678	159	33	of	of	ADP
easat-1678	159	34	the	the	DET
easat-1678	159	35	american	american	ADJ
easat-1678	159	36	society	society	NOUN
easat-1678	159	37	of	of	ADP
easat-1678	159	38	hematology	hematology	NOUN
easat-1678	159	39	,	,	PUNCT
easat-1678	159	40	vol	vol	NOUN
easat-1678	159	41	.	.	PROPN
easat-1678	159	42	116	116	NUM
easat-1678	159	43	,	,	PUNCT
easat-1678	159	44	no	no	INTJ
easat-1678	159	45	.	.	NOUN
easat-1678	159	46	16	16	NUM
easat-1678	159	47	,	,	PUNCT
easat-1678	159	48	pp	pp	ADJ
easat-1678	159	49	.	.	PUNCT
easat-1678	160	1	2875	2875	NUM
easat-1678	160	2	-	-	SYM
easat-1678	160	3	2883	2883	NUM
easat-1678	160	4	,	,	PUNCT
easat-1678	160	5	2010	2010	NUM
easat-1678	160	6	.	.	PUNCT
easat-1678	161	1	[	[	X
easat-1678	161	2	3	3	X
easat-1678	161	3	]	]	X
easat-1678	161	4	w.	w.	NOUN
easat-1678	161	5	wanachiwanawin	wanachiwanawin	PROPN
easat-1678	161	6	,	,	PUNCT
easat-1678	161	7	"	"	PUNCT
easat-1678	161	8	infections	infection	NOUN
easat-1678	161	9	in	in	ADP
easat-1678	161	10	e	e	NOUN
easat-1678	161	11	-	-	NOUN
easat-1678	161	12	β	β	X
easat-1678	161	13	thalassemia	thalassemia	NOUN
easat-1678	161	14	,	,	PUNCT
easat-1678	161	15	"	"	PUNCT
easat-1678	161	16	journal	journal	NOUN
easat-1678	161	17	of	of	ADP
easat-1678	161	18	pediatric	pediatric	ADJ
easat-1678	161	19	haematology	haematology	NOUN
easat-1678	161	20	/	/	SYM
easat-1678	161	21	oncology	oncology	NOUN
easat-1678	161	22	,	,	PUNCT
easat-1678	161	23	vol	vol	NOUN
easat-1678	161	24	.	.	PROPN
easat-1678	161	25	22	22	NUM
easat-1678	161	26	,	,	PUNCT
easat-1678	161	27	no	no	INTJ
easat-1678	161	28	.	.	NOUN
easat-1678	161	29	6	6	NUM
easat-1678	161	30	,	,	PUNCT
easat-1678	161	31	pp	pp	ADJ
easat-1678	161	32	.	.	PUNCT
easat-1678	161	33	581587	581587	NUM
easat-1678	161	34	,	,	PUNCT
easat-1678	161	35	2000	2000	NUM
easat-1678	161	36	.	.	PUNCT
easat-1678	162	1	[	[	X
easat-1678	162	2	4	4	X
easat-1678	162	3	]	]	PUNCT
easat-1678	162	4	s.	s.	PROPN
easat-1678	162	5	pornprasert	pornprasert	PROPN
easat-1678	162	6	et	et	PROPN
easat-1678	162	7	al	al	PROPN
easat-1678	162	8	.	.	PROPN
easat-1678	162	9	,	,	PUNCT
easat-1678	162	10	"	"	PUNCT
easat-1678	162	11	effect	effect	NOUN
easat-1678	162	12	of	of	ADP
easat-1678	162	13	haematological	haematological	ADJ
easat-1678	162	14	alterations	alteration	NOUN
easat-1678	162	15	on	on	ADP
easat-1678	162	16	thalassaemia	thalassaemia	NOUN
easat-1678	162	17	investigation	investigation	NOUN
easat-1678	162	18	in	in	ADP
easat-1678	162	19	hiv‐1‐infected	hiv‐1‐infected	PROPN
easat-1678	162	20	thai	thai	NOUN
easat-1678	162	21	patients	patient	NOUN
easat-1678	162	22	receiving	receive	VERB
easat-1678	162	23	antiretroviral	antiretroviral	ADJ
easat-1678	162	24	therapy	therapy	NOUN
easat-1678	162	25	,	,	PUNCT
easat-1678	162	26	"	"	PUNCT
easat-1678	162	27	hiv	hiv	PROPN
easat-1678	162	28	medicine	medicine	NOUN
easat-1678	162	29	,	,	PUNCT
easat-1678	162	30	vol	vol	NOUN
easat-1678	162	31	.	.	PROPN
easat-1678	163	1	9	9	NUM
easat-1678	163	2	,	,	PUNCT
easat-1678	163	3	no	no	INTJ
easat-1678	163	4	.	.	NOUN
easat-1678	163	5	8	8	NUM
easat-1678	163	6	,	,	PUNCT
easat-1678	163	7	pp	pp	ADJ
easat-1678	163	8	.	.	PUNCT
easat-1678	164	1	660	660	NUM
easat-1678	164	2	-	-	SYM
easat-1678	164	3	666	666	NUM
easat-1678	164	4	,	,	PUNCT
easat-1678	164	5	2008	2008	NUM
easat-1678	164	6	.	.	PUNCT
easat-1678	165	1	[	[	X
easat-1678	165	2	5	5	X
easat-1678	165	3	]	]	PUNCT
easat-1678	165	4	f.	f.	PROPN
easat-1678	165	5	n.	n.	PROPN
easat-1678	165	6	syed	syed	PROPN
easat-1678	165	7	,	,	PUNCT
easat-1678	165	8	n.	n.	PROPN
easat-1678	165	9	kashif	kashif	PROPN
easat-1678	165	10	,	,	PUNCT
easat-1678	165	11	m.	m.	PROPN
easat-1678	165	12	r.	r.	PROPN
easat-1678	165	13	khan	khan	PROPN
easat-1678	165	14	,	,	PUNCT
easat-1678	165	15	f.	f.	PROPN
easat-1678	165	16	a.	a.	PROPN
easat-1678	165	17	memon	memon	PROPN
easat-1678	165	18	,	,	PUNCT
easat-1678	165	19	m.	m.	NOUN
easat-1678	165	20	z.	z.	PROPN
easat-1678	165	21	jabbar	jabbar	PROPN
easat-1678	165	22	,	,	PUNCT
easat-1678	165	23	and	and	CCONJ
easat-1678	165	24	s.	s.	PROPN
easat-1678	165	25	k.	k.	PROPN
easat-1678	165	26	palleti	palleti	PROPN
easat-1678	165	27	,	,	PUNCT
easat-1678	165	28	"	"	PUNCT
easat-1678	165	29	hepatitis	hepatitis	NOUN
easat-1678	165	30	c	c	PROPN
easat-1678	165	31	virus	virus	NOUN
easat-1678	165	32	infection	infection	NOUN
easat-1678	165	33	in	in	ADP
easat-1678	165	34	patients	patient	NOUN
easat-1678	165	35	with	with	ADP
easat-1678	165	36	beta	beta	NOUN
easat-1678	165	37	thalassemia	thalassemia	NOUN
easat-1678	165	38	after	after	ADP
easat-1678	165	39	multiple	multiple	ADJ
easat-1678	165	40	transfusions	transfusion	NOUN
easat-1678	165	41	at	at	ADP
easat-1678	165	42	a	a	DET
easat-1678	165	43	tertiary	tertiary	ADJ
easat-1678	165	44	care	care	NOUN
easat-1678	165	45	hospital	hospital	NOUN
easat-1678	165	46	,	,	PUNCT
easat-1678	165	47	"	"	PUNCT
easat-1678	165	48	pakistan	pakistan	PROPN
easat-1678	165	49	journal	journal	PROPN
easat-1678	165	50	of	of	ADP
easat-1678	165	51	medical	medical	PROPN
easat-1678	165	52	&	&	CCONJ
easat-1678	165	53	health	health	PROPN
easat-1678	165	54	sciences	sciences	PROPN
easat-1678	165	55	,	,	PUNCT
easat-1678	165	56	vol	vol	NOUN
easat-1678	165	57	.	.	PROPN
easat-1678	165	58	17	17	NUM
easat-1678	165	59	,	,	PUNCT
easat-1678	165	60	no	no	INTJ
easat-1678	165	61	.	.	NOUN
easat-1678	165	62	1	1	NUM
easat-1678	165	63	,	,	PUNCT
easat-1678	165	64	pp	pp	ADJ
easat-1678	165	65	.	.	PUNCT
easat-1678	166	1	363	363	NUM
easat-1678	166	2	-	-	SYM
easat-1678	166	3	363	363	NUM
easat-1678	166	4	,	,	PUNCT
easat-1678	166	5	2023	2023	NUM
easat-1678	166	6	.	.	PUNCT
easat-1678	167	1	[	[	X
easat-1678	167	2	6	6	NUM
easat-1678	167	3	]	]	PUNCT
easat-1678	167	4	s.	s.	PROPN
easat-1678	167	5	mirmomen	mirmomen	PROPN
easat-1678	167	6	et	et	PROPN
easat-1678	167	7	al	al	PROPN
easat-1678	167	8	.	.	PROPN
easat-1678	167	9	,	,	PUNCT
easat-1678	167	10	"	"	PUNCT
easat-1678	167	11	epidemiology	epidemiology	NOUN
easat-1678	167	12	of	of	ADP
easat-1678	167	13	hepatitis	hepatitis	PROPN
easat-1678	167	14	b	b	PROPN
easat-1678	167	15	,	,	PUNCT
easat-1678	167	16	hepatitis	hepatitis	NOUN
easat-1678	167	17	c	c	NOUN
easat-1678	167	18	,	,	PUNCT
easat-1678	167	19	and	and	CCONJ
easat-1678	167	20	human	human	ADJ
easat-1678	167	21	immunodeficiency	immunodeficiency	NOUN
easat-1678	167	22	virus	virus	NOUN
easat-1678	167	23	infections	infection	NOUN
easat-1678	167	24	in	in	ADP
easat-1678	167	25	patients	patient	NOUN
easat-1678	167	26	with	with	ADP
easat-1678	167	27	beta	beta	NOUN
easat-1678	167	28	-	-	PUNCT
easat-1678	167	29	thalassemia	thalassemia	NOUN
easat-1678	167	30	in	in	ADP
easat-1678	167	31	iran	iran	PROPN
easat-1678	167	32	:	:	PUNCT
easat-1678	167	33	a	a	DET
easat-1678	167	34	multicenter	multicenter	ADJ
easat-1678	167	35	study	study	NOUN
easat-1678	167	36	,	,	PUNCT
easat-1678	167	37	"	"	PUNCT
easat-1678	167	38	archives	archive	NOUN
easat-1678	167	39	of	of	ADP
easat-1678	167	40	iranian	iranian	ADJ
easat-1678	167	41	medicine	medicine	NOUN
easat-1678	167	42	,	,	PUNCT
easat-1678	167	43	vol	vol	NOUN
easat-1678	167	44	.	.	PROPN
easat-1678	167	45	9	9	NUM
easat-1678	167	46	,	,	PUNCT
easat-1678	167	47	no	no	INTJ
easat-1678	167	48	.	.	NOUN
easat-1678	167	49	4	4	NUM
easat-1678	167	50	,	,	PUNCT
easat-1678	167	51	pp	pp	ADJ
easat-1678	167	52	.	.	PUNCT
easat-1678	168	1	319	319	NUM
easat-1678	168	2	-	-	SYM
easat-1678	168	3	323	323	NUM
easat-1678	168	4	,	,	PUNCT
easat-1678	168	5	2006	2006	NUM
easat-1678	168	6	.	.	PUNCT
easat-1678	169	1	[	[	X
easat-1678	169	2	7	7	NUM
easat-1678	169	3	]	]	X
easat-1678	169	4	gharbi	gharbi	NOUN
easat-1678	169	5	,	,	PUNCT
easat-1678	169	6	a.	a.	PROPN
easat-1678	169	7	j.	j.	PROPN
easat-1678	169	8	h.	h.	PROPN
easat-1678	169	9	w.	w.	PROPN
easat-1678	169	10	a.	a.	PROPN
easat-1678	169	11	,	,	PUNCT
easat-1678	169	12	&	&	CCONJ
easat-1678	169	13	razzaq	razzaq	PROPN
easat-1678	169	14	,	,	PUNCT
easat-1678	169	15	s.	s.	PROPN
easat-1678	169	16	a.	a.	PROPN
easat-1678	169	17	a.	a.	PROPN
easat-1678	169	18	(	(	PUNCT
easat-1678	169	19	2022	2022	NUM
easat-1678	169	20	)	)	PUNCT
easat-1678	169	21	.	.	PUNCT
easat-1678	170	1	estimation	estimation	NOUN
easat-1678	170	2	of	of	ADP
easat-1678	170	3	liver	liver	NOUN
easat-1678	170	4	enzymes	enzyme	NOUN
easat-1678	170	5	in	in	ADP
easat-1678	170	6	patients	patient	NOUN
easat-1678	170	7	infected	infect	VERB
easat-1678	170	8	with	with	ADP
easat-1678	170	9	hepatitis	hepatitis	PROPN
easat-1678	170	10	b	b	PROPN
easat-1678	170	11	virus	virus	NOUN
easat-1678	170	12	in	in	ADP
easat-1678	170	13	baghdad	baghdad	PROPN
easat-1678	170	14	hospitals	hospital	NOUN
easat-1678	170	15	.	.	PUNCT
easat-1678	171	1	iraqi	iraqi	ADJ
easat-1678	171	2	journal	journal	PROPN
easat-1678	171	3	of	of	ADP
easat-1678	171	4	biotechnology	biotechnology	NOUN
easat-1678	171	5	,	,	PUNCT
easat-1678	171	6	21(2	21(2	NUM
easat-1678	171	7	)	)	PUNCT
easat-1678	171	8	.	.	PUNCT
easat-1678	172	1	[	[	X
easat-1678	172	2	8	8	NUM
easat-1678	172	3	]	]	X
easat-1678	172	4	shawkat	shawkat	PROPN
easat-1678	172	5	,	,	PUNCT
easat-1678	172	6	a.	a.	PROPN
easat-1678	172	7	j.	j.	PROPN
easat-1678	172	8	,	,	PUNCT
easat-1678	172	9	&	&	CCONJ
easat-1678	172	10	jwaid	jwaid	PROPN
easat-1678	172	11	,	,	PUNCT
easat-1678	172	12	a.	a.	PROPN
easat-1678	172	13	h.	h.	PROPN
easat-1678	172	14	(	(	PUNCT
easat-1678	172	15	2019	2019	NUM
easat-1678	172	16	)	)	PUNCT
easat-1678	172	17	.	.	PUNCT
easat-1678	173	1	clinical	clinical	ADJ
easat-1678	173	2	complications	complication	NOUN
easat-1678	173	3	of	of	ADP
easat-1678	173	4	beta	beta	NOUN
easat-1678	173	5	-	-	PUNCT
easat-1678	173	6	thalassemia	thalassemia	NOUN
easat-1678	173	7	major	major	NOUN
easat-1678	173	8	.	.	PUNCT
easat-1678	174	1	iraqi	iraqi	ADJ
easat-1678	174	2	journal	journal	PROPN
easat-1678	174	3	of	of	ADP
easat-1678	174	4	pharmaceutical	pharmaceutical	ADJ
easat-1678	174	5	sciences	science	NOUN
easat-1678	174	6	(	(	PUNCT
easat-1678	174	7	p	p	NOUN
easat-1678	174	8	-	-	PUNCT
easat-1678	174	9	issn	issn	PROPN
easat-1678	174	10	1683	1683	NUM
easat-1678	174	11	-	-	SYM
easat-1678	174	12	3597	3597	NUM
easat-1678	174	13	e	e	NOUN
easat-1678	174	14	-	-	NOUN
easat-1678	174	15	issn	issn	PROPN
easat-1678	174	16	2521	2521	NUM
easat-1678	174	17	-	-	SYM
easat-1678	174	18	3512	3512	NUM
easat-1678	174	19	)	)	PUNCT
easat-1678	174	20	,	,	PUNCT
easat-1678	174	21	28(2	28(2	NUM
easat-1678	174	22	)	)	PUNCT
easat-1678	174	23	,	,	PUNCT
easat-1678	174	24	1	1	NUM
easat-1678	174	25	-	-	SYM
easat-1678	174	26	8	8	NUM
easat-1678	174	27	.	.	PUNCT
easat-1678	175	1	[	[	X
easat-1678	175	2	9	9	NUM
easat-1678	175	3	]	]	PUNCT
easat-1678	175	4	m.	m.	NOUN
easat-1678	175	5	peters	peters	PROPN
easat-1678	175	6	,	,	PUNCT
easat-1678	175	7	h.	h.	PROPN
easat-1678	175	8	heijboer	heijboer	PROPN
easat-1678	175	9	,	,	PUNCT
easat-1678	175	10	f.	f.	PROPN
easat-1678	175	11	smiers	smiers	PROPN
easat-1678	175	12	,	,	PUNCT
easat-1678	175	13	and	and	CCONJ
easat-1678	175	14	p.	p.	PROPN
easat-1678	175	15	giordano	giordano	PROPN
easat-1678	175	16	,	,	PUNCT
easat-1678	175	17	"	"	PUNCT
easat-1678	175	18	diagnosis	diagnosis	NOUN
easat-1678	175	19	and	and	CCONJ
easat-1678	175	20	management	management	NOUN
easat-1678	175	21	of	of	ADP
easat-1678	175	22	thalassaemia	thalassaemia	NOUN
easat-1678	175	23	,	,	PUNCT
easat-1678	175	24	"	"	PUNCT
easat-1678	175	25	bmj	bmj	NOUN
easat-1678	175	26	,	,	PUNCT
easat-1678	175	27	vol	vol	NOUN
easat-1678	175	28	.	.	PROPN
easat-1678	175	29	344	344	NUM
easat-1678	175	30	,	,	PUNCT
easat-1678	175	31	2012	2012	NUM
easat-1678	175	32	.	.	PUNCT
easat-1678	176	1	[	[	X
easat-1678	176	2	10	10	NUM
easat-1678	176	3	]	]	PUNCT
easat-1678	176	4	a.	a.	NOUN
easat-1678	176	5	taher	taher	PROPN
easat-1678	176	6	,	,	PUNCT
easat-1678	176	7	h.	h.	PROPN
easat-1678	176	8	isma'eel	isma'eel	PROPN
easat-1678	176	9	,	,	PUNCT
easat-1678	176	10	and	and	CCONJ
easat-1678	176	11	m.	m.	PROPN
easat-1678	176	12	d.	d.	PROPN
easat-1678	176	13	cappellini	cappellini	PROPN
easat-1678	176	14	,	,	PUNCT
easat-1678	176	15	"	"	PUNCT
easat-1678	176	16	thalassemia	thalassemia	NOUN
easat-1678	176	17	intermedia	intermedia	PROPN
easat-1678	176	18	:	:	PUNCT
easat-1678	176	19	revisited	revisit	VERB
easat-1678	176	20	,	,	PUNCT
easat-1678	176	21	"	"	PUNCT
easat-1678	176	22	blood	blood	NOUN
easat-1678	176	23	cells	cell	NOUN
easat-1678	176	24	,	,	PUNCT
easat-1678	176	25	molecules	molecule	NOUN
easat-1678	176	26	,	,	PUNCT
easat-1678	176	27	and	and	CCONJ
easat-1678	176	28	diseases	disease	NOUN
easat-1678	176	29	,	,	PUNCT
easat-1678	176	30	vol	vol	NOUN
easat-1678	176	31	.	.	PROPN
easat-1678	177	1	37	37	NUM
easat-1678	177	2	,	,	PUNCT
easat-1678	177	3	no	no	INTJ
easat-1678	177	4	.	.	NOUN
easat-1678	177	5	1	1	NUM
easat-1678	177	6	,	,	PUNCT
easat-1678	177	7	pp	pp	ADJ
easat-1678	177	8	.	.	PUNCT
easat-1678	178	1	12	12	NUM
easat-1678	178	2	-	-	SYM
easat-1678	178	3	20	20	NUM
easat-1678	178	4	,	,	PUNCT
easat-1678	178	5	2006	2006	NUM
easat-1678	178	6	.	.	PUNCT
easat-1678	179	1	[	[	X
easat-1678	179	2	11	11	NUM
easat-1678	179	3	]	]	PUNCT
easat-1678	179	4	a.	a.	NOUN
easat-1678	179	5	t.	t.	PROPN
easat-1678	179	6	taher	taher	PROPN
easat-1678	179	7	,	,	PUNCT
easat-1678	179	8	k.	k.	PROPN
easat-1678	179	9	m.	m.	PROPN
easat-1678	179	10	musallam	musallam	PROPN
easat-1678	179	11	,	,	PUNCT
easat-1678	179	12	and	and	CCONJ
easat-1678	179	13	m.	m.	PROPN
easat-1678	179	14	d.	d.	PROPN
easat-1678	179	15	cappellini	cappellini	PROPN
easat-1678	179	16	,	,	PUNCT
easat-1678	179	17	"	"	PUNCT
easat-1678	179	18	liver	liver	NOUN
easat-1678	179	19	disease	disease	NOUN
easat-1678	179	20	,	,	PUNCT
easat-1678	179	21	"	"	PUNCT
easat-1678	179	22	in	in	ADP
easat-1678	179	23	guidelines	guideline	NOUN
easat-1678	179	24	for	for	ADP
easat-1678	179	25	the	the	DET
easat-1678	179	26	management	management	NOUN
easat-1678	179	27	of	of	ADP
easat-1678	179	28	nontransfusion	nontransfusion	NOUN
easat-1678	179	29	-	-	PUNCT
easat-1678	179	30	dependent	dependent	ADJ
easat-1678	179	31	β	β	NOUN
easat-1678	179	32	-	-	NOUN
easat-1678	179	33	thalassaemia	thalassaemia	NOUN
easat-1678	179	34	[	[	X
easat-1678	179	35	internet	internet	NOUN
easat-1678	179	36	]	]	PUNCT
easat-1678	179	37	.	.	PUNCT
easat-1678	180	1	3rd	3rd	ADJ
easat-1678	180	2	edition	edition	NOUN
easat-1678	180	3	:	:	PUNCT
easat-1678	180	4	thalassaemia	thalassaemia	PROPN
easat-1678	180	5	international	international	PROPN
easat-1678	180	6	federation	federation	PROPN
easat-1678	180	7	,	,	PUNCT
easat-1678	180	8	2023	2023	NUM
easat-1678	180	9	.	.	PUNCT
easat-1678	181	1	[	[	X
easat-1678	181	2	12	12	NUM
easat-1678	181	3	]	]	X
easat-1678	181	4	khalaf	khalaf	PROPN
easat-1678	181	5	,	,	PUNCT
easat-1678	181	6	m.	m.	NOUN
easat-1678	181	7	a.	a.	PROPN
easat-1678	181	8	,	,	PUNCT
easat-1678	181	9	al	al	PROPN
easat-1678	181	10	-	-	PUNCT
easat-1678	181	11	saadi	saadi	PROPN
easat-1678	181	12	,	,	PUNCT
easat-1678	181	13	b.	b.	PROPN
easat-1678	181	14	q.	q.	PROPN
easat-1678	181	15	h.	h.	PROPN
easat-1678	181	16	,	,	PUNCT
easat-1678	181	17	&	&	CCONJ
easat-1678	181	18	mohammed	mohammed	PROPN
easat-1678	181	19	,	,	PUNCT
easat-1678	181	20	h.	h.	PROPN
easat-1678	181	21	q.	q.	PROPN
easat-1678	181	22	(	(	PUNCT
easat-1678	181	23	2022	2022	NUM
easat-1678	181	24	)	)	PUNCT
easat-1678	181	25	.	.	PUNCT
easat-1678	182	1	evaluation	evaluation	NOUN
easat-1678	182	2	of	of	ADP
easat-1678	182	3	tlr-3	tlr-3	PRON
easat-1678	182	4	,	,	PUNCT
easat-1678	182	5	tlr4	tlr4	NOUN
easat-1678	182	6	,	,	PUNCT
easat-1678	182	7	il-7	il-7	X
easat-1678	182	8	,	,	PUNCT
easat-1678	182	9	and	and	CCONJ
easat-1678	182	10	il37	il37	PROPN
easat-1678	182	11	immunological	immunological	ADJ
easat-1678	182	12	markers	marker	NOUN
easat-1678	182	13	in	in	ADP
easat-1678	182	14	β	β	NOUN
easat-1678	182	15	-	-	ADJ
easat-1678	182	16	thalassemia	thalassemia	VERB
easat-1678	182	17	major	major	ADJ
easat-1678	182	18	iraqi	iraqi	ADJ
easat-1678	182	19	patients	patient	NOUN
easat-1678	182	20	.	.	PUNCT
easat-1678	183	1	iraqi	iraqi	ADJ
easat-1678	183	2	journal	journal	PROPN
easat-1678	183	3	of	of	ADP
easat-1678	183	4	biotechnology	biotechnology	NOUN
easat-1678	183	5	,	,	PUNCT
easat-1678	183	6	21(1	21(1	NUM
easat-1678	183	7	)	)	PUNCT
easat-1678	183	8	.	.	PUNCT
easat-1678	184	1	[	[	X
easat-1678	184	2	13	13	NUM
easat-1678	184	3	]	]	PUNCT
easat-1678	184	4	s.	s.	PROPN
easat-1678	184	5	peslak	peslak	PROPN
easat-1678	184	6	and	and	CCONJ
easat-1678	184	7	f.	f.	PROPN
easat-1678	184	8	sayani	sayani	PROPN
easat-1678	184	9	,	,	PUNCT
easat-1678	184	10	"	"	PUNCT
easat-1678	184	11	hemoglobinopathies	hemoglobinopathy	NOUN
easat-1678	184	12	and	and	CCONJ
easat-1678	184	13	thalassemias	thalassemia	NOUN
easat-1678	184	14	,	,	PUNCT
easat-1678	184	15	"	"	PUNCT
easat-1678	184	16	in	in	ADP
easat-1678	184	17	emery	emery	PROPN
easat-1678	184	18	and	and	CCONJ
easat-1678	184	19	rimoin	rimoin	PROPN
easat-1678	184	20	's	's	PART
easat-1678	184	21	principles	principle	NOUN
easat-1678	184	22	and	and	CCONJ
easat-1678	184	23	practice	practice	NOUN
easat-1678	184	24	of	of	ADP
easat-1678	184	25	medical	medical	ADJ
easat-1678	184	26	genetics	genetic	NOUN
easat-1678	184	27	and	and	CCONJ
easat-1678	184	28	genomics	genomic	NOUN
easat-1678	184	29	:	:	PUNCT
easat-1678	184	30	elsevier	elsevier	NOUN
easat-1678	184	31	,	,	PUNCT
easat-1678	184	32	2023	2023	NUM
easat-1678	184	33	,	,	PUNCT
easat-1678	184	34	pp	pp	ADJ
easat-1678	184	35	.	.	PUNCT
easat-1678	185	1	143	143	NUM
easat-1678	185	2	-	-	SYM
easat-1678	185	3	172	172	NUM
easat-1678	185	4	.	.	PUNCT
easat-1678	186	1	[	[	X
easat-1678	186	2	14	14	NUM
easat-1678	186	3	]	]	PUNCT
easat-1678	186	4	a.	a.	NOUN
easat-1678	186	5	t.	t.	PROPN
easat-1678	186	6	taher	taher	PROPN
easat-1678	186	7	,	,	PUNCT
easat-1678	186	8	k.	k.	PROPN
easat-1678	186	9	m.	m.	PROPN
easat-1678	186	10	musallam	musallam	PROPN
easat-1678	186	11	,	,	PUNCT
easat-1678	186	12	and	and	CCONJ
easat-1678	186	13	m.	m.	PROPN
easat-1678	186	14	d.	d.	PROPN
easat-1678	186	15	cappellini	cappellini	PROPN
easat-1678	186	16	,	,	PUNCT
easat-1678	186	17	"	"	PUNCT
easat-1678	186	18	iron	iron	NOUN
easat-1678	186	19	overload	overload	NOUN
easat-1678	186	20	,	,	PUNCT
easat-1678	186	21	"	"	PUNCT
easat-1678	186	22	in	in	ADP
easat-1678	186	23	guidelines	guideline	NOUN
easat-1678	186	24	for	for	ADP
easat-1678	186	25	the	the	DET
easat-1678	186	26	management	management	NOUN
easat-1678	186	27	of	of	ADP
easat-1678	186	28	nontransfusion	nontransfusion	NOUN
easat-1678	186	29	-	-	PUNCT
easat-1678	186	30	dependent	dependent	ADJ
easat-1678	186	31	β	β	NOUN
easat-1678	186	32	-	-	NOUN
easat-1678	186	33	thalassaemia	thalassaemia	NOUN
easat-1678	186	34	[	[	X
easat-1678	186	35	internet	internet	NOUN
easat-1678	186	36	]	]	PUNCT
easat-1678	186	37	.	.	PUNCT
easat-1678	187	1	3rd	3rd	ADJ
easat-1678	187	2	edition	edition	NOUN
easat-1678	187	3	:	:	PUNCT
easat-1678	187	4	thalassaemia	thalassaemia	PROPN
easat-1678	187	5	international	international	PROPN
easat-1678	187	6	federation	federation	PROPN
easat-1678	187	7	,	,	PUNCT
easat-1678	187	8	2023	2023	NUM
easat-1678	187	9	.	.	PUNCT
easat-1678	188	1	[	[	X
easat-1678	188	2	15	15	NUM
easat-1678	188	3	]	]	X
easat-1678	188	4	r.	r.	PROPN
easat-1678	188	5	bou	bou	PROPN
easat-1678	188	6	-	-	PUNCT
easat-1678	188	7	fakhredin	fakhredin	PROPN
easat-1678	188	8	,	,	PUNCT
easat-1678	188	9	s.	s.	PROPN
easat-1678	188	10	rivella	rivella	PROPN
easat-1678	188	11	,	,	PUNCT
easat-1678	188	12	m.	m.	PROPN
easat-1678	188	13	d.	d.	PROPN
easat-1678	188	14	cappellini	cappellini	PROPN
easat-1678	188	15	,	,	PUNCT
easat-1678	188	16	and	and	CCONJ
easat-1678	188	17	a.	a.	NOUN
easat-1678	188	18	t.	t.	PROPN
easat-1678	188	19	taher	taher	PROPN
easat-1678	188	20	,	,	PUNCT
easat-1678	188	21	"	"	PUNCT
easat-1678	188	22	pathogenic	pathogenic	ADJ
easat-1678	188	23	mechanisms	mechanism	NOUN
easat-1678	188	24	in	in	ADP
easat-1678	188	25	thalassemia	thalassemia	NOUN
easat-1678	188	26	i	i	PRON
easat-1678	188	27	:	:	PUNCT
easat-1678	188	28	ineffective	ineffective	ADJ
easat-1678	188	29	erythropoiesis	erythropoiesis	NOUN
easat-1678	188	30	and	and	CCONJ
easat-1678	188	31	hypercoagulability	hypercoagulability	NOUN
easat-1678	188	32	,	,	PUNCT
easat-1678	188	33	"	"	PUNCT
easat-1678	188	34	hematology	hematology	NOUN
easat-1678	188	35	/	/	SYM
easat-1678	188	36	oncology	oncology	NOUN
easat-1678	188	37	clinics	clinic	NOUN
easat-1678	188	38	,	,	PUNCT
easat-1678	188	39	vol	vol	NOUN
easat-1678	188	40	.	.	PROPN
easat-1678	188	41	37	37	NUM
easat-1678	188	42	,	,	PUNCT
easat-1678	188	43	no	no	INTJ
easat-1678	188	44	.	.	NOUN
easat-1678	188	45	2	2	NUM
easat-1678	188	46	,	,	PUNCT
easat-1678	188	47	pp	pp	ADJ
easat-1678	188	48	.	.	PUNCT
easat-1678	189	1	341	341	NUM
easat-1678	189	2	-	-	SYM
easat-1678	189	3	351	351	NUM
easat-1678	189	4	,	,	PUNCT
easat-1678	189	5	2023	2023	NUM
easat-1678	189	6	.	.	PUNCT
easat-1678	190	1	[	[	X
easat-1678	190	2	16	16	NUM
easat-1678	190	3	]	]	PUNCT
easat-1678	190	4	z.	z.	PROPN
easat-1678	190	5	sharifi	sharifi	PROPN
easat-1678	190	6	,	,	PUNCT
easat-1678	190	7	s.	s.	PROPN
easat-1678	190	8	milani	milani	PROPN
easat-1678	190	9	,	,	PUNCT
easat-1678	190	10	and	and	CCONJ
easat-1678	190	11	m.	m.	NOUN
easat-1678	190	12	m.	m.	NOUN
easat-1678	190	13	shooshtari	shooshtari	PROPN
easat-1678	190	14	,	,	PUNCT
easat-1678	190	15	"	"	PUNCT
easat-1678	190	16	study	study	NOUN
easat-1678	190	17	on	on	ADP
easat-1678	190	18	efficacy	efficacy	NOUN
easat-1678	190	19	of	of	ADP
easat-1678	190	20	hepatitis	hepatitis	PROPN
easat-1678	190	21	b	b	PROPN
easat-1678	190	22	immunization	immunization	NOUN
easat-1678	190	23	in	in	ADP
easat-1678	190	24	vaccinated	vaccinated	ADJ
easat-1678	190	25	betathalassemia	betathalassemia	NOUN
easat-1678	190	26	children	child	NOUN
easat-1678	190	27	in	in	ADP
easat-1678	190	28	tehran	tehran	PROPN
easat-1678	190	29	,	,	PUNCT
easat-1678	190	30	"	"	PUNCT
easat-1678	190	31	iranian	iranian	ADJ
easat-1678	190	32	journal	journal	NOUN
easat-1678	190	33	of	of	ADP
easat-1678	190	34	pediatrics	pediatric	NOUN
easat-1678	190	35	,	,	PUNCT
easat-1678	190	36	vol	vol	NOUN
easat-1678	190	37	.	.	PROPN
easat-1678	190	38	20	20	NUM
easat-1678	190	39	,	,	PUNCT
easat-1678	190	40	no	no	INTJ
easat-1678	190	41	.	.	NOUN
easat-1678	190	42	2	2	NUM
easat-1678	190	43	,	,	PUNCT
easat-1678	190	44	p.	p.	NOUN
easat-1678	190	45	211	211	NUM
easat-1678	190	46	,	,	PUNCT
easat-1678	190	47	2010	2010	NUM
easat-1678	190	48	.	.	PUNCT
easat-1678	191	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-1678	191	2	532	532	NUM
easat-1678	191	3	edelweiss	edelweiss	PROPN
easat-1678	191	4	applied	apply	VERB
easat-1678	191	5	science	science	NOUN
easat-1678	191	6	and	and	CCONJ
easat-1678	191	7	technology	technology	NOUN
easat-1678	191	8	issn	issn	PROPN
easat-1678	191	9	:	:	PUNCT
easat-1678	191	10	2576	2576	NUM
easat-1678	191	11	-	-	SYM
easat-1678	191	12	8484	8484	NUM
easat-1678	191	13	vol	vol	NOUN
easat-1678	191	14	.	.	PROPN
easat-1678	191	15	8	8	NUM
easat-1678	191	16	,	,	PUNCT
easat-1678	191	17	no	no	INTJ
easat-1678	191	18	.	.	NOUN
easat-1678	192	1	3	3	NUM
easat-1678	192	2	:	:	PUNCT
easat-1678	192	3	523	523	NUM
easat-1678	192	4	-	-	SYM
easat-1678	192	5	532	532	NUM
easat-1678	192	6	,	,	PUNCT
easat-1678	192	7	2024	2024	NUM
easat-1678	192	8	doi	doi	NOUN
easat-1678	192	9	:	:	PUNCT
easat-1678	192	10	10.55214/25768484.v8i3.1678	10.55214/25768484.v8i3.1678	NUM
easat-1678	192	11	©	©	PROPN
easat-1678	192	12	2024	2024	NUM
easat-1678	192	13	by	by	ADP
easat-1678	192	14	the	the	DET
easat-1678	192	15	authors	author	NOUN
easat-1678	192	16	;	;	PUNCT
easat-1678	192	17	licensee	licensee	PROPN
easat-1678	192	18	learning	learning	NOUN
easat-1678	192	19	gate	gate	NOUN
easat-1678	193	1	[	[	X
easat-1678	193	2	17	17	NUM
easat-1678	193	3	]	]	X
easat-1678	193	4	c.	c.	PROPN
easat-1678	193	5	a.	a.	NOUN
easat-1678	193	6	dinarello	dinarello	PROPN
easat-1678	193	7	,	,	PUNCT
easat-1678	193	8	"	"	PUNCT
easat-1678	193	9	overview	overview	NOUN
easat-1678	193	10	of	of	ADP
easat-1678	193	11	the	the	DET
easat-1678	193	12	il‐1	il‐1	NOUN
easat-1678	193	13	family	family	NOUN
easat-1678	193	14	in	in	ADP
easat-1678	193	15	innate	innate	ADJ
easat-1678	193	16	inflammation	inflammation	NOUN
easat-1678	193	17	and	and	CCONJ
easat-1678	193	18	acquired	acquire	VERB
easat-1678	193	19	immunity	immunity	NOUN
easat-1678	193	20	,	,	PUNCT
easat-1678	193	21	"	"	PUNCT
easat-1678	193	22	immunological	immunological	ADJ
easat-1678	193	23	reviews	review	NOUN
easat-1678	193	24	,	,	PUNCT
easat-1678	193	25	vol	vol	NOUN
easat-1678	193	26	.	.	PROPN
easat-1678	193	27	281	281	NUM
easat-1678	193	28	,	,	PUNCT
easat-1678	193	29	no	no	INTJ
easat-1678	193	30	.	.	NOUN
easat-1678	193	31	1	1	NUM
easat-1678	193	32	,	,	PUNCT
easat-1678	193	33	pp	pp	ADJ
easat-1678	193	34	.	.	PUNCT
easat-1678	194	1	8	8	NUM
easat-1678	194	2	-	-	SYM
easat-1678	194	3	27	27	NUM
easat-1678	194	4	,	,	PUNCT
easat-1678	194	5	2018	2018	NUM
easat-1678	194	6	.	.	PUNCT
easat-1678	195	1	[	[	X
easat-1678	195	2	18	18	NUM
easat-1678	195	3	]	]	PUNCT
easat-1678	195	4	k.	k.	PROPN
easat-1678	195	5	yasuda	yasuda	PROPN
easat-1678	195	6	,	,	PUNCT
easat-1678	195	7	k.	k.	PROPN
easat-1678	195	8	nakanishi	nakanishi	PROPN
easat-1678	195	9	,	,	PUNCT
easat-1678	195	10	and	and	CCONJ
easat-1678	195	11	h.	h.	PROPN
easat-1678	195	12	tsutsui	tsutsui	PROPN
easat-1678	195	13	,	,	PUNCT
easat-1678	195	14	"	"	PUNCT
easat-1678	195	15	interleukin-18	interleukin-18	PROPN
easat-1678	195	16	in	in	ADP
easat-1678	195	17	health	health	NOUN
easat-1678	195	18	and	and	CCONJ
easat-1678	195	19	disease	disease	NOUN
easat-1678	195	20	,	,	PUNCT
easat-1678	195	21	"	"	PUNCT
easat-1678	195	22	international	international	ADJ
easat-1678	195	23	journal	journal	NOUN
easat-1678	195	24	of	of	ADP
easat-1678	195	25	molecular	molecular	ADJ
easat-1678	195	26	sciences	science	NOUN
easat-1678	195	27	,	,	PUNCT
easat-1678	195	28	vol	vol	NOUN
easat-1678	195	29	.	.	PROPN
easat-1678	195	30	20	20	NUM
easat-1678	195	31	,	,	PUNCT
easat-1678	195	32	no	no	INTJ
easat-1678	195	33	.	.	NOUN
easat-1678	195	34	3	3	NUM
easat-1678	195	35	,	,	PUNCT
easat-1678	195	36	p.	p.	NOUN
easat-1678	195	37	649	649	NUM
easat-1678	195	38	,	,	PUNCT
easat-1678	195	39	2019	2019	NUM
easat-1678	195	40	.	.	PUNCT
easat-1678	196	1	[	[	X
easat-1678	196	2	19	19	NUM
easat-1678	196	3	]	]	X
easat-1678	196	4	n.	n.	NOUN
easat-1678	196	5	afdhal	afdhal	NOUN
easat-1678	196	6	et	et	PROPN
easat-1678	196	7	al	al	PROPN
easat-1678	196	8	.	.	PROPN
easat-1678	196	9	,	,	PUNCT
easat-1678	196	10	"	"	PUNCT
easat-1678	196	11	ledipasvir	ledipasvir	PROPN
easat-1678	196	12	and	and	CCONJ
easat-1678	196	13	sofosbuvir	sofosbuvir	PROPN
easat-1678	196	14	for	for	ADP
easat-1678	196	15	untreated	untreated	ADJ
easat-1678	196	16	hcv	hcv	NOUN
easat-1678	196	17	genotype	genotype	NOUN
easat-1678	196	18	1	1	NUM
easat-1678	196	19	infection	infection	NOUN
easat-1678	196	20	,	,	PUNCT
easat-1678	196	21	"	"	PUNCT
easat-1678	196	22	new	new	PROPN
easat-1678	196	23	england	england	PROPN
easat-1678	196	24	journal	journal	PROPN
easat-1678	196	25	of	of	ADP
easat-1678	196	26	medicine	medicine	NOUN
easat-1678	196	27	,	,	PUNCT
easat-1678	196	28	vol	vol	NOUN
easat-1678	196	29	.	.	PROPN
easat-1678	196	30	370	370	NUM
easat-1678	196	31	,	,	PUNCT
easat-1678	196	32	no	no	INTJ
easat-1678	196	33	.	.	NOUN
easat-1678	196	34	20	20	NUM
easat-1678	196	35	,	,	PUNCT
easat-1678	196	36	pp	pp	ADJ
easat-1678	196	37	.	.	PUNCT
easat-1678	197	1	1889	1889	NUM
easat-1678	197	2	-	-	SYM
easat-1678	197	3	1898	1898	NUM
easat-1678	197	4	,	,	PUNCT
easat-1678	197	5	2014	2014	NUM
easat-1678	197	6	.	.	PUNCT
easat-1678	198	1	[	[	X
easat-1678	198	2	20	20	NUM
easat-1678	198	3	]	]	X
easat-1678	198	4	hussein	hussein	PROPN
easat-1678	198	5	,	,	PUNCT
easat-1678	198	6	s.	s.	PROPN
easat-1678	198	7	a.	a.	PROPN
easat-1678	198	8	,	,	PUNCT
easat-1678	198	9	&	&	CCONJ
easat-1678	198	10	al	al	PROPN
easat-1678	198	11	-	-	PUNCT
easat-1678	198	12	azzawi	azzawi	PROPN
easat-1678	198	13	,	,	PUNCT
easat-1678	198	14	r.	r.	PROPN
easat-1678	198	15	h.	h.	PROPN
easat-1678	198	16	(	(	PUNCT
easat-1678	198	17	2024	2024	NUM
easat-1678	198	18	)	)	PUNCT
easat-1678	198	19	.	.	PUNCT
easat-1678	199	1	single	single	ADJ
easat-1678	199	2	nucleotide	nucleotide	ADJ
easat-1678	199	3	polymorphism	polymorphism	NOUN
easat-1678	199	4	of	of	ADP
easat-1678	199	5	interleukin-28β	interleukin-28β	NOUN
easat-1678	199	6	subunit	subunit	NOUN
easat-1678	199	7	genes	gene	NOUN
easat-1678	199	8	predict	predict	VERB
easat-1678	199	9	host	host	NOUN
easat-1678	199	10	susceptibility	susceptibility	NOUN
easat-1678	199	11	to	to	ADP
easat-1678	199	12	hepatitis	hepatitis	PROPN
easat-1678	199	13	c	c	PROPN
easat-1678	199	14	virus	virus	NOUN
easat-1678	199	15	(	(	PUNCT
easat-1678	199	16	hcv	hcv	NOUN
easat-1678	199	17	)	)	PUNCT
easat-1678	199	18	infection	infection	NOUN
easat-1678	199	19	among	among	ADP
easat-1678	199	20	iraqi	iraqi	ADJ
easat-1678	199	21	patients	patient	NOUN
easat-1678	199	22	.	.	PUNCT
easat-1678	200	1	iraqi	iraqi	ADJ
easat-1678	200	2	journal	journal	PROPN
easat-1678	200	3	of	of	ADP
easat-1678	200	4	science	science	NOUN
easat-1678	200	5	,	,	PUNCT
easat-1678	200	6	2385	2385	NUM
easat-1678	200	7	-	-	SYM
easat-1678	200	8	2396	2396	NUM
easat-1678	200	9	.	.	PUNCT
easat-1678	201	1	[	[	X
easat-1678	201	2	21	21	NUM
easat-1678	201	3	]	]	X
easat-1678	201	4	d.	d.	PROPN
easat-1678	201	5	lapa	lapa	PROPN
easat-1678	201	6	,	,	PUNCT
easat-1678	201	7	a.	a.	PROPN
easat-1678	201	8	r.	r.	PROPN
easat-1678	201	9	garbuglia	garbuglia	PROPN
easat-1678	201	10	,	,	PUNCT
easat-1678	201	11	m.	m.	PROPN
easat-1678	201	12	r.	r.	PROPN
easat-1678	201	13	capobianchi	capobianchi	PROPN
easat-1678	201	14	,	,	PUNCT
easat-1678	201	15	and	and	CCONJ
easat-1678	201	16	p.	p.	PROPN
easat-1678	201	17	del	del	PROPN
easat-1678	201	18	porto	porto	PROPN
easat-1678	201	19	,	,	PUNCT
easat-1678	201	20	"	"	PUNCT
easat-1678	201	21	hepatitis	hepatitis	PROPN
easat-1678	201	22	c	c	PROPN
easat-1678	201	23	virus	virus	NOUN
easat-1678	201	24	genetic	genetic	ADJ
easat-1678	201	25	variability	variability	NOUN
easat-1678	201	26	,	,	PUNCT
easat-1678	201	27	human	human	ADJ
easat-1678	201	28	immune	immune	ADJ
easat-1678	201	29	response	response	NOUN
easat-1678	201	30	,	,	PUNCT
easat-1678	201	31	and	and	CCONJ
easat-1678	201	32	genome	genome	NOUN
easat-1678	201	33	polymorphisms	polymorphism	NOUN
easat-1678	201	34	:	:	PUNCT
easat-1678	201	35	which	which	PRON
easat-1678	201	36	is	be	AUX
easat-1678	201	37	the	the	DET
easat-1678	201	38	interplay	interplay	NOUN
easat-1678	201	39	?	?	PUNCT
easat-1678	201	40	,	,	PUNCT
easat-1678	201	41	"	"	PUNCT
easat-1678	201	42	cells	cell	NOUN
easat-1678	201	43	,	,	PUNCT
easat-1678	201	44	vol	vol	NOUN
easat-1678	201	45	.	.	PROPN
easat-1678	201	46	8	8	NUM
easat-1678	201	47	,	,	PUNCT
easat-1678	201	48	no	no	INTJ
easat-1678	201	49	.	.	NOUN
easat-1678	201	50	4	4	NUM
easat-1678	201	51	,	,	PUNCT
easat-1678	201	52	p.	p.	NOUN
easat-1678	201	53	305	305	NUM
easat-1678	201	54	,	,	PUNCT
easat-1678	201	55	2019	2019	NUM
easat-1678	201	56	.	.	PUNCT
easat-1678	202	1	[	[	X
easat-1678	202	2	22	22	NUM
easat-1678	202	3	]	]	X
easat-1678	202	4	talak	talak	ADJ
easat-1678	202	5	,	,	PUNCT
easat-1678	202	6	m.	m.	NOUN
easat-1678	202	7	a.	a.	NOUN
easat-1678	202	8	(	(	PUNCT
easat-1678	202	9	2023	2023	NUM
easat-1678	202	10	)	)	PUNCT
easat-1678	202	11	.	.	PUNCT
easat-1678	203	1	evaluation	evaluation	NOUN
easat-1678	203	2	of	of	ADP
easat-1678	203	3	gene	gene	NOUN
easat-1678	203	4	expression	expression	NOUN
easat-1678	203	5	of	of	ADP
easat-1678	203	6	some	some	DET
easat-1678	203	7	toll	toll	NOUN
easat-1678	203	8	-	-	PUNCT
easat-1678	203	9	like	like	ADJ
easat-1678	203	10	receptors	receptor	NOUN
easat-1678	203	11	genes	gene	NOUN
easat-1678	203	12	among	among	ADP
easat-1678	203	13	iraqi	iraqi	ADJ
easat-1678	203	14	meningitis	meningiti	NOUN
easat-1678	203	15	.	.	PUNCT
easat-1678	204	1	iraqi	iraqi	ADJ
easat-1678	204	2	journal	journal	PROPN
easat-1678	204	3	of	of	ADP
easat-1678	204	4	biotechnology	biotechnology	NOUN
easat-1678	204	5	,	,	PUNCT
easat-1678	204	6	22(1	22(1	NUM
easat-1678	204	7	)	)	PUNCT
easat-1678	204	8	.	.	PUNCT
easat-1678	205	1	[	[	X
easat-1678	205	2	23	23	NUM
easat-1678	205	3	]	]	X
easat-1678	205	4	f.	f.	PROPN
easat-1678	205	5	holmström	holmström	PROPN
easat-1678	205	6	,	,	PUNCT
easat-1678	205	7	development	development	NOUN
easat-1678	205	8	and	and	CCONJ
easat-1678	205	9	evaluation	evaluation	NOUN
easat-1678	205	10	of	of	ADP
easat-1678	205	11	new	new	ADJ
easat-1678	205	12	therapeutic	therapeutic	ADJ
easat-1678	205	13	interventions	intervention	NOUN
easat-1678	205	14	for	for	ADP
easat-1678	205	15	chronic	chronic	ADJ
easat-1678	205	16	hepatitis	hepatitis	PROPN
easat-1678	205	17	c	c	PROPN
easat-1678	205	18	virus	virus	NOUN
easat-1678	205	19	infection	infection	NOUN
easat-1678	205	20	.	.	PUNCT
easat-1678	206	1	karolinska	karolinska	PROPN
easat-1678	206	2	institutet	institutet	PROPN
easat-1678	206	3	(	(	PUNCT
easat-1678	206	4	sweden	sweden	PROPN
easat-1678	206	5	)	)	PUNCT
easat-1678	206	6	,	,	PUNCT
easat-1678	206	7	2015	2015	NUM
easat-1678	206	8	.	.	PUNCT
easat-1678	207	1	[	[	X
easat-1678	207	2	24	24	NUM
easat-1678	207	3	]	]	PUNCT
easat-1678	207	4	j.	j.	PROPN
easat-1678	207	5	j.	j.	PROPN
easat-1678	207	6	feld	feld	PROPN
easat-1678	207	7	et	et	PROPN
easat-1678	207	8	al	al	PROPN
easat-1678	207	9	.	.	PROPN
easat-1678	207	10	,	,	PUNCT
easat-1678	207	11	"	"	PUNCT
easat-1678	207	12	sofosbuvir	sofosbuvir	PROPN
easat-1678	207	13	and	and	CCONJ
easat-1678	207	14	velpatasvir	velpatasvir	PROPN
easat-1678	207	15	for	for	ADP
easat-1678	207	16	hcv	hcv	NOUN
easat-1678	207	17	genotype	genotype	NOUN
easat-1678	207	18	1	1	NUM
easat-1678	207	19	,	,	PUNCT
easat-1678	207	20	2	2	NUM
easat-1678	207	21	,	,	PUNCT
easat-1678	207	22	4	4	NUM
easat-1678	207	23	,	,	PUNCT
easat-1678	207	24	5	5	NUM
easat-1678	207	25	,	,	PUNCT
easat-1678	207	26	and	and	CCONJ
easat-1678	207	27	6	6	NUM
easat-1678	207	28	infection	infection	NOUN
easat-1678	207	29	,	,	PUNCT
easat-1678	207	30	"	"	PUNCT
easat-1678	207	31	new	new	PROPN
easat-1678	207	32	england	england	PROPN
easat-1678	207	33	journal	journal	PROPN
easat-1678	207	34	of	of	ADP
easat-1678	207	35	medicine	medicine	NOUN
easat-1678	207	36	,	,	PUNCT
easat-1678	207	37	vol	vol	NOUN
easat-1678	207	38	.	.	PUNCT
easat-1678	207	39	373	373	NUM
easat-1678	207	40	,	,	PUNCT
easat-1678	207	41	no	no	INTJ
easat-1678	207	42	.	.	NOUN
easat-1678	207	43	27	27	NUM
easat-1678	207	44	,	,	PUNCT
easat-1678	207	45	pp	pp	ADJ
easat-1678	207	46	.	.	PUNCT
easat-1678	207	47	2599	2599	NUM
easat-1678	207	48	-	-	SYM
easat-1678	207	49	2607	2607	NUM
easat-1678	207	50	,	,	PUNCT
easat-1678	207	51	2015	2015	NUM
easat-1678	207	52	.	.	PUNCT
easat-1678	208	1	[	[	X
easat-1678	208	2	25	25	NUM
easat-1678	208	3	]	]	PUNCT
easat-1678	208	4	q.	q.	PROPN
easat-1678	208	5	zhao	zhao	PROPN
easat-1678	208	6	et	et	PROPN
easat-1678	208	7	al	al	PROPN
easat-1678	208	8	.	.	PROPN
easat-1678	208	9	,	,	PUNCT
easat-1678	208	10	"	"	PUNCT
easat-1678	208	11	glucocorticoid	glucocorticoid	NOUN
easat-1678	208	12	regulates	regulate	VERB
easat-1678	208	13	nlrp3	nlrp3	NOUN
easat-1678	208	14	in	in	ADP
easat-1678	208	15	acute	acute	NOUN
easat-1678	208	16	-	-	PUNCT
easat-1678	208	17	on	on	ADP
easat-1678	208	18	-	-	PUNCT
easat-1678	208	19	chronic	chronic	ADJ
easat-1678	208	20	hepatitis	hepatitis	NOUN
easat-1678	208	21	b	b	PROPN
easat-1678	208	22	liver	liver	NOUN
easat-1678	208	23	failure	failure	NOUN
easat-1678	208	24	,	,	PUNCT
easat-1678	208	25	"	"	PUNCT
easat-1678	208	26	international	international	ADJ
easat-1678	208	27	journal	journal	NOUN
easat-1678	208	28	of	of	ADP
easat-1678	208	29	medical	medical	ADJ
easat-1678	208	30	sciences	science	NOUN
easat-1678	208	31	,	,	PUNCT
easat-1678	208	32	vol	vol	NOUN
easat-1678	208	33	.	.	PROPN
easat-1678	209	1	16	16	NUM
easat-1678	209	2	,	,	PUNCT
easat-1678	209	3	no	no	INTJ
easat-1678	209	4	.	.	NOUN
easat-1678	209	5	3	3	NUM
easat-1678	209	6	,	,	PUNCT
easat-1678	209	7	p.	p.	NOUN
easat-1678	209	8	461	461	NUM
easat-1678	209	9	,	,	PUNCT
easat-1678	209	10	2019	2019	NUM
easat-1678	209	11	.	.	PUNCT
easat-1678	210	1	[	[	X
easat-1678	210	2	26	26	NUM
easat-1678	210	3	]	]	PUNCT
easat-1678	210	4	a.	a.	NOUN
easat-1678	210	5	a.	a.	NOUN
easat-1678	210	6	salama	salama	PROPN
easat-1678	210	7	,	,	PUNCT
easat-1678	210	8	a.	a.	PROPN
easat-1678	210	9	el	el	PROPN
easat-1678	210	10	-	-	PUNCT
easat-1678	210	11	hamid	hamid	PROPN
easat-1678	210	12	,	,	PUNCT
easat-1678	210	13	e.	e.	PROPN
easat-1678	210	14	alaa	alaa	PROPN
easat-1678	210	15	,	,	PUNCT
easat-1678	210	16	a.	a.	NOUN
easat-1678	210	17	esmaeel	esmaeel	NOUN
easat-1678	210	18	,	,	PUNCT
easat-1678	210	19	and	and	CCONJ
easat-1678	210	20	g.	g.	PROPN
easat-1678	210	21	r.	r.	PROPN
easat-1678	210	22	el	el	PROPN
easat-1678	210	23	-	-	PROPN
easat-1678	210	24	hendawy	hendawy	PROPN
easat-1678	210	25	,	,	PUNCT
easat-1678	210	26	"	"	PUNCT
easat-1678	210	27	study	study	NOUN
easat-1678	210	28	of	of	ADP
easat-1678	210	29	interleukin-18	interleukin-18	PROPN
easat-1678	210	30	during	during	ADP
easat-1678	210	31	antiviral	antiviral	ADJ
easat-1678	210	32	therapy	therapy	NOUN
easat-1678	210	33	for	for	ADP
easat-1678	210	34	hepatitis	hepatitis	PROPN
easat-1678	210	35	c	c	PROPN
easat-1678	210	36	with	with	ADP
easat-1678	210	37	sofosbuvir	sofosbuvir	PROPN
easat-1678	210	38	,	,	PUNCT
easat-1678	210	39	ribavirin	ribavirin	NOUN
easat-1678	210	40	,	,	PUNCT
easat-1678	210	41	and	and	CCONJ
easat-1678	210	42	interferon	interferon	NOUN
easat-1678	210	43	in	in	ADP
easat-1678	210	44	menoufia	menoufia	NOUN
easat-1678	210	45	hospitals	hospital	NOUN
easat-1678	210	46	,	,	PUNCT
easat-1678	210	47	"	"	PUNCT
easat-1678	210	48	menoufia	menoufia	PROPN
easat-1678	210	49	medical	medical	ADJ
easat-1678	210	50	journal	journal	PROPN
easat-1678	210	51	,	,	PUNCT
easat-1678	210	52	vol	vol	NOUN
easat-1678	210	53	.	.	PROPN
easat-1678	210	54	31	31	NUM
easat-1678	210	55	,	,	PUNCT
easat-1678	210	56	no	no	INTJ
easat-1678	210	57	.	.	NOUN
easat-1678	210	58	3	3	NUM
easat-1678	210	59	,	,	PUNCT
easat-1678	210	60	pp	pp	ADJ
easat-1678	210	61	.	.	PUNCT
easat-1678	211	1	762	762	NUM
easat-1678	211	2	-	-	SYM
easat-1678	211	3	771	771	NUM
easat-1678	211	4	,	,	PUNCT
easat-1678	211	5	2018	2018	NUM
easat-1678	211	6	.	.	PUNCT
easat-1678	212	1	[	[	X
easat-1678	212	2	27	27	NUM
easat-1678	212	3	]	]	X
easat-1678	212	4	al	al	PROPN
easat-1678	212	5	-	-	PUNCT
easat-1678	212	6	thwani	thwani	PROPN
easat-1678	212	7	,	,	PUNCT
easat-1678	212	8	a.	a.	NOUN
easat-1678	212	9	n.	n.	NOUN
easat-1678	212	10	(	(	PUNCT
easat-1678	212	11	2021	2021	NUM
easat-1678	212	12	)	)	PUNCT
easat-1678	212	13	.	.	PUNCT
easat-1678	213	1	evaluation	evaluation	NOUN
easat-1678	213	2	of	of	ADP
easat-1678	213	3	il-17	il-17	NOUN
easat-1678	213	4	,	,	PUNCT
easat-1678	213	5	il-18	il-18	NOUN
easat-1678	213	6	and	and	CCONJ
easat-1678	213	7	il-22	il-22	NOUN
easat-1678	213	8	as	as	ADP
easat-1678	213	9	vital	vital	ADJ
easat-1678	213	10	indicators	indicator	NOUN
easat-1678	213	11	of	of	ADP
easat-1678	213	12	iraqi	iraqi	ADJ
easat-1678	213	13	patients	patient	NOUN
easat-1678	213	14	with	with	ADP
easat-1678	213	15	psoriasis	psoriasis	NOUN
easat-1678	213	16	.	.	PUNCT
easat-1678	214	1	iraqi	iraqi	ADJ
easat-1678	214	2	journal	journal	PROPN
easat-1678	214	3	of	of	ADP
easat-1678	214	4	biotechnology	biotechnology	NOUN
easat-1678	214	5	,	,	PUNCT
easat-1678	214	6	1(20	1(20	NUM
easat-1678	214	7	)	)	PUNCT
easat-1678	214	8	.	.	PUNCT
easat-1678	215	1	[	[	X
easat-1678	215	2	28	28	NUM
easat-1678	215	3	]	]	X
easat-1678	215	4	s.	s.	PROPN
easat-1678	215	5	zeuzem	zeuzem	PROPN
easat-1678	215	6	et	et	PROPN
easat-1678	215	7	al	al	PROPN
easat-1678	215	8	.	.	PROPN
easat-1678	215	9	,	,	PUNCT
easat-1678	215	10	"	"	PUNCT
easat-1678	215	11	sofosbuvir	sofosbuvir	PROPN
easat-1678	215	12	and	and	CCONJ
easat-1678	215	13	ribavirin	ribavirin	NOUN
easat-1678	215	14	in	in	ADP
easat-1678	215	15	hcv	hcv	NOUN
easat-1678	215	16	genotypes	genotype	NOUN
easat-1678	215	17	2	2	NUM
easat-1678	215	18	and	and	CCONJ
easat-1678	215	19	3	3	NUM
easat-1678	215	20	,	,	PUNCT
easat-1678	215	21	"	"	PUNCT
easat-1678	215	22	new	new	PROPN
easat-1678	215	23	england	england	PROPN
easat-1678	215	24	journal	journal	PROPN
easat-1678	215	25	of	of	ADP
easat-1678	215	26	medicine	medicine	NOUN
easat-1678	215	27	,	,	PUNCT
easat-1678	215	28	vol	vol	NOUN
easat-1678	215	29	.	.	PROPN
easat-1678	215	30	370	370	NUM
easat-1678	215	31	,	,	PUNCT
easat-1678	215	32	no	no	INTJ
easat-1678	215	33	.	.	NOUN
easat-1678	215	34	21	21	NUM
easat-1678	215	35	,	,	PUNCT
easat-1678	215	36	pp	pp	ADJ
easat-1678	215	37	.	.	PUNCT
easat-1678	215	38	1993	1993	NUM
easat-1678	215	39	-	-	SYM
easat-1678	215	40	2001	2001	NUM
easat-1678	215	41	,	,	PUNCT
easat-1678	215	42	2014	2014	NUM
easat-1678	215	43	.	.	PUNCT
easat-1678	216	1	[	[	X
easat-1678	216	2	29	29	NUM
easat-1678	216	3	]	]	PUNCT
easat-1678	216	4	a.	a.	PROPN
easat-1678	216	5	r.	r.	PROPN
easat-1678	216	6	mansur	mansur	PROPN
easat-1678	216	7	and	and	CCONJ
easat-1678	216	8	f.	f.	PROPN
easat-1678	216	9	i.	i.	PROPN
easat-1678	216	10	handian	handian	PROPN
easat-1678	216	11	,	,	PUNCT
easat-1678	216	12	"	"	PUNCT
easat-1678	216	13	understanding	understand	VERB
easat-1678	216	14	thalassemia	thalassemia	NOUN
easat-1678	216	15	in	in	ADP
easat-1678	216	16	children	child	NOUN
easat-1678	216	17	:	:	PUNCT
easat-1678	216	18	a	a	DET
easat-1678	216	19	comprehensive	comprehensive	ADJ
easat-1678	216	20	guide	guide	NOUN
easat-1678	216	21	,	,	PUNCT
easat-1678	216	22	"	"	PUNCT
easat-1678	216	23	2024	2024	NUM
easat-1678	216	24	.	.	PUNCT
easat-1678	217	1	[	[	X
easat-1678	217	2	30	30	NUM
easat-1678	217	3	]	]	PUNCT
easat-1678	217	4	ahmed	ahmed	PROPN
easat-1678	217	5	,	,	PUNCT
easat-1678	217	6	a.	a.	PROPN
easat-1678	217	7	k.	k.	PROPN
easat-1678	217	8	,	,	PUNCT
easat-1678	217	9	&	&	CCONJ
easat-1678	217	10	yenzeel	yenzeel	PROPN
easat-1678	217	11	,	,	PUNCT
easat-1678	217	12	j.	j.	PROPN
easat-1678	217	13	h.	h.	PROPN
easat-1678	217	14	(	(	PUNCT
easat-1678	217	15	2017	2017	NUM
easat-1678	217	16	)	)	PUNCT
easat-1678	217	17	.	.	PUNCT
easat-1678	218	1	determination	determination	NOUN
easat-1678	218	2	of	of	ADP
easat-1678	218	3	some	some	DET
easat-1678	218	4	oxidative	oxidative	ADJ
easat-1678	218	5	stress	stress	NOUN
easat-1678	218	6	parameters	parameter	NOUN
easat-1678	218	7	and	and	CCONJ
easat-1678	218	8	antioxidants	antioxidant	NOUN
easat-1678	218	9	in	in	ADP
easat-1678	218	10	sample	sample	NOUN
easat-1678	218	11	of	of	ADP
easat-1678	218	12	iraqi	iraqi	ADJ
easat-1678	218	13	beta	beta	NOUN
easat-1678	218	14	thalassemia	thalassemia	NOUN
easat-1678	218	15	major	major	ADJ
easat-1678	218	16	patients	patient	NOUN
easat-1678	218	17	.	.	PUNCT
easat-1678	219	1	iraqi	iraqi	ADJ
easat-1678	219	2	journal	journal	PROPN
easat-1678	219	3	of	of	ADP
easat-1678	219	4	science	science	NOUN
easat-1678	219	5	,	,	PUNCT
easat-1678	219	6	1	1	NUM
easat-1678	219	7	-	-	SYM
easat-1678	219	8	3	3	NUM
easat-1678	219	9	.	.	PUNCT
easat-1678	220	1	[	[	X
easat-1678	220	2	31	31	NUM
easat-1678	220	3	]	]	PUNCT
easat-1678	220	4	b.	b.	PROPN
easat-1678	220	5	wonke	wonke	PROPN
easat-1678	220	6	,	,	PUNCT
easat-1678	220	7	"	"	PUNCT
easat-1678	220	8	clinical	clinical	ADJ
easat-1678	220	9	management	management	NOUN
easat-1678	220	10	of	of	ADP
easat-1678	220	11	β	β	NOUN
easat-1678	220	12	-	-	PUNCT
easat-1678	220	13	thalassemia	thalassemia	NOUN
easat-1678	220	14	major	major	NOUN
easat-1678	220	15	,	,	PUNCT
easat-1678	220	16	"	"	PUNCT
easat-1678	220	17	in	in	ADP
easat-1678	220	18	seminars	seminar	NOUN
easat-1678	220	19	in	in	ADP
easat-1678	220	20	haematology	haematology	NOUN
easat-1678	220	21	,	,	PUNCT
easat-1678	220	22	2001	2001	NUM
easat-1678	220	23	,	,	PUNCT
easat-1678	220	24	vol	vol	NOUN
easat-1678	220	25	.	.	PROPN
easat-1678	220	26	38	38	NUM
easat-1678	220	27	,	,	PUNCT
easat-1678	220	28	no	no	INTJ
easat-1678	220	29	.	.	NOUN
easat-1678	220	30	4	4	NUM
easat-1678	220	31	:	:	PUNCT
easat-1678	220	32	elsevier	elsevier	X
easat-1678	220	33	,	,	PUNCT
easat-1678	220	34	pp	pp	PROPN
easat-1678	220	35	.	.	PUNCT
easat-1678	221	1	350	350	NUM
easat-1678	221	2	-	-	SYM
easat-1678	221	3	359	359	NUM
easat-1678	221	4	.	.	PUNCT
easat-1678	222	1	[	[	X
easat-1678	222	2	32	32	NUM
easat-1678	222	3	]	]	X
easat-1678	222	4	ibrahim	ibrahim	PROPN
easat-1678	222	5	,	,	PUNCT
easat-1678	222	6	m.	m.	PROPN
easat-1678	222	7	i.	i.	PROPN
easat-1678	222	8	i.	i.	PROPN
easat-1678	222	9	,	,	PUNCT
easat-1678	222	10	&	&	CCONJ
easat-1678	222	11	al	al	PROPN
easat-1678	222	12	-	-	PUNCT
easat-1678	222	13	saffar	saffar	PROPN
easat-1678	222	14	,	,	PUNCT
easat-1678	222	15	j.	j.	PROPN
easat-1678	222	16	m.	m.	PROPN
easat-1678	222	17	(	(	PUNCT
easat-1678	222	18	2018	2018	NUM
easat-1678	222	19	)	)	PUNCT
easat-1678	222	20	.	.	PUNCT
easat-1678	223	1	serum	serum	NOUN
easat-1678	223	2	level	level	NOUN
easat-1678	223	3	evaluation	evaluation	NOUN
easat-1678	223	4	of	of	ADP
easat-1678	223	5	interleukin-18	interleukin-18	PROPN
easat-1678	223	6	in	in	ADP
easat-1678	223	7	obese	obese	ADJ
easat-1678	223	8	women	woman	NOUN
easat-1678	223	9	with	with	ADP
easat-1678	223	10	polycystic	polycystic	ADJ
easat-1678	223	11	ovary	ovary	ADJ
easat-1678	223	12	syndrome	syndrome	NOUN
easat-1678	223	13	.	.	PUNCT
easat-1678	224	1	iraqi	iraqi	ADJ
easat-1678	224	2	journal	journal	PROPN
easat-1678	224	3	of	of	ADP
easat-1678	224	4	science	science	NOUN
easat-1678	224	5	,	,	PUNCT
easat-1678	224	6	1989	1989	NUM
easat-1678	224	7	-	-	SYM
easat-1678	224	8	1994	1994	NUM
easat-1678	224	9	.	.	PUNCT
easat-1678	225	1	[	[	X
easat-1678	225	2	33	33	NUM
easat-1678	225	3	]	]	PUNCT
easat-1678	225	4	v.	v.	ADP
easat-1678	225	5	m.	m.	NOUN
easat-1678	225	6	pinto	pinto	NOUN
easat-1678	225	7	and	and	CCONJ
easat-1678	225	8	g.	g.	PROPN
easat-1678	225	9	l.	l.	PROPN
easat-1678	225	10	forni	forni	PROPN
easat-1678	225	11	,	,	PUNCT
easat-1678	225	12	"	"	PUNCT
easat-1678	225	13	management	management	NOUN
easat-1678	225	14	of	of	ADP
easat-1678	225	15	iron	iron	NOUN
easat-1678	225	16	overload	overload	NOUN
easat-1678	225	17	in	in	ADP
easat-1678	225	18	beta	beta	NOUN
easat-1678	225	19	-	-	PUNCT
easat-1678	225	20	thalassemia	thalassemia	NOUN
easat-1678	225	21	patients	patient	NOUN
easat-1678	225	22	:	:	PUNCT
easat-1678	225	23	clinical	clinical	ADJ
easat-1678	225	24	practice	practice	NOUN
easat-1678	225	25	update	update	NOUN
easat-1678	225	26	based	base	VERB
easat-1678	225	27	on	on	ADP
easat-1678	225	28	case	case	NOUN
easat-1678	225	29	series	series	NOUN
easat-1678	225	30	,	,	PUNCT
easat-1678	225	31	"	"	PUNCT
easat-1678	225	32	international	international	ADJ
easat-1678	225	33	journal	journal	NOUN
easat-1678	225	34	of	of	ADP
easat-1678	225	35	molecular	molecular	ADJ
easat-1678	225	36	sciences	science	NOUN
easat-1678	225	37	,	,	PUNCT
easat-1678	225	38	vol	vol	NOUN
easat-1678	225	39	.	.	PROPN
easat-1678	225	40	21	21	NUM
easat-1678	225	41	,	,	PUNCT
easat-1678	225	42	no	no	INTJ
easat-1678	225	43	.	.	NOUN
easat-1678	225	44	22	22	NUM
easat-1678	225	45	,	,	PUNCT
easat-1678	225	46	p.	p.	NOUN
easat-1678	225	47	8771	8771	NUM
easat-1678	225	48	,	,	PUNCT
easat-1678	225	49	2020	2020	NUM
easat-1678	225	50	.	.	PUNCT